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ABSTRACT 
 
Peterson, Brent Michael. Effects of a Twelve-Week Aerobic and Cognitive Training 
Intervention on Cognitive Function in Cancer Survivors. Published Doctor of 
Philosophy, University of Northern Colorado, 2015. 
 
Chemotherapy-related cognitive impairment (CRCI) has been reported to negatively 
affect upwards of 75% of cancer patients. Decreased reaction times, cognitive and 
linguistic inabilities, decreased quality of life (QOL), decreased concentration and 
memory, and attentional difficulties may be due to CRCI. Exercise and cognitive 
training, independently, have been shown to improve functional capacity and aspects of 
cognitive function in various populations. However, to our knowledge there have been no 
studies that have examined the effects of aerobic and cognitive training on cognitive 
function in cancer survivors. Purpose: To examine the effects of a quasi-randomized, 
controlled 12-week or 36 session aerobic and cognitive intervention on cancer survivors 
(CAN) versus non-cancer participants (NC). Methods: CAN (n = 28) who were in 
treatment or had completed treatment within eight weeks and NC (n = 7) were included 
in this study. Pre and post physical and cognitive assessments, Beck Depression, QOL, 
and Piper fatigue inventories were completed. Following initial assessments, a 12-week 
computer-based cognitive training and flexibility training intervention was conducted. 
CAN participants were assigned to aerobic, flexibility, and cognitive training (CAN-
AER-COG), aerobic and flexibility training (CAN-AER), flexibility training only (CAN-
CON), or cognitive and flexibility (CAN-COG) training groups. The apparently healthy 
group completed aerobic, flexibility, and cognitive training (NC-CON). Results: No 
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significant (p > 0.05) main effects were observed between groups for all variables of 
interest. Wilcoxon sign ranks tests revealed significant improvements among within-
group measures. The AER-CAN-COG significantly (p < 0.05) decreased (-33%) in the 
Piper B subcategory. The CAN-AER group significantly (p < 0.05) increased in measures 
of logical memory raw and scaled scores (28%, 33%, respectively), delayed recall raw 
and scaled scores (39%, 27%, respectively, p < 0.05), block design raw and scaled scores 
(20%, 19%, respectively, p < 0.05), and letter-number sequencing scaled scores (12%, p 
< 0.05). Piper S scores significantly (34%, p < 0.05) decreased while the Piper C subscale 
trended toward significant (p = 0.06) decreases (26%). The CAN-CON group 
significantly (p < 0.05) increased in gender, age, and education verbal fluidity scores 
(750%, 320%, and 205%, respectively). VO2peak trended toward significant increased, 
while QOL significantly increased (16%, p = 0.05; and 26%, p < 0.01, respectively). The 
NC-CON group delayed recall scaled scores trended toward significant increases (12%, p 
= 0.07). The CAN-COG group failed to significantly (p < 0.05) increase in any measure 
of cognitive function. Beck depression significantly (p < 0.05) decreased (-59%) and 
QOL significantly (p < 0.05) increased (6%). Conclusion: Aerobic training impacted 
cognitive, physiological, and psychosocial measures the greatest. Individually, cognitive 
training and flexibility training resulted in notable cognitive, physiological, and 
psychosocial improvements. Yet, the combined cognitive, aerobic, and flexibility training 
failed to produce the synergistic and compounded results as hypothesized. Results 
suggest that, individually, aerobic, cognitive, and flexibility training are appropriate for 
addressing CRCI in this population, but combined training of this nature may actually be 
too demanding for those undergoing treatment.
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CHAPTER I 
 
INTRODUCTION 
 
Cancer patients experience a multitude of various physical, emotional, and 
psychological effects during and following chemotherapy. Despite the substantial 
methodological improvements, the positives are matched with sometimes debilitating 
negative side effects. Of the many different side effects that may occur with treatment, 4-
75% of patients have been estimated to experience some form of cognitive dysfunction 
following treatment (Jackson, 2008; Konat, Kraszpulski, James, Zhang, & Abraham, 
2008; Myers, 2009; Raffa & Tallarida, 2010). Staat and Segatore (2005) reported that 
cognitive impairment associated with chemotherapy treatment has been often described 
as “chemo-fog” or “chemo-brain;” however, it has more recently been defined as 
chemotherapy-related cognitive impairment (CRCI) (Myers, 2009; Wefel, Lenzi, 
Theriault, Davis, & Meyers, 2004). A formal definition of cognitive function is cognitive 
action in the everyday world. It is multifaceted, being composed of attention, language, 
learning and memory, visual-spatial processing, executive skills, and reasoning (La Rue, 
2010). It (CRCI) has been described as presenting itself as impaired speed of processing 
information or reaction time, cognitive inability, and diminished organizational skills, as 
well as decreased linguistic abilities, and attention (Staat & Segatore, 2005). In addition, 
executive function, described as foresight, hindsight, and judgment may also be 
negatively impacted. 
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Chemotherapy-related cognitive impairment has been reported to negatively 
affect patients’ quality of life (QOL), impact daily living activities, impair memory and 
concentration, and may persist long after completion of treatment (Carlsson, Strang, & 
Bjurstrom, 2000; Mitchell & Turton, 2011; Schilling, Jenkins, Morris, Deutsh, & 
Bloomfield, 2005). Patients have also described CRCI as forgetfulness, 
absentmindedness, and an inability to focus while performing daily tasks (Hess & Insel, 
2007).  
Three potential mechanisms have been proposed to help illuminate the 
mechanisms of CRCI. These are immunologic or inflammatory toxicity, direct 
neurotoxicity, or micro-vascular toxicity (Saykin & Ahles, 2003). Proliferating cells are 
targeted by chemotherapy, and these drugs (such as 5-fluorouracil) are able to cross the 
blood-brain barrier, and collect in cerebral-spinal fluid (Bourke, West, Cheda, & Tower, 
1973; Kerr, Zimm, Collins, O’Neill, & Poplack, 1984). Chemotherapy-related cognitive 
impairment memory deficits may be due to direct toxicity on neurogenic zones such as 
the denate gyrus of the hippocampus (Mustafa, Walker, Bennett, & Wigmore, 2008). 
More recent evidence suggests that CRCI may be linked to cytotoxic agents releasing 
excessive cytokines contributing to toxic collateral damage to healthy tissue, potentially 
disrupting cognitive performance (Raffa, 2011).   
 In human and animal chemotherapeutic treatment models, investigators have 
demonstrated decrements in short-term memory and high order brain function (Konat et 
al., 2008), memory acquisition impairment (Liedke et al., 2009), learning and memory 
impairment (Schilling, Jenkins, Morris, Deutsh, & Bloomfield, 2005; Winocur, Vardy, 
Binns, Kerr, & Tannock, 2006), spatial memory, neutrotrophic protein, neurogenic 
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protein, vascular proliferating cell dysfunction (Mustafa et al., 2008), contextual memory 
dysfunction (Macleod et al., 2007), verbal and working memory impairment (Schilling, 
Jenkins, Morris, Deutsh, & Bloomfield, 2005), decreases in cerebral white matter, 
processing speed (Deprez et al., 2011), and decreases in attention/concentration scores 
(Yoshikawa et al., 2005). 
It has been well established that exercise has been positively associated with 
increases in cardiopulmonary function, resting heart rate, pulmonary function, forced 
vital capacity (FVC), upper-body muscular endurance, lower-body muscular endurance, 
core muscular endurance and flexibility, as well as reductions in behavioral, sensory, 
affective, cognitive and mood, total fatigue scores, and reductions in inflammation in 
apparently healthy populations (Fairey et al., 2005; Hsieh et al., 2008; Schneider, Hsieh, 
Sprod, Carter, & Hayward, 2007a; Schneider, Hsieh, Sprod, Carter, & Hayward, 2007b; 
Schneider, Hsieh, Sprod, Carter, & Hayward, 2007c; Van Weert et al., 2010). 
Furthermore, investigators have also demonstrated that aerobic exercise and cognitive 
training may increase QOL and cognitive function in apparently healthy adults, cancer 
survivors, and Alzheimer’s patients (Ferguson et al., 2007a; Potter, & Keeling, 2005; 
Wood, Alvarez-Reyes, Maraj, Metoyer, & Welsh, 1999), increase cognitive control and 
attention (Hillman et al., 2009), improve cognitive function and recall (Lautenschlager et 
al., 2008), and increase mental speed, memory, reaction time, attention, and cognitive 
flexibility (Masley, Roetzheim, & Gualtieri, 2009). In addition, during brain-based 
cognitive training studies using Posit-Science®, a commercially available home brain 
training software, investigators have demonstrated improvements on auditory processing 
speed, self-reported everyday cognitive skills, memory performance, increases in speed 
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and accuracy of central auditory system, and benefits potentially lasting well beyond the 
training interventions (Mahncke, Bronstone, & Merzenich, 2006; Mahncke et al., 2006; 
Smith, et al., 2009). However, to our knowledge, there were no current studies that had 
examined a combined exercise and cognitive intervention on measures of cognitive 
function in a cancer rehabilitation population.  
Statement of Purpose 
 Therefore, the purpose of this study was to examine the effects of a quasi-
randomized, controlled 12-week aerobic and cognitive intervention on cancer survivors 
(CAN) versus non-cancer participants (NC).    
Research Hypotheses 
H1  Aerobic training consisting of moderate intensity cycling on a stationary 
cycle ergometer would increase measures of cognitive function in CAN. 
 
H2 Cognitive training using computer software consisting of brain training 
exercises would increase measures of cognitive function in CAN. 
 
H3 The combined cognitive and aerobic training would have a synergistic 
effect on increases in cognitive function in CAN. 
 
Significance of Study 
 Cancer is a staggering disease. Global estimates have revealed that approximately 
12.7 million people were diagnosed with cancer as of 2008 (Jemal, Bray, Center, Ferlay, 
Ward, & Forman, 2011). The efforts to treat the disease are often times accompanied by 
varying degrees and severity to which treatment-related side effects may occur. In the 
war on cancer, the patient is often prescribed treatment modalities that may affect 
physical, psychological as well as cognitive abilities of the individual. The phenomenon 
of cognitive dysfunction related to chemotherapeutic treatment, commonly known as 
“chemo brain” or “chemo fog” may present considerably different among individuals. 
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Regardless, there is substantial information to suggest that certain areas of the brain are 
affected by current methods of treatment for cancer. The mission of cancer rehabilitation 
at The Rocky Mountain Cancer Rehabilitation Institute (RMCRI) is to relieve suffering, 
promote self-sufficiency, improve quality of life, and eliminate secondary cancers and 
cancer recurrence for cancer survivors through prescriptive exercise and nutrition 
evidence-based interventions. By implementing methods of aerobic exercise, flexibility, 
and cognitive training using a specifically designed software program to target areas of 
the brain most affected by treatment, not only will the mission be upheld, but this 
approach to cancer rehabilitation is completely novel. To our knowledge there were no 
other quasi-randomized or controlled studies conducted using specific cognitive training 
interventions combined with elements of exercise on cancer survivors in a cancer 
rehabilitation program.    
Limitations 
 Although the novelty of this project was the major strong point of this study, 
much akin to many studies throughout history, many unforeseen limitations presented 
themselves throughout the course of data collection. The limitation with the most 
noteworthy influence on the process of data collection was the complexity of cancer 
itself. When clients are referred to the RMCRI, they may present at very different time 
points along the cancer continuum. We had participants who initially qualified for the 
study but presented at different stages, types of cancer, types of treatment, combinations 
of types of treatment and stages, and experienced a multitude of physiological and 
psychological responses to the treatment itself. Despite working with cancer survivors 
since 2008, having immersed myself in the literature, and having a modicum of 
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expectations, most participants presented with a combination of factors that forced 
reevaluation on an individual and frequent basis. For example, a particular participant 
(who was prescreened and met qualification standards for this study) was undergoing 
treatment for stage III brain cancer and would often have moments where she would 
randomly cease talking, slow or stop cycling, and appear to be awake, but not coherent. It 
was determined that because of her type of cancer, treatment, and being on frequently 
oscillating dosages of GABApentin that this was something that needed to be addressed 
on a daily basis, but did not fit the requirements for removal from the study. Throughout 
the study she continued to improve, but because of her particularities, we had to make 
appropriate adjustments in order to accommodate her needs. In addition, treatment-
related side effects were also a source of difficulty. Since many were undergoing 
treatment, dosages and regimens often changed, and because many times participants, 
especially those who were undergoing treatment, often did not feel well enough to 
complete physical or cognitive training to the exact specifications of the study. When the 
study began in 2010, the process of referral from local oncologists predominantly 
included those that had just completed treatment or were upwards of eight weeks out of 
treatment. As the study progressed, the amount of referrals of clients that were currently 
undergoing treatment continued to increase to a point where those who were out of 
treatment were seldom observed. In light of the individual experiences with treatment, 
often times training had to be reduced to a comparable rate of perceived exertion (RPE) 
just so ambitious clients who were so worn out from treatment in the preceding days 
could complete the training without harming themselves. Medical emergencies, 
recurrence, inclement weather, holidays, or last minute appointment changes with 
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physicians were also significant factors in the delay of completing this study. For 
example, a particular client that, again was prescreened and qualified for the study, had a 
medical emergency where he contracted an infection near an incision site and 
consequently was admitted to the hospital for a month. Even though the requirements 
were explicitly conveyed prior to the start of the study, it is almost impossible with this 
population to expect perfect adherence. For example, all participants in the study had 
work or family-related situations which inhibited them from making all training sessions. 
In addition, participants included during the fall semesters were often the most difficult to 
complete because of the amount of family holidays that occur from late October until 
after January. Furthermore, clients dropping the study for health-reasons was also a factor 
that inhibited the completion of this study within the confines of the proposed timeline. 
Small sample sizes were a substantial limitation in this study for both the CAN and NC 
groups. Had the proposed amount of subjects refrained from withdrawal from this study, 
group differences may have been more pronounced. Yet, many participants did withdraw, 
which forced the alterations in statistical analyses. In fact, for the N of 35 that was 
completed and considered for this analysis, a total of 11 participants dropped the study at 
some point between 2010 and 2014. Furthermore, not all participants completed every 
single assessment variable of interest in this study. Consequently, data imputation 
methods were employed to explain approximately 1.3% of cognitive data and 3.6% of 
physiological and psychosocial data. This is reported in greater detail in the methods 
section. Finally, with the many other factors that acted as barriers to the completion of 
this study, death of participants because of cancer was also a factor that, sorrowfully, 
occurred for a couple of people directly following their involvement in the study. One 
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participant in particular passed away from brain cancer during the course of the study. 
Taken together, the results of this study should be interpreted with caution.  
Assumptions 
 This study was based on the assumptions that participants would follow the 
instructions for maintaining normal activities of daily living (ADL) and not be involved 
with any other forms of physical exercise beyond what was administered during the 
study. With respect to the condition of each individual as cancer survivors, all 
participants were screened via a preliminary phone conversation for health-related 
conditions that would have been considered detrimental to the outcomes of the study and 
therefore were considered in relatively good health pending completion of a physical 
assessment. Participants were also prescreened for cognitive impairments and tested for 
sound mental status via Mini Mental Status Examination (MMSE) and were, therefore, 
considered mentally capable to participate in this study.     
Definition of Terms 
Cancer: A group of diseases characterized by uncontrolled growth and spread of 
abnormal cells (American Cancer Society, 2014).  
Executive Control/Function: A subset of multiple procedures including: planning, 
working memory, scheduling, task coordination, and interference control 
(Hillman et al., 2006). 
 
Non Matching to Sample testing: A series of paired sample and test trials focused on 
object recognition and non-spatial memory testing. The stimulus for the testing 
consists of a series of suspended cylinders above a water maze where rodents 
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must recognize familiar objects when placed in novel areas while being timed 
(Winocur et al., 2006).  
Cognitive Function: Cognitive action in the everyday world. It is multifaceted, being 
composed of attention, language, learning and memory, visual-spatial processing, 
executive skills, and reasoning (La Rue, 2010). 
Anisotropy: Diffusion that is dependent on direction (Beaulieu, 2002). 
Morris Water Maze Test: Test of reference memory depending on functional integrity of 
rodent hippocampal tissue (Morris, Garrud, Rawlins & O’Keefe, 1982). 
Brain derived neurotropic factor (BDNF): Reported to be involved in neurogenesis 
cultivation, learning, and memory (Mustafa et al., 2008).    
Dentate Gyrus: Region of brain located within the hippocampus reported to be associated 
with neuronal proliferation and neurogenesis (Mustafa et al., 2008).  
Ovariectomized: Surgical removal of one or both ovaries (Macleod et al., 2007) 
Hippocampus: Limbic system component with the amygdala. The location of the 
hippocampus is composed of the medial aspect of the temporal lobe. Bilateral 
brain damage may inhibit new memory acquisition and retention; however, pre 
tissue insult memories may remain. Limbic structures have been reported to aid in 
the consolidation of memories but not storage (Marieb and Mallatt, 1997).   
Praxis: The ability to carry out learned or purposeful action. 
 
List of Abbreviations 
WMS IV BCOG: Weschler Memory Scale (4th Ed.) general cognitive screener. 
WMS IV LMI Raw: Weschler Memory Scale (4th Ed.) Logical Memory I raw score.  
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WMS IV LMI Scaled: Weschler Memory Scale (4th Ed.) Logical Memory I scaled score. 
WMS IV LMII DR Raw: Weschler Memory Scale (4th Ed.) Logical Memory II delayed 
recall raw score. 
WMS IV LMII DR Scaled: Weschler Memory Scale (4th Ed.) Logical Memory II delayed 
recall scaled score. 
WMS IV LMIICP Raw: Weschler Memory Scale (4th Ed.) Logical Memory II cumulative 
percentage raw score. 
TMT A Raw: Trail Making Test A raw score. 
TMT B Raw: Trail Making Test B raw score. 
WAIS IV BD Raw: Weschler Adult Intelligence Scale (4th Ed.) Block Design raw score. 
WAIS IV BD Scaled: Weschler Adult Intelligence Scale (4th Ed.) Block Design scaled 
score. 
WAIS IV LNS Raw: Weschler Adult Intelligence Scale (4th Ed.) Letter Number Sequence 
raw score. 
WAIS IV LNS Scaled: Weschler Adult Intelligence Scale (4th Ed.) Letter Number 
Sequence scaled score. 
WAIS IV CD Raw: Weschler Adult Intelligence Scale (4th Ed.) Coding raw score. 
WAIS IV CD Scaled: Weschler Adult Intelligence Scale (4th Ed.) Coding scaled score. 
COWAT Z G: Controlled Oral Word Association Test gender z-score. 
COWAT Z A: Controlled Oral Word Association Test age z-score. 
COWAT Z ED: Controlled Oral Word Association Test education z-score. 
SBP: Systolic blood pressure. 
DBP: Diastolic bold pressure. 
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RHR: Resting blood pressure. 
VO2peak: The highest rate of oxygen consumption measured during the exercise test, 
regardless of whether a VO2 plateau is reached.  
SANDR: Sit and Reach test.  
PIPER I: Piper Fatigue Index overall score. 
PIPER B: Piper Fatigue Index behavioral score. 
PIPER A: Piper Fatigue Index affective score. 
PIPER S: Piper Fatigue Index sensory score.  
PIPER C: Piper Fatigue Index cognitive/mood score.  
BECK: Beck Depression Inventory score.  
QOL: Quality of Life score.  
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CHAPTER II 
 
REVIEW OF LITERATURE 
  
Cancer Overview  
On a global scale, cancer is a substantial health concern. From a fiscal standpoint, 
by 2020 it is projected that direct annual costs of cancer will skyrocket from 
approximately $104 billion in 2006 to over $173 billion (Smith & Hillner, 2011). From 
an overall healthcare standpoint, cancer has been described as being multifaceted, having 
multiple, considerable factors to be aware of when approaching the topic. The American 
Cancer Society (ACS), in Cancer Facts & Figures 2014, described the postulated causes 
of cancer as being composed of potentially several internal and external factors. The 
internal factors may be composed of one or a combination of inherited and/or metabolic 
mutations, and compromised hormonal and/or immune function. External factors may 
include exposure to: chemicals, radiation, infectious organisms, and/or tobacco products. 
It is estimated that a total of 1,665,540 new cases of cancer were expected to be 
diagnosed in the United States in 2014 (ACS, 2014). The probability, in one’s lifetime, of 
being diagnosed with some form of invasive cancer is 44% and 38% for males and 
females, respectively (Siegal, Naishadham, & Jemal, 2013). In addition, 585,720 people 
are also projected to succumb to the disease, with as many as 1600 people expected to 
perish each day.
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Approximately one third (195,240) of the 585,720 deaths will be related to obesity, poor 
nutrition, and inactive lifestyles, which could be considered preventable occurrences. 
Behind heart disease, cancer is the second leading cause of death (ACS, 2014; Siegal et 
al., 2013). As disparaging as those numbers sound, Kohler et al. (2011) indicated that in 
data collected from 1975-2007, overall cancer incidence and mortality rates have 
decreased 1% across all races. More recent data (2005-2009) have indicated that 
incidence numbers across all races have maintained at 1% however, death rates have 
decreased 1.8% per year in men, and 1.5% per year in women, with the noted exception 
of Native Americans and Alaska Natives. These reductions have been attributable to, 
what was described as, “avoidances” of 1,180,000 deaths from cancer in the United 
States, since 1990 (Siegal et al., 2013). The five-year relative survival rate for all cancers 
diagnosed between 2002 and 2009 is 68%, up from 49% from 1975-1977 (ACS, 2014). 
In addition, our laboratory also found specifically individualized cancer rehabilitation 
interventions to be associated with significant increases in five-year survival rates 
(Peterson, Repka, Hayward, & Schneider, 2010). These witnessed reductions in death and 
increased five-year survival rates may be attributable to current progressive methods of 
prevention, detection, education, improved precision of treatment methods, as well as 
increased implementation of individualized cancer rehabilitation programs.  
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Effects of Chemotherapy on the Brain 
In recent years, chemotherapeutic interventions have been instrumental in 
contributing to the survival and clinical outcomes of cancer patients. The positive effects 
that are witnessed with chemotherapy and associated cancer treatments are often matched 
or exceeded by the many different types of negative side effects. During the past two 
decades, notoriety has advanced within the body of literature regarding attention and 
memory decrements associated with chemotherapy treatment (Ferguson, Cassel, & 
Dawson, 2010). Approximately 77% of all cancer(s) diagnosed generally occur among 
those who are 55 years of age or older (ACS, 2014). With the combination of advances in 
detection and treatment methods, it is likely that more people will be either living with 
cancer, have been diagnosed and are residing within the treatment spectrum, or are 
beyond the process. Matsuda et al. (2005) reported that at least 10-40% of breast cancer 
survivors may experience various gradations of cognitive deficits when returning to their 
daily lives, negatively affecting QOL. With regards to cognitive difficulties witnessed 
during and following various chemotherapeutic treatments, there is an increasing demand 
to address this matter of survivorship and develop methods to better approach the issue, 
whether that be symptom management or rehabilitation to reduce, or offset some of the 
witnessed side effects, has yet to be determined.  
Cognitive dysfunction or impairment that is associated with chemotherapy 
treatment has been reported in the literature as far back as the early 1980’s. During 
various neuropsychological assessments, chemotherapy treatment has been indicated to 
negatively affect anxiety, stress, and depressive symptoms. Each having been observed in 
various extents in cancer patients, and have been suggested to adversely influence these 
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cognitive testing measures (Ferguson et al., 2010). In addition, during the early 1990’s a 
substantial portion of the literature was focused on elements of sustained attention and 
working memory and how they are affected by various chemotherapeutic agents. Of the 
more prominent investigations on the topic, Van Dam et al. (1998) examined levels of 
cognition in high-risk breast cancer patients receiving standard or high dosages of 
chemotherapy. Thirty-two percent of the high dosage group and 17% of the standard 
dosage group exhibited significantly noticeable measures of cognitive dysfunction, as 
compared to 9% witnessed in the control group; this indicates a greater risk of cognitive 
impairment with increasing dosages of chemotherapy. However, the observed 
psychological and cognitive dysfunction by the investigators was attributed to emotional 
distress as opposed to direct or indirect effects of chemotherapy (Van Dam et al., 1998). 
In retrospect, Ferguson et al. (2010) elucidated that the compilation of CRCI literature 
during the 1990’s could be considered an establishment of the functional relationship 
between chemotherapy dosage and observed cognitive dysfunction. When chemotherapy 
dosage increased, so did the level to which cognitive dysfunction was observed or 
experienced.  
Chemotherapy and the intended toxicities on cancer cells, unfortunately have 
inadvertent effects on healthy cells (Raffa, 2011). In addition, these observed toxicities 
have been speculated to elicit extensive collateral damage to healthy tissue, as well as 
components of the central and peripheral nervous systems. Of those who have 
experienced chemotherapy-related side effects, an estimated 4-75% of patients 
experience some form of cognitive dysfunction following treatment (Jackson, 2008; 
Konat et al., 2008; Myers, 2009; Raffa & Tallarida, 2010). Therefore, understanding 
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CRCI is an important aspect to cancer rehabilitation. More recent evidence may suggest 
that these cognitive dysfunctions may be related to excessive cytokine release by 
cytotoxic agents, inflammatory issues, or direct neurotoxicity.  
Cognitive Functioning 
 La Rue (2010) formally defined general cognitive functioning as daily cognition 
in action. Furthermore, language, executive functioning, learning, memory, visuo-spatial 
processing, and attention have been described as components of cognitive functioning. It 
is possible for individuals to classify as “fit” in certain areas like language and attention 
but may be less fit in other areas like learning or executive functioning (La Rue, 2010). 
Individuals with optimal brain fitness levels should be absent of brain disease or systemic 
illness that may critically disrupt normal brain function. Although, La Rue (2010) 
suggested that brain fitness may be impacted by genetic predispositions, endowments, 
lifestyle choices, and life experiences thereby making the task of monitoring brain fitness 
difficult to quantify. 
In elderly breast cancer patients, Wefel, Saleeba, Buzdar, and Meyers (2010) 
examined the effects of pre-existing cognitive impairments prior to administration of 
treatment. The investigators measured affective status, QOL, and cognitive function 
before and after treatment. Wefel et al. (2010) determined that although 21% of patients 
were cognitively impaired prior to treatment, 65% of the sample exhibited significant 
declines in measures of learning, memory, executive function, and processing speed in 
analyses following treatment. Sixty-one percent experienced cognitive decline, with 30% 
displaying onset of previously unobserved cognitive impairments (Wefel et al., 2010). 
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Therefore, it may be worthwhile to consider that there may be a compounding effect of 
CRCI and pre-existing cognitive dysfunction witnessed in elderly cancer patients.   
As of 2005, 925 million people across the globe were estimated to be 55 years of 
age or older. By 2015 this cohort is expected to increase to 1.4 billion people (Angevaren, 
Aufdemkampe, Verhaar, Aleman, & Vanhees, 2008). Research has indicated that age-
related cognitive declines involving processing and working speed, and short and long-
term memory are related to changes in brain structure and function (Hillman et al., 2006). 
In older adults, who have not had cancer, it is estimated that 3-19% will have experienced 
various elements of mild cognitive impairment which may be characterized by impaired 
performance on memory tasks and memory complaints (Belleville et al., 2006).  
Pre-dispositional engagement has been defined as the relatively stable mental disposition 
toward the enjoyment of a novel task, intellectual challenge, and creativity (Parisi, Stine-
Morrow, Noh, & Morrow, 2009). In the investigation of relationships between the 
approaching of experiences in a mindful and creative way, cognition, and activity of 
participation in older adults, Parisi et al. (2009) administered a battery of neuro-
psychological tests that evaluated processing speed, working memory, inductive 
reasoning, visuo-spatial processing, activity level, divergent thinking, and mental 
engagement predisposition. Factor analyses were then run on data collected from the 
neuropsychological tests to evaluate dimensions of engagement in various activities.  
These dimensions were also compared to overall cognition. The investigators found that 
performance on cognitive assessments could be explained, in part, by level of enjoyment 
and preference toward intellectually stimulating challenges. In particular, older adults 
who engaged in intellectually challenging activity tended to approach life experiences 
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with greater levels of creativity, thoughtfulness, and curiosity than their counterparts. 
Additionally, these older adults appeared to maintain healthy levels of lifetime cognitive 
functioning, which was a positive factor for cognitive vitality throughout life. Belleville 
et al. (2006) assessed a two-month cognitive training intervention with older adults 
experiencing mild cognitive impairment against older adults with normal levels of 
cognitive aging. The training included addressing episodic memory performance through 
mnemonics and semantic elaboration. The investigators found that the aforementioned 
cognitive training produced positive and long-lasting effects in healthy older adults’ 
cognitive performance.  
Age-associated cognitive losses may be substantially ameliorated by physical 
activity. Hillman et al. (2006) assessed primarily the executive control component of 
cognition function related to physical activity in 241 participants ranging from 15-71 
years of age. The investigators evaluated physical activity by self-reported number of 
walked city blocks and estimated caloric expenditure. Executive control was defined as 
being a subset of multiple procedures including: planning, working memory, scheduling, 
task coordination, and interference control. These processes were reported to have an 
involvement in the intentional component of interaction with the environment, which 
may also decline with age. However, physical activity may serve to protect against losses, 
with the greatest benefits witnessed in some aspect of executive control. The results 
indicated that response accuracy (% correct) increased as amount of physical activity 
(days per week) increased across all conditions for older adults [(congruent condition) 0, 
88%; 1, 92%, 2, 93%, 3, 95%, and 4, 97%, p < 0.05], [(incongruent condition) 0, 65%, 1, 
81%, 2, 82%, 3, 86%, and 4, 88%, p < 0.05]. For the older adults, greater levels of 
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physical activity were associated with performance on tasks eliciting greater accuracy of 
responses. There were no significant (p >0.05) associations between physical activity and 
accuracy of responses for the younger adults [(congruent condition) 0, 97%, 1, 95%, 2, 
97%, 3, 97%, and 4, 96%], [(incongruent condition) 0, 88%, 1, 90%, 2, 86%, 3, 91%, and 
4, 85%]. No differences were observed between the groups for task conditions containing 
smaller executive control components, suggesting that aerobic fitness may selectively 
protect against cognitive aging on tasks requiring extensive executive control. The 
investigators concluded that physical activity may be beneficial to cognition during early 
and middle periods of the human life span and may continue to protect against age-
related loss of cognitive abilities during older adulthood (Hillman et al., 2006).  
In a review of literature, Angevaren et al. (2008) examined studies that 
incorporated fitness, cognitive functioning, and physical activity in sample populations 
reporting ages of participants greater than 55 years. The analysis of literature revealed 
significantly positive effects of exercise on cognitive speed, delayed memory functions, 
and visual attention as compared interventions other than listed [(SMD random effects-
cognitive speed) 0.3, 95% CI (0.04, 0.5), p < 0.05, (SMD random effects-visual attention) 
0.3, 95% CI (0.02, 0.5), p < 0.05). In studies that compared aerobic training interventions 
to balance or flexibility programs, the positive effects of aerobic exercise were 
significantly greater in delayed memory functions, than balance or flexibility alone. As 
compared to no intervention (controls) the effects of aerobic exercise on cognitive 
function yielded significant positive effects on auditory attention [(WMD random effects) 
0.5, 95% CI (0.1, 0.9), p < 0.01) and motor function (WMD random effects 1.2, 95% CI 
(0.2, 2.2), p < 0.05). In a majority of the studies, improved VO2max values of 
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approximately 14% were also linked to improvements in cognitive function; specifically, 
improvements in cognitive speed, delayed memory recall, observed motor function, and 
auditory and visual attention capabilities. 
Mechanisms of Cognitive Dysfunction 
 In a review of literature, Ahles and Saykin (2007) stated that risk factors for the 
development of cancer and CRCI have been suggested as being composed of shared 
genetic risk factors which may include low efficiency efflux pumps, dysfunctional DNA 
repair mechanisms, and immune response incapacitation. The combined systemic effects 
of chemotherapy and the aforementioned shared genetic risk factors may pose as 
negatively compounding contributors to cognitive decline in patients following 
chemotherapy. Changes in cognitive abilities may present subtly and may occur at a 
range of gradations across various domains of cognition. Ahles and Saykin (2007) 
elaborated on the primary model of classical thought regarding cognitive dysfunction 
following chemotherapy. Treatment itself was suspected to be a secondary or tertiary 
factor originating from psychological complexities such as anxiety, fatigue, or 
depression. In studies implementing brain imaging techniques, the investigators indicated 
volumetric alterations in brain tissue have been associated with chemotherapy dosage. In 
addition, the investigators described that some studies have even shown that white matter 
integrity and volumes of brain constituencies profoundly involved in cognitive function 
have been observed to reduce in patients who have undergone chemotherapy. Ahles and 
Saykin (2007) also noted that within the realm of normal central nervous system function, 
cytokines play a substantial role in the modulation of glial and neuronal functioning, 
metabolism of dopamine and serotonin, and neural repair. The neurotransmitters 
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serotonin and dopamine play an important role in normal cognitive functioning, and have 
been associated with neurotoxicity and neurodegenerative disorders such as Parkinson’s 
disease, Multiple Sclerosis, and Alzheimer’s disease. Furthermore, cytokine induced 
“sickness behavior” is also associated with cognitive disturbance, fatigue and depression 
separate from cancer occurrence (Ahles & Saykin, 2007).   
More recent literature has expanded on the concept that certain cytokines, 
specifically IL-1β, IL-6, and TNF-α play a significant role in complex cognitive 
processes, such as synaptic plasticity, neuro-genesis, and neuro-modulation. McAfoose 
and Baune (2009) indicated that cytokine-mediated cognitive processes may substantially 
facilitate the pathogenesis and long term development of specific neuropsychiatric 
disorders such as depression and dementia. Identification of this central role in various 
brain activities illuminates the mechanisms of brain function and elaborates on biological 
mechanisms, especially synaptic plasticity, memory, and cognition. McAfoose and 
Baune, (2009) referred to cognition as the combination of collective processes, such as 
attention, learning, executive function, memory, language, and consciousness. Of these 
cognitive processes, much of the research has centered on memory and learning. 
Depression may also represent an exaggerated form of cytokine-mediated behavior even 
in apparently healthy individuals. Individuals exhibiting “sickness behavior” are likely 
generating a hyper-expressed state of bioavailable cytokines similarly akin to disease 
models. In apparently healthy individuals, the investigators noted, these physiological 
modifications are adaptive and may be triggered by psychological stress. 
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Brain Structural Alterations 
Phenotypic relationships between intelligence and brain volumes have been 
examined in many different studies. Wallace et al. (2010) examined the shared genetic 
and environmental factors between brain volumes and intelligence in a population sample 
composed of 649 adolescents, children, twins, and singletons. There were observed 
relationships between brain volumes and intelligence, however they were insignificant. 
Volumes of gray matter were uniquely affected by measured verbal perspicacity, whereas 
non-verbal skills were reported to have an association with gray and white matter brain 
regions. This would suggest that there are distinct mechanisms that may contribute to the 
relationships between brain volumes and verbal/non-verbal intelligence. There were no 
significant differences in brain volume means or variances between monozygotic (MZ) 
twins, dizygotic (DZ) twins, singletons, and siblings of twins (1172.5 ± 106.5cc, 1146.1 ± 
105.9cc, 1164  ± 117.5cc, and 1165.8 ± 118.6cc, respectively), with the exception of 
significant volume differences in lateral ventricles among MZ and siblings of twins (11.5 
± 6.6cc, and 8.4 ± 4.1cc) ventricles. A majority of correlations (phenotypic) were 
significant (gray matter + white matter p < 0.01, r = 0.1; gray matter p < 0.01, r = 0.1; 
white matter p < 0.05, r = 0.1; frontal gray matter p < 0.01, r = 0.1; frontal white matter p 
< 0.01, r = 0.1; parietal gray matter p < 0.01, r = 0.1; temporal gray matter p < 0.01, r = 
0.1; temporal white matter p < 0.01, r = 0.1; and the caudate nucleus p < 0.01, r = 0.2); 
however, they were small. A significant genetic correlation was also detected between the 
caudate nucleus volumes and vocabulary scores; however, after statistical correction, 
only unique environmental correlations for frontal gray matter, gray matter + white 
matter, and total gray matter remained significant (frontal gray matter p < 0.01, r = 0.1; 
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gray matter p < 0.01, r = 0.13; and total gray matter p < 0.05, r = 0.1). The findings 
suggest that different genetic and environmental influences may underpin the phenotypic 
relationship between brain volumes and verbal versus visual-spatial skills; however, 
Wallace et al. (2010) were unable to directly or succinctly model those shared 
contributions.  
In a case study examining cognitive function between one set of twins (one who 
had received chemotherapy and one who did not), Ferguson, McDonald, Saykin, and 
Ahles (2007b) examined how chemotherapy would elicit cognitive changes between 
siblings. The twin that underwent chemotherapy received four cycles of doxorubicin 
(DOX), cyclophosphamide, tamoxifen, and docetaxel. There were significantly greater 
amounts of verbal complaints of cognitive trouble reported for the twin who had 
undergone chemotherapy as compared to the untreated twin. The investigators reported 
that during structural image testing that there were no significant volumetric differences 
witnessed. However, the investigators also noted that the treated twin’s cortical activity 
pattern was increased significantly greater than that of the untreated twin. Volumes of 
white matter lesions were observed to be greater in the treated twin in the left (6075 mm3 
vs. 3343.4 mm3, respectively, and right cerebral hemispheres (3725.7 mm3 vs. 2897.8 
mm3, respectively). The investigators noted that these observed increases in activation of 
cortical regions (as observed in functional magnetic resonance imaging) in the treated 
twin’s brain may signify a compensatory adaptation of neural circuitry in unaffected 
regions of the brain to the toxic effects of chemotherapy on affected regions.   
Examination of brain activity has yielded results for cancer survivors as far out as 
ten years. Silverman et al. (2007) administered positron emission tomography (PET) 
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testing on age-matched apparently healthy older adults and breast cancer patients who 
previously had undergone chemotherapy between five and ten years prior to examination. 
Regardless of the time since treatment, those who had undergone chemotherapy 
significantly differed from those who had not in neural activation patterns during short-
term memory tasks. In particular, those who had undergone treatment exhibited a 
statistically significant, 2% increase in peak activation in the inferior frontal gyrus during 
recall tasks. Performance on delayed recall tasks by chemotherapy-treated patients also 
elicited 3.2 points less, or a 13% decrease when as compared to controls (20.6 ± 4.8 vs. 
23.8 ± 6.3, respectively).The researchers noted that the areas that were significantly 
active were the inferior frontal gyrus, the contralateral posterior cerebellum near the 
midline, as well as the superior frontal gyrus. However, the most significant alterations in 
brain activity were witnessed in the basal ganglia. Metabolism was significantly 
decreased in patients who had received chemotherapy. The most substantial side-effects 
patients reported having difficulties with were diminished attention, memory, 
concentration, and processing speed disruption. The investigators also indicated that 
cognitive-related complaints have typically centered on their perception of mental 
slowness and diminished abilities to maintain attention, concentrate, and remember 
things. Abnormal activation in the inferior frontal cortex during performances of short-
term memory tasks were witnessed in images taken from chemotherapy treated patients. 
Untreated patients, in contrast, demonstrated greatest cortical activation in the parietal 
and occipital cortices when performing the same task. Thus, overall, the altered cortical 
activation associated with performance of a memory task in chemotherapy treated 
patients could be characterized as involving greater recruitment of frontal cortical tissue. 
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Metabolism in the inferior frontal gyrus was significantly related to cognitive 
performance on short-term memory recall tasks, suggesting that the chemotherapy 
associated changes in cerebellar activation were related to cognitive deficits. The 
observed increases in frontal activation may represent a compensatory response to lower 
resting metabolism found in this region of the brain in chemotherapy treated, cognitively 
impaired patients. 
Brain Imaging and Direct Entry 
 of Chemotherapy 
 
As previously stated, chemotherapeutic agents were classically thought to be 
unable to cross the blood-brain barrier. However, in various human and animal models, 
research has indicated that chemotherapeutic drugs have been observed in cerebrospinal 
fluid and brain tissue. Drugs, such as 5-flourouracil, have been observed to traverse by 
simple diffusion (Bourke et al., 1973; Kerr et al., 1984). Beaulieu (2002) described a 
method that may help explain the mechanisms involved in chemotherapy traveling across 
the blood brain barrier or traversing into other central nervous system structures. Direct 
neurotoxicity may disrupt brain parenchyma, producing demyelination and/or altered 
water content, resulting in white matter disruptions. Although this technical review 
outlined anisotropic mobility of water, the investigators noted literature that examined the 
effects of the methyl mercury and studies of vinblastine on nervous system components 
during in vitro and in vivo animal models. The investigators indicated that in each of the 
aforementioned models that anisotropy is a noticeable factor in the fluid mechanics of 
neurological microstructure. The investigators also noted that with simple diffusion there 
is a dependence on the interactions of the diffusing molecule which results in diffusion in 
all directions. In anisotropic diffusion, there is a directional movement based on 
26 
 
 
 
neurological structuring, much like the example of placing a cut portion of a flower or a 
stalk of celery in a colored aqueous solution. There is a distinct method of diffusion of 
color throughout the plant microtubules. Chemotherapeutic entry into central nervous 
system components may follow this same delivery method.  
Micro-structural abnormalities have also been observed in chemotherapy-exposed 
brain white matter. Deprez et al. (2011) examined the cerebral white matter integrity of 
patients, who had undergone chemotherapy. The investigators used magnetic diffusion 
tensor imaging (DTI) as well as implemented measures of cognitive abilities. Decreased 
performance on attention and processing speed analyses were significantly correlated 
[(Attention) Bourdon-Wiersma Dot Cancellation Test-parietal p < 0.01, T = -5.5; Test of  
Everyday Attention-auditory elevator-parietal p < 0.05, T = 6.1; (Processing Speed) 
Nine-Hole Pegboard Test- parietal-temporal (3 measures) p < 0.01, p < 0.05, p < 0.05, T 
= -5.5,-4.2, and -4.6; WAIS-digit symbol temporal p < 0.05, T = 5.7, and Trail Marking 
Test-A- parietal p < 0.01, T = -5.3] with parietal and temporal white matter tracts, 
suggesting micro-structural damage to white matter may underlie CRCI. The results of 
this study indicated that there were significant differences witnessed in patients’ brain 
volumes [(fractal anisotropy) .39 x 10mm2·s-1 vs. .43 x 10mm2•s-1 (mean diffusivity), .8 x 
10mm2•s-1 vs. .7 x 10mm2•s-1, and (radial diffusivity) .6 x 10mm2•s-1 vs. .5 x 10mm2•s-1, 
that underwent chemotherapy within four months of starting data collection. The 
investigators concluded that the CRCI observed during cognitive assessments may be 
attributed to recent chemotherapy treatment exposure.  
High resolution magnetic resonance imaging (Hi-res MRI) and cognitive function 
techniques conducted on breast cancer survivors and non-cancer patients have also been 
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utilized to examine soft tissue damage in brain tissue at one and three-year intervals post-
treatment (Inagaki et al., 2007). No significant differences in soft tissue damage were 
observed between cancer survivors and apparently healthy non-cancer controls at one and 
three-year increments. Although, smaller right prefrontal and parahippocampal regions in 
the brain were reported for cancer patients whose time out of treatment was less than four 
months. The investigators noted that significantly smaller frontal regions of the brain may 
account for the decreases in score on attention/concentration and visual memory indices 
of the WMS-R cognitive assessments. The prefrontal cortex, including superior and 
middle frontal gyrus, has been reported to have roles in various functions including 
memory, planning, execution, monitoring and cognitive processing, behavior, inhibition, 
and change in circumstantial behavior. The investigators concluded that the current study 
showed significantly smaller regional brain volumes (right middle frontal gyrus p < 0.05, 
right superior frontal gyrus p < 0.05, right parahippocampal gyrus p < 0.05, left 
precuneus p < 0.05, left parahippocampal gyrus p < 0.05, right cingulate gyrus p < 0.05, 
and left middle frontal gyrus p < 0.05) in areas related to cognitive functions in cancer 
survivors who received adjuvant chemotherapy. However, at the three-year assessment 
there were no significant volumetric differences.  
 As speculated, the hippocampus plays a significant role in memory acuity, which 
may be profoundly affected by the decreases in brain volumes observed during 
chemotherapy. Yoshikawa et al. (2005) examined the effects of adjuvant chemotherapy 
on hippocampal volumes in Japanese breast cancer survivors via magnetic resonance 
imaging (MRI), and memory via WMS-R testing. Breast cancer patients included in the 
study had completed chemotherapy regimens which included: cyclophosphamide, 
28 
 
 
 
methotrexate, fluoruracil, DOX, tegafuracil, doxofluridine, and carmofur. There were no 
significant differences witnessed in memory function, including the delayed recall index 
and percent retention, or hippocampal volume observed between the treatment and non-
chemotherapy group. There were, however, significant differences in the 
attention/concentration scores (95.7 ± 9.5 vs. 100.7 ± 9.9) for those in the chemotherapy 
group compared to those who did not receive chemotherapy. Some of the participants had 
been out of treatment for three years when data were being collected for this study. The 
investigators suggested that this may account for the lack of significance found between 
groups, and may be attributable to healing and repair of damaged areas in the brain 
following treatment.    
In a review of literature, Myers (2009) stated that there are also a variety of 
potentially associated factors that have been identified as contributors to CRCI. These 
include: age, educational level, intelligence, social support, anxiety, depression, fatigue, 
disease site, stage, and co-morbidities; treatment regimen, timing, duration, and 
concomitant therapies; and hormonal levels, cytokine levels, damage to neural progenitor 
cells, and the presence of apolipoprotein E-4 allele. Patients have described the effects of 
cognitive dysfunction as forgetfulness, absentmindedness, and an inability to focus when 
performing daily tasks (Hess & Insel, 2007). 
Chemotherapeutic Agents 
 In a combined in vivo and ex vivo animal model, Han et al. (2008) found that 
progenitor cells and oligodendrocytes were particularly vulnerable to clinically relevant 
dosages of 5-FU. A major cause of decreased cell numbers in 5-FU treated cultures was 
due to a reduction in progenitor cell division. When mice were treated in vivo with 5-FU, 
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significant induction of apoptosis in multiple CNS regions were noted. In the corpus 
callosum, there was also a significant increase in apoptosis at day one to approximately 
70% above control values. However, six months following treatment, excessive apoptosis 
was reported to have normalized following treatment. Mice that were treated with 
chemotherapy were significantly deficient in delayed white matter. Midline longitudinal 
sections of corpus callosum displayed scattered foci of demyelinated axons, including 
partial or complete loss of the myelin sheaths and increases in interlaminar splitting of the 
myelin sheaths. In examination of transverse sections, there were significant amounts of 
degenerating axons with multi-laminated structures and collapsed centers, swelling of 
axons and altered axonal cytoskeleton and organelles. The usage of 5-FU in the treatment 
of many types of cancers is of concern considering the evidence of acute and delayed 
toxicity side effects. The investigators also noted that even transient exposure to 5-FU 
increased apoptosis by 2.5-fold in the subventricular zone and a 4-fold increase in the 
dentate gyrus in the hippocampus. The investigators also noted that the increasing 
amount of cells dying continued for 14 days, however was at normal values six months 
following administration of 5-FU.   
Van Der Kooy, Zito, and Roberts (1985) examined the effects of DOX 
administration on brain tissue in Sprague-Dawley rats. The researchers separated the two 
halves of the brain by strategic incisions and administered DOX unilaterally. The 
protective effect of incisions against neurotoxicity was evidence to support the retrograde 
transport of DOX which led to neurotoxic effects in the treated portion of the brain.  
Administration of DOX was reported to have destroyed dopaminergic and thalamic 
neurons, which are afferent to the striatum, and damaged gamma-aminobuteric acid 
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(GABA) neurological interfaces via retrograde transport. The investigators concluded 
that DOX may have useful purposes for discriminatory destruction of afferent neurons 
localized to site of injection by way of retrograde transport. 
Joshi et al. (2005) examined the effects of oxidative stress parameters in light of 
the knowledge that Adriamycin (ADR) has been shown to produce reactive oxygen 
species (ROS) upon administration. In addition, oxidative stress that is facilitated by free 
radicals has been associated with neurodegenerative disorders with aging (Butterfield & 
Kanski, 2001). The investigators measured protein carbonyls (protein oxidation), 3-
nitrotyrosine levels, and 4-hydroxynonenal levels (lipid oxidation) in the brain tissue of 
mice that were injected 72 hours prior to excision. In the ADR treated brain tissue there 
was approximately a 60% increased expression of protein carbonyls, a 25% increased 
expression of 4-hydroxyneonenal, 220% increase in multidrug resistance protein-1, and a 
55% increased expression of 3-nitrotyrosine which would suggest the susceptibility of the 
brain to oxidative stress (Joshi et al., 2005). The high levels of polyunsaturated fatty 
acids, low antioxidant capacity, presence of redox metal ions, and high utilization of 
oxygen, increases the vulnerability of the tissue. In addition, oxidative stress induced by 
ADR in the brain could cause damage to proteins critical for cell functioning, possibly 
leading to cell death. Finally, the investigators concluded that ADR, its metabolites or 
downstream sequelae is likely to enter the brain and increase oxidative stress, which is 
likely to contribute to CRCI.  
Madhyastha, Somayaji, Rao, Nalini, and Laxminarayana-Bairy (2002) examined 
the effects of intracerebroventricular dosages of methotrexate on cognitive dysfunction in 
Wistar rats at various dosages; specifically 3, 4, 5, or 6 mg/kg of body mass depending on 
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group randomization for acute toxicity testing. Behavior during an avoidance task, as 
well as a dark/bright arena task was then observed follow four hours of monitoring for 
gross behavioral alterations. The acute observances were as follows: convulsions, 
hyperactivity, grooming, sedation, hypothermia, and increased respiration (Madhyastha et 
al., 2002). A 16% mortality rate was observed among rats that were administered 6mg/kg 
dosages of methotrexate. During task performance assessments, two groups were 
administered chemotherapy; one at 1.5mg/kg and the other at 2 mg/kg. Significant 
reductions in task performance [line crossings in dark area (p < 0.01), line crossings in 
bright area (p < 0.05), and time spent in dark area (p < 0.01)] were witnessed in rats that 
were treated with 2mg/kg of methotrexate as compared to the non-treated rats across five 
days of testing. The investigators noted that results suggest drug-related disruptions in 
exploratory and locomotor activity. Scores on task retention significantly increased as the 
dosages increased, indicating dose-dependent toxicities. There were significant declines 
in hippocampal brain amines, as quantified by high pressure liquid chromatography 
(HPLC). Dopamine was the most significant [1.5mg/kg (63.2 ±3.6ng/g), 2 mg/kg (61.5 
±1.8), p < 0.01] then serotonin [1.5mg/kg (150.7 ±4.9ng/g), 2 mg/kg (150.4 ±3.7ng/g), p 
< 0.01] followed by norepinephrine [1.5mg/kg (136.5 ±5.6ng/g), 2 mg/kg (136.0 
±6.7ng/g), p < 0.01] when compared to the control group. The investigators noted 
significant decreases in overall number of neuroglial cells and neurons in the CA-3 and 
CA-4 hippocampal regions of the brains. The loss of physical number of neurons, 
behavioral and learning impairment, and depletion of hippocampal brain amines led the 
investigators to suspect direct neurotoxicity as a strikingly likely factor. Foley, Raffa, and 
Walker (2008) examined the combined effects of 5-FU and methotrexate on memory and 
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learning acquisition in a mouse model. The greatest dosages administered were 32mg/kg 
for methotrexate, and 75 mg/kg for 5-FU across the two-day study. The results indicated 
that the 5-FU alone at 75mg/kg significantly (p < 0.05) increased latencies versus 
controls for retrieval of behavioral responses that were previously learned. The combined 
administration of 5-FU and methotrexate significantly increased adjusted latencies. The 
combination of administered drugs during this study elicited profoundly negative effects 
on retrieval and retention tasks. The effects appear to be a more selective disruption in 
learning and memory processes.  
Determining the mechanisms that underlie the problem of CRCI has yet to be 
accomplished. Konat et al. (2008) reported that cognitive dysfunction, particularly 
attention and memory deficits, have been observed in upwards of 75% of cancer patients 
who have undergone chemotherapy. The investigators sought to determine whether CRCI 
was attributable to the malignancy itself or the chemotherapy. ADR was administered to 
rats four times (one per week) at a dosage of 2.5mg/kg, while cytoxan (CTX) was 
administered at 25mg/kg for a period of four total doses; again once per week. The rats 
were subjected to 30 minutes of open field testing comprised of hind leg rearing and line 
crossings within a lined black box. They were also subjected to a passive avoidance test 
in which they were placed in a lit box and were timed on their latency of entering the 
darkened box from the lit box. There were undesirable effects of chemotherapy on 
integrity of higher brain functioning. Chronic administration of commonly used 
chemotherapeutic agents and the combination of ADR and CTX significantly impaired 
short-term memory function. However, these ADR and CTX cocktails may not 
substantially hinder or impair long-term memory functioning (Konat et al., 2008). In a 
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study conducted on primates, Bourke, West, Cheda, and Tower (1973) examined the 
effects of 5-FU administration and diffusion into cerebral spinal fluid (CSF). 
Examination of bilateral perfusion in overexposed cerebral cortex or vertebral cisternal 
perfusion demonstrated that 5-FU crosses the blood brain barrier. In addition, the 
investigators explained that 5-FU may be a useful drug to combat tumors that invade 
central nervous system structures. Furthermore, because of the exceptional ability of 5-
FU to access the brain, oncologists should demonstrate caution with administration.  
Chemotherapy-related cognitive impairment has also been reported to be possibly 
affected mechanistically by altered primary sex hormones, telomere shortening, blood-
brain barrier disruption, cytokine dysfunction, and genetic susceptibility (Ahles & 
Saykin, 2007). On a single-trial step-down inhibitory avoidance protocol, Liedke et al. 
(2009) examined the effects of a single bolus dosage of DOX in Wistar rats at increasing 
levels similar to those given to humans (.5mg/kg, 2mg/kg, and 8mg/kg). Prior to training, 
DOX was administered. Training consisted of a fear-motivated hippocampal memory 
dependent protocol where animals learned to associate training apparatus locations with 
electric shock to their feet. On day one and day seven, assessments of cognitive function 
were administered via retention test trials that were identical to training except for the 
lack of electric shocks to the feet. It was determined that a single dose of DOX did not 
cause permanent brain damage, which was indicated by improvements in the DOX group 
seven days later. In addition, the investigators suggested that a single dosage of DOX 
produces reversible memory acquisition impairment but not memory consolidation. 
Winocur et al. (2006) examined the effects of a combination of two anticancer 
drugs, methotrexate and 5-FU on cognitive function in a mouse model. The investigators 
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used the Morris Water Maze Test of spatial memory, which has been reported to be 
sensitive to hippocampal dysfunction. Secondly, mice were also administered a non-
spatial test of memory in which a discrete cue signaled the location of the submerged 
platform in the water. These were followed by a test of Non Matching to Sample rule 
learning, which is highly sensitive to frontal-lobe dysfunction. Mice were either injected 
with 37.5mg/kg methotrexate and 75mg/kg 5-FU or comparable amounts of saline 
solution and were comparable to human dosages and schedules. The results indicated that 
learning and memory impairment were significantly associated [trials 18.9 ± 7.7 (drug) 
vs. 14.2 ± 8.5 (control), p < 0.05, and errors 20.5 ± 10.1 (drug) vs. 14.9 ± 6.8 (control), p 
< 0.05] with treatment of 5-FU and methotrexate, a widely used combination of drugs in 
the treatment of breast cancer. Drug induced deficits were observed in tests of spatial 
memory and conditional rule learning. However, there were no significant differences 
between drug and control groups on cued memory or discriminate learning.  
 Vascular proliferating cells within the dentate gyrus in the hippocampus have 
been associated with neurogenesis, neuronal proliferation, differentiation, and have been 
reported to be involved in learning and memory. Mustafa et al. (2008) reported that these 
brain regions require brain-derived neutrotrophic factor (BDNF) to aid in the process of 
neurogenesis. The researchers examined the effect of 5-FU on spatial working memory as 
modeled by a location recognition test in rats. Vascular-associated proliferating cell 
numbers and changes in neutrotrophic and neurogenic proteins were also measured. The 
object location task was determined by the amount of exploratory time each rat spent 
licking, sniffing, chewing, or moving while directing their nose toward an object. Objects 
were then randomly rearranged. The rats received 5 injections of 5-FU at 20mg/kg over 
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the course of 12 days. Indicative of unaffected spatial working memory, control animals 
proceeded to explore novel locations of objects as much as 14% greater amounts of time 
than treated rats. There was no significant difference witnessed between exploratory 
times of novel and familiar locations in 5-FU treated rats. The investigators also 
suggested that treated rats were unable to discriminate between objects in novel locations 
and familiar ones when compared to controls. There were no significant alterations 
observed in proliferating cell counts. However, there was an approximately 50% 
reduction in BDNF. These deficits may suggest structural changes or alterations in the 
hippocampus and potentially alterations in neurogenesis. 
In an examination of a standard breast cancer therapy protocol, Macleod et al. 
(2007) examined the effects a combined cyclophosphamide (40mg/kg) and DOX 
(4mg/kg) treatment regimen on ovariectomized rats for three weeks. Rats were treated 
once a week with chemotherapy. The investigators implemented a fear-type experiment 
which examined learning following treatment. The training consisted of a standard 
operant conditioning apparatus which audible tones were paired with mild shocks to their 
feet. The investigators noted that significant impairments in contextual fear memory were 
observed, suggesting detrimental effects on the hippocampal-related learning and 
memory (Macleod et al., 2007).  
In a longitudinal study Schilling, Jenkins, Morris, Deutsh, and Bloomfield (2005) 
administered cognitive assessments on 50 patients who had undergone chemotherapy at 
six and 18 month intervals. A wide array of cognitive assessments were administered 
which included: measures of verbal memory (WMS logical memory, AVLT recall 1-7), 
visual memory (complex figure, copy, immediate and delayed recall), executive function 
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(Stroop Task), working memory (spatial span, letter/number sequencing, digital span), 
FSIQ estimate (national adult reading test), processing speed (letter cancellation task), 
and self-report [cognitive failures questionnaires, GHQ12, FACTB, ES, F (patients only)]. 
The three measures that showed significant group by time interaction were: the AVLT 
supraspan, total recall, and the WMS letter number sequencing task. All three require a 
high degree of concentration and attention, precisely the function that patients complain 
about the most (Schilling et al., 2005).There were significant differences observed 
between patients who had undergone chemotherapy compared to apparently healthy non-
cancer controls. The results also indicated a group by time interaction for three measures 
of verbal and working memory. The investigators speculated that the neurotoxic effects 
observed during cognitive assessments may be indicative of direct neurotoxicity.  
In addition, female cancer survivors of menopausal age may be at greater risk of 
CRCI considering the modifications of hormonal levels. In particular, Schilling et al. 
(2005) indicated that menopausal females undergoing hormone therapy in addition to 
receiving chemotherapy may be at a significantly greater risk for CRCI. Lastly, the 
investigators noted that QOL, anxiety, and fatigue can be affective of cognitive 
functioning, although patients undergoing chemotherapy were 2.3 times more likely to 
show cognitive impairment than the control group. The investigators suggested that while 
low dosages of chemotherapy, as expressed in the self-report portion of the patient 
evaluation, may not induce noticeable impairment, it should be expected that greater 
doses may cause more severe and lasting impairments.  
Life decisions regarding career and educational choices may be profoundly 
affected by the negative side-effects of chemotherapy on memory and concentration. 
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These decrements may also have an effect on general QOL (Mitchell & Turton, 2011). 
Four cancer patients were interviewed, and their experiences with CRCI and QOL 
measures were recorded. Reduction in the ability to make smooth transitions back to 
activities of daily living, such as returning to work, may persist long after treatment is 
completed (Carlsson et al., 2000; Schilling et al., 2005). With the difficulties that patients 
face along the cancer continuum, Mitchell and Turton (2011) suggested that on average, 
patients were significantly less likely to share their experiences with cancer to their 
healthcare provider than to fellow cancer survivors. In addition, they suggested that 
healthcare providers should educate their patients about the potential sequelae of side 
effects they may experience as they complete treatment, especially with the incidence of 
cognitive dysfunction. If patients were more aware of the negative effects of CRCI, they 
may be more encouraged to report incidences to their healthcare provider. 
Exercise Benefits in a Cancer Population 
Physical activity and cognitive function are important to QOL as well as overall 
health, and are vitally important to the reduction of disease impact and maintaining a 
healthy cognitive function. Wood, Alvarez-Reyes, Maraj, Metoyer, and Welsh (1999) 
investigated self-reported physical fitness, QOL, visual acuity, and cognitive function on 
two separate occasions within a two week period of time and determined that increased 
physical and cognitive function was significantly related to observed increases in QOL 
scores among older adults. In pre-adolescent school-based academic performance, 
Hillman et al. (2009) examined the effects of walking during a 20-minute Balke treadmill 
protocol on neurological and behavioral indices on aspects of cognitive control and 
attention. The investigators found that a single, moderately intense acute bout of aerobic 
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exercise may improve attention, cognitive control, and academic performance in pre-
adolescent children.  
During the past few decades, advances in health care and treatment of various 
diseases have been a factor in healthcare cost increases. Considering resource and 
financial limitations, interventions aimed at the improvement of overall health should 
lead to maximal health benefit utilizing as minimal of an amount of resources as possible. 
In oncology, advances in treatment have prolonged life expectancy. With increasing life 
expectancy for cancer survivors, the chances of increased amount of treatment-related 
side effects also become more pronounced. In a review of literature, Roine et al. (2009) 
examined 61 studies reporting on the cost effectiveness of exercise-based interventions 
and the treatment of various diseases. Although some of the research presented minor 
conflicting arguments as to the efficacy of certain exercise interventions, the overall 
results indicated that exercise is a cost effective method of healthcare.    
It has been well established that exercise has been positively associated with 
increases in cardiovascular function, resting heart rate, pulmonary function, forced vital 
capacity (FVC), upper-body muscular endurance, lower-body muscular endurance, core 
muscular endurance and flexibility, improvements in body composition, as well as 
reductions in behavioral, sensory, affective, cognitive, mood, and total fatigue scores 
(Fong et al., 2012; Hsieh et al., 2008; Schneider, Hsieh, Sprod, Carter, & Hayward, 
2007a; 2007b; 2007c; Van Weert, et al., 2010). In addition, exercise has been linked with 
reductions in inflammation (Fairey et al., 2005). Furthermore, individualized cancer 
rehabilitation interventions have been shown to increase five-year survival rates 
(Peterson, Repka, Hayward, & Schneider, 2010). 
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Cognitive Training 
 
The term brain plasticity refers to the inherent capacity of the brain itself to 
respond to physical and functional changes (Mahncke et al., 2006). Brain function can be 
strengthened or degraded, depending on the circumstances. Manipulating learning 
context can alter plasticity that can be both positive and negative, which would imply that 
physical, environmental, and behavioral stimuli may strengthen or degrade brain function 
across the aging process. Manipulation of learning context can also alter plasticity. 
Stimuli leading to positive plastic changes may be a fundamental tenet of cognitive 
therapy to help restore memory, cognitive, motor, and sensory cognitive functions. In 
recent years, brain training software packages have gained momentum in sales and 
notoriety. One commercially available program, Brain Fitness® by Posit Science®, 
consists of progressive online cognitive exercises designed to enhance “brain plasticity” 
(Smith et al., 2009). Mahncke et al. (2006) reported that training brain plasticity utilizing 
appropriately designed training archetypes may substantially improve function and 
recovery from losses in sensation, cognition, memory, and motor control. In addition, this 
process should be initiated early in the aging process to enhance brain health and 
cognitive fitness before significant losses develop but also could be effective later in the 
aging process when significant losses have already emerged. Furthermore, the 
investigators noted that when a clinically validated model is available, this scientifically 
based approach unambiguously targets the primary causes of cognitive decline associated 
with aging, this could revolutionize therapeutic techniques for aging adults.  
The demand for delaying or preventing age-associated declines in older adults has 
been steadily increasing. Designing and implementing cost effective alternatives to 
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standard care may be beneficial for the reduction of the need for home care, nursing 
homes, and hospital stays, and therefore reduce health care costs. Ball et al. (2007) 
evaluated the associations between three Advanced Cognitive Training for Independent 
and Vital Elderly (ACTIVE) interventions (memory, reasoning, and speed of processing 
training), in a sample of 2802 independently thriving older adults. This training was 
aimed to improve mental abilities as well as daily functioning. Research has indicated in 
human and animal populations that neural plasticity endures across the lifespan, and that 
cognitive stimulation in the environment is an important predictor of enhancement and 
maintenance of cognitive functioning. The investigators noted that limited education is a 
risk factor for dementia. Primary and secondary follow-up analyses indicated significant, 
immediate gains on cognitive outcomes in all groups except the no contact control. 
Eighty-seven percent of speed-trained, 74% of reasoning-trained, and 26% of ACTIVE-
trained participants demonstrated reliable improvement on the pertinent cognitive 
composite immediately following intervention. Furthermore, the proximal effects 
occurred and continued throughout the following 24-months, further implying that 
cognitive training may have residual effects that may have prolonged improvements. 
Finally, those who participated in booster training showed improved gains (speed-92% 
vs. none-68%; reasoning-72% vs. none-49%) beyond normal cognitive training.  
In breast cancer patients who were about to receive chemotherapy, Wefel, 
Saleeba, Buzdar, and Meyers (2010) examined cognitive functioning to gauge levels of 
preexisting dysfunction. In particular, measures of affective status, cognitive function, 
and QOL were measured prior to administration of treatment, during treatment, and 
directly following treatment. Prior to treatment, approximately 21% of the sample 
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displayed evidence of cognitive dysfunction. In addition, older patients appeared to be at 
a greater risk of displaying evidence of cognitive dysfunction. The investigators noted 
that approximately 65% (during and following treatment) of the sample exhibited acute 
declines in cognitive function. Learning, executive function, memory, and processing 
speed were domains of cognitive function that were most affected by chemotherapy 
treatment. There were no significant differences between patients exhibiting acute 
cognitive decline and those who did not decline on any clinical, demographic, or mood 
variable. Sixty-one percent of the sample exhibited late decline (one year) in cognitive 
function with 30% of the sample demonstrating new onset of cognitive dysfunction that 
was not present beforehand. The investigators concluded that the impact of diminished 
brain/cognitive reserve may play a substantial role in the vulnerability and failure to fully 
recover from acute treatment-related changes in cognition and/or the development of late 
cognitive decline of post chemotherapy patients. 
Reduction of disease impact and conditions generally affecting older population 
has become increasingly important. Exercise and maintaining a healthy level of cognitive 
function have become methods that have been progressively more supported. Elements of 
cognitive functioning are considerably connected to overall health and QOL (Wood, 
Alvarez-Reyes, Maraj, Metoyer, & Welsh, 1999). Wood et al. (1999) tested pre versus 
post levels of physical fitness, cognitive function, visual acuity, and QOL during a two-
week intervention in 44 older adults. The investigators then examined the relationships 
between values of physical fitness against the aforementioned variables. It was 
determined that there were significant relationships between QOL, physical fitness, and 
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cognitive function. It may be that greater levels of physical fitness and cognitive function 
lead to increased QOL scores in older adults.  
 Decrements in cognitive performance have also been observed in individuals 
undergoing treatment for high grade gliomas. Hassler et al. (2010), in a pilot study, 
examined the effects of ten weeks of cognitive training on 11 patients with high grade 
gliomas. The training intervention consisted of ten weekly group meetings consisting of 
90 minutes of holistic mnemonic training that encompassed attention, memory, and 
verbal skills. Cognitive function testing was completed before and following completion 
of the training intervention. Specifically, the Controlled Oral Word Association Test 
(COWAT) for verbal acuity, Trail Making Tests A and B for executive function and 
visual motor speed, and the Hopkins Verbal Learning Test (HVLT) for verbal memory 
were implemented. Hassler et al. (2010) speculated that the location of the tumor in high 
grade glioma patients may compound the effect of CRCI because of the location of the 
tumor being located within the brain or spine. There were improvements observed in all 
cognitive measures however, significant improvements were only detected during the 
HVLT (score 19.6 ± 8.9- baseline, 23.6 ± 8.8-12 weeks, p < 0.05) assessments. The 
investigators also noted that this pilot work demonstrated that patients with central 
nervous system tumors can not only tolerate the stress of training, but they also can 
improve on measures of cognitive functioning.  
 In a combined assessment of Memory and Attention Adaptation Training 
(MAAT), Ferguson et al. (2007a) assessed cognitive function via assessment of multiple 
cognitive and behavioral components on 29 breast cancer survivors who had recently 
completed treatment. The MAAT was composed of education on memory and attention, 
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self-awareness, self-regulation focusing on reduction of arousal through relaxation 
training, activity scheduling and pacing, and training of cognitive compensatory 
strategies. The MAAT interventions were implemented once a month for four months. 
Prior to and following interventions participants were tested via the following for 
cognitive functioning: The California Verbal Learning Test-II, Logical Memory I and II 
from Weschler Memory Scale, Digit Symbol Subtest from the Weschler Adult 
Intelligence Scale III, Trail Making tests A and B, and the Stroop Color-Word 
Interference Test. The results indicated that participants significantly (p < 0.05) improved 
from pre to post for cognitive functioning in a daily life setting for all participants. 
Quality of life, as measured by the Quality of Life-Cancer Survivors Scale (QOL-CS), 
also revealed significant improvements from pre to post intervention. 
In a sample population of cognitively healthy, well-educated older adults near the 
age of 75, Smith et al. (2009) evaluated the effects of cognitive training on cognitive 
function using the Posit Science® Brain Fitness® program. Participants were either 
randomized into the experimental cognitive training group or were randomized as active 
controls and were given content-oriented coursework that required an equivalent amount 
of time as the cognitive training group. The results indicated that there were significant 
improvements on auditory processing speed (3.9 points vs. 1.8 points, p < 0.05), and 
small but statistically significant benefits on memory performance for the group using the 
Posit Science® Brain Fitness® program (99.6 ± 14 to 103.8 ± 14). The investigators 
explained that this type of cognitive training software has been developed to focus 
improvement on central auditory system speed and accuracy. In addition, the training of 
neuromodulatory systems may positively impact generalized benefits in measures of 
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memory and attention greater than general cognitive simulation. Smith et al. (2009) 
added that brain plasticity-based training may develop information flow through language 
and auditory pathways in the brain that can possibly translate training benefits to non-
trained tasks and that training based improvements may endure following training 
completion.  
Wolinsky, Unverzagt, Smith, Jones, Stoddard, and Tennstedt (2006) examined the 
ability of three ACTIVE cognitive training interventions (memory, reasoning, and speed 
of processing). Health-related QOL (HRQOL) was measured using a test consisting of 
eight 36-item health surveys (SF-36). At two years’ post training, 24% and 37% had 
clinically relevant drops on ≥ 4 and ≥ 3 SF-36 scales. At five years’ post training, 33% 
and 47% had clinically relevant drops on ≥ 4 and ≥ 3 SF-36 scales. Participants in the 
speed of processing intervention were significantly less likely to have extensive HRQOL 
decline compared to participants in the control group regardless of the threshold or time 
period, whereas participants in the memory and reasoning intervention were significantly 
less likely to have HRQOL decline only at five-years post-training and only at the lower 
threshold. The effect of the speed of processing intervention was stronger and evident 
earlier than those for the memory and reasoning interventions. The result stems from the 
speed of processing intervention being the most procedural intervention, operating 
through sensory-motor elaboration and repetition, bringing about a broader pattern of 
regional brain activation. At five years’ post-training, however, all three interventions 
were successful in protecting against a lower threshold of age-related extensive declines 
in cognitive function. Older adults face declining cognitive ability and increasing 
difficulty with activities of daily living. 
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Physical Activity and Cognitive Function 
In a longitudinal study consisting of healthy older adults, Barnes, Yaffe, Satarino, 
and Tager (2003) examined cardiorespiratory fitness at baseline and compared the 
association between those values and cognitive function over the course of six years. 
Cardiorespiratory fitness may provide a means to bridging the gap between cognitive 
function and history of physical activity because it is largely determined by habitual 
physical activity and is based on objective physiological measurements (Barnes et al., 
2003). The investigators hypothesized that baseline measures of cardiorespiratory fitness 
would be associated positively with maintenance of cognitive function over time and with 
levels of cognitive function at follow-up. The results indicated that cardiorespiratory 
fitness was positively associated with preservation of cognitive function over a six-year 
period. Participants with worse cardiorespiratory fitness at baseline experienced greater 
decline percentage on the MMSE over six years 95% CI [lowest 0.5 (0.8-0.3), global 
score-28.5 (28.3-28.7), middle-0.2 (0.5-0.0), global score-28.9 (28.7- 29.1), highest-0.0 
(0.3-0.2), global score-29.2 (29.0-29.5) p < 0.01]. After adjustment for demographic and 
health-related covariates, baseline measures of cardiorespiratory fitness were also 
positively associated with performance on cognitive testing conducted 12 years later. The 
association between cognition and cardiorespiratory fitness was the most robust for 
measures of attention/executive function and global cognitive function. It is possible that 
fitness has a more pronounced effect on the frontal lobes, which the investigators 
suggested mediates attention/executive function (Barnes et al., 2003). It is also possible 
that cardiorespiratory fitness is a better marker of underlying health status, which is 
associated with cognitive function over time. The investigators concluded that 
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participants with greater baseline levels of cardiorespiratory fitness experienced cognitive 
decline to a lesser extent over the course of 12 years following completion of the study. 
This suggests that maintaining high levels of cardiorespiratory fitness may help provide 
long-term protection against cognitive dysfunction in older adults.  
There appears to be a universal acceptance of the fact that exercise on a regular 
basis has benefits for muscular strength, cardiovascular fitness and function, management 
of weight, metabolic health, disease prevention, bone mineral density, disease 
management and prevention, as well as decreases in mortality; however, much less is 
known about the brain and the effect of exercise upon it (Zoeller, 2010). In a review of 
literature, Zoeller (2010) described aging as being accompanied by varying degrees of 
decline in cognitive function declination. In particular, processing speed, memory, and 
increases in risk of dementia and Alzheimer’s disease have been linked to age-related 
cognitive decrements. Physical performance and speed of gait were indicated to be 
predictors of dementia in individuals with or without baseline levels of cognitive 
impairment. Large improvements in certain measures of cognitive function such as, 
auditory attention, delayed memory and motor function have been linked to interventions 
with results indicating improvements in aerobic training interventions. Lesser 
improvements in aerobic interventions have been associated with cognitive speed and 
visual attention improvements. Exercise was most significantly related to executive 
function improvements as opposed to any other measure of cognitive function. In 
addition, habitual exercise has been associated with neurogenesis, enhanced central 
nervous system metabolism, improvements in memory and angiogenesis, as well as 
attenuation of the age-related brain volume, structure, and density losses (Zoller, 2010).  
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Acute bouts of moderate exercise have also been indicated to positively affect 
outcomes of memory in circadian rhythm altered shift workers. Potter and Keeling (2005) 
hypothesized that acute bouts of moderate intensity exercise would improve memory 
ability to encode and recall words in a 15-item list. The second portion of the study was 
to examine whether circadian rhythms in memory performance might interact with the 
exercise intervention to produce different levels of performance change at different time 
of day for 31 male shift workers, working at all hours of the day. Following each exercise 
trial there were significant increases (approximately 8, 10, 12, 13, 14 words per trial, p < 
0.01) on overall number of words recalled. There was also a significant interaction with 
exercise and time of day, in addition to the exercise intervention and average number of 
recalled words. This would suggest that moderate, short term; intensity exercise may be 
beneficial for memory function and may significantly reduce the effects of daytime 
circadian rhythms on memory performance. 
Lautenschlager et al. (2008) examined the effects of a 24-week physical activity 
intervention consisting of at least 150 minutes of moderate intensity activity per week in 
older adults exhibiting objective or mild cognitive impairment. Prior to the exercise 
intervention, all participants were assessed via Alzheimer Disease Assessment Scale 
(ADAS-Cog). This assessment consists of 11 brief cognitive tests assessing memory, 
language, and praxis. All participants chose to do walking or some other form of aerobic 
activity as well as some strength training. Participants were outfitted with a pedometer to 
help monitor progress each week. The results indicated during follow-up assessments of 
cognitive function that older adults in the exercise group performed to a greater extent 
during measures of delayed memory recall. In addition, those in the exercise group 
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showed better delayed memory recall. In summary, this study demonstrated that aerobic 
exercise improves cognitive function in older adults with subjective and objective mild 
cognitive impairment.   
In a progressive aerobic only intervention, Masley, Roetzheim, and Gualtieri, 
(2009) examined the effects of a ten-week progressive aerobic intervention on cognitive 
function. The cognitive function measures were: mental speed, memory, reaction time, 
attention, and cognitive flexibility. The investigators indicated that those who were in the 
aerobic training groups had significantly (p < 0.05) greater percentage scores on memory 
(2.8), mental speed (5.2), reaction time (5.1), attention (45.9), and cognitive flexibility 
(31.7), which is a measure of executive function. Of interest is that the investigators 
mentioned that those individuals who were more aerobically active during the week had 
significantly greater scores than those who were less aerobically active during the week. 
The investigators suggested that these positive effects on neurocognition may be dose-
response dependent.  
In a 12-week mental and physical intervention, Barnes, Santos-Modesitt, Poelke, 
Kramer, Castro, Middleton, and Yaffe (2013) examined the combined effects of mental 
activity in addition to physical activity on measures of cognitive function in older adults 
who were considered inactive. Participants were assigned to groups that were involved 
with home-based mental activity (Posit Science®, or educational DVDs) and/or class-
based physical activity, and the group combinations therein. A stretching and toning 
based control was also utilized to compare group differences. The investigators found 
that cognitive scores on a global scale significantly improved over time. However, those 
who participated in the mental activity training (Posit Science®) did not significantly 
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differ from those who were in the mental activity control group that watched educational 
DVDs. The results indicated that although the groups that participated in mental activity 
training improved on measures of cognitive function, there were no significant 
differences between those who used PositScience® or the educational DVD’s. The 
investigators concluded that amount of mental activity may be a greater factor than the 
type of mental activities.   
Within the literature it is apparent that cancer treatment(s) devastate not only 
cancerous cells in the body, but to varying degrees across treatments, cancer types, and 
stage of cancer have been observed to negatively and destructively affect healthy cellular 
tissue. Whether it be inflammatory toxicity, micro-vascular toxicity, or direct neuro-
toxicity; the implementation of combative measures, with the purpose of treatment-
related side-effect reduction, or alleviation is of importance. Cancer incidence has been 
reported to be increasing which may also signify an increasing amount of prescribed 
treatments. Although, following treatment people are also living longer, which suggests 
potentially greater incidence of treatment-related side-effects. Unaccompanied, research 
has indicated the benefits of exercise and cognitive training on physiological, 
psychological, and cognitive variables. Implementing combined regimens of aerobic and 
cognitive training may be a substantially greater method of treating the treatment 
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CHAPTER III 
 
METHODS 
 
Experimental Design 
 
 The intervention consisted of 12 weeks (or 36 sessions) of aerobic, cognitive, or a 
combination of aerobic and cognitive training on the Motion Fitness Brain-Bike®. This 
study provided allowance for the investigation of the implications of cognitive and 
aerobic training on physiological and psychological parameters in cancer survivors who 
were undergoing, or underwent treatment. Participation in this study was according to 
pre-determined inclusion and exclusion criteria. In addition, participants were screened 
for any secondary factors such as medication(s) or physical limitations not included in 
inclusion/exclusion criteria, but that could have potentially altered the outcomes of the 
study. Selection of CAN participants was conducted during or following initial physical 
assessment. Selection of NC participants was via email listserv and university-related 
recruitment websites. In certain circumstances where offsite recruiting resulted in 
participants expressing interest in this study, selection may have occurred prior to initial 
physical assessment. In depth cognitive and psychological assessment parameters 
included: general cognitive functioning, processing speed, working memory, executive 
function, attention, verbal learning and memory, verbal fluidity, perpetual reasoning, 
mood, anxiety, depression, fatigue, and QOL.
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  Medical history, fatigue, depression, mood, and anxiety information was collected 
prior to initial assessment. Comprehensive cognitive assessment data were gathered prior 
to and following the exercise intervention, and have been explained in detail in the 
cognitive assessment section. Physiological baseline measures were gathered prior to and 
following the exercise intervention, including the assessment of peak aerobic capacity 
(VO2peak). Further details have been included in the subsequent physiological assessment 
section.  
Participants 
Participants in this study were males and females (56.9 ± 8.8 years of age), who 
had been diagnosed with cancer (CAN) (n = 28) and age-matched participants who had 
not been diagnosed with any type of cancer (NC) (n = 7). Individual group stratification 
abbreviations are listed in Table 1. Participants who had cancer, were either undergoing, 
or had underwent chemotherapy or chemotherapy and radiation treatment, and were 
referred to the RMCRI from local oncologists. Following physician referral to the 
RMCRI, participants were asked to read and complete the following paperwork required 
for pre-screening: complete medical history, cardiovascular disease risk assessment, 
cancer history, and a lifestyle/activity evaluation. All of the aforementioned paperwork 
items were evaluated prior to initial assessment for potential limitations or co-morbidities 
that might have affected the outcomes of the study. Lifestyle factors such as, tobacco, 
alcohol, dietary intake have been highlighted through questioning on the lifestyle/activity 
evaluation. Participants were informed on the overview of the procedures and purpose as 
explicitly delineated within the informed consent (Appendix A).  
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Participants were then asked to read and sign the informed consent form. Pending 
acceptance of terms and conditions of the study as well as complying with 
inclusion/exclusion criteria as described in the following paragraph, participants were 
then randomized into one of five groups as described in Table 1. The CAN-AER-COG (n 
= 9) group was composed of cancer survivors that participated in aerobic, cognitive, and 
flexibility training. The CAN-AER group (n = 7) was composed of cancer survivors and 
participated in aerobic and flexibility training; however, they did not participate in 
cognitive training. The CAN-CON group (n = 7) was composed of cancer survivors that 
participated in flexibility training, but did not participate in aerobic or cognitive training. 
The NC-CON group (n = 7) was the control group consisting of participants who had not 
been diagnosed with any form of cancer. The NC-CON group completed aerobic, 
cognitive, and flexibility training. The CAN-COG group (n = 5) was composed of cancer 
survivors who participated in cognitive training and flexibility training; however, they did 
not participate in aerobic training. This study followed and abided by guidelines 
established by University Institutional Review Board following approval (Appendix B). 
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Table 1 
 
Group stratification 
 
Group Participants Aerobic Cognition Flexibility 
1 
CAN-AER-COG 
 
Cancer Yes Yes Yes 
2 
CAN-AER 
 
Cancer Yes No Yes 
3 
CAN-CON 
 
Cancer No  No Yes 
4 
NC-CON 
 
No Cancer Yes Yes Yes 
5 
CAN-COG 
Cancer No  Yes Yes 
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Figure 1. Experimental Design. CAN, cancer; COG, cognitive training; AER, aerobic training; CON, non-cancer controls.  
CAN groups, n = 28; CON group, n = 7. 
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Inclusion/ Exclusion Criteria 
Participants in the study were excluded from the study if they reported having any 
history of psychiatric diagnoses, neurological disease, past or present alcohol or 
substance abuse, difficulty with mobility, auditory dysfunction, and non-corrected visual 
issues. Participants were not allowed to partake in the study if they had undergone any 
type of software based cognitive training in the past 6 months including: Neuro-Active®, 
Posit-Science®, Mindfit®, Lumosity®, My Brain Trainer®, or any other brain fitness 
program. It was also a preliminary requirement that participants be right handed because 
the mechanical design of the original Brain Bike® mouse pad assembly only allowed for 
individuals who were right handed, however in 2013 our lab acquired a second Brain 
Bike® which had a detachable mouse pad assembly which could be moved from the right 
side of the Brain Bike® to the left side allowing for left hand dominant individuals to be 
included. Participants were told they could not have participated in any type of aerobic 
activity such as walking or running greater than two times per week for eight weeks prior 
to starting the study. Participants were also required to score greater than or equal to 26 
on the MMSE, had been undergoing, or had completed chemotherapy within eight weeks 
of starting the study, or completed the combination of chemotherapy and radiation 
treatments, in upwards of six years.  
Physiological Assessment 
Following the completion of preliminary paperwork, participants completed a 
physical examination for clearance to exercise. Initial values for heart rate (HR), blood 
pressure (BP), oxygen saturation (SpO2), height, weight, body composition, 
circumference measurements, cardiovascular fitness (VO2peak, RMCRI protocol), balance 
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(Bertec Balance Screener or Unipedal Stance Test), pulmonary function (Spirometry), 
estimated 1RM (Brzycki equation), muscular endurance (plate loaded cable assisted 
machines), handgrip dynamometry, abdominal muscular endurance (plank test), and 
flexibility measures (Modified Sit and Reach and Shoulder Reach Behind Back) were 
determined and recorded as part of the standard RMCRI physical assessment protocol. 
Since this study was conducted over a period of nearly four years, certain procedural 
changes were introduced that altered some components of the overall RMCRI 
assessment. These include additions or removals of the following: Unipedal stance test, 
Bertec balance screening, circumference measures, crunch test, plank test, shoulder reach 
behind back test, muscular endurance via (plate loaded cable assisted machines), 
estimated 1RM and the waist-to-hip ratio measures and data collected had varying values 
for the aforementioned, and therefore could not be included in analyses. For the purposes 
of this evaluation, descriptions and analyses concerning anything other than measures of 
HR, BP, cognitive function, VO2peak, and Modified Sit and Reach were conducted during 
pre and post assessments, but have been purposely excluded from this evaluation. Any 
other relevant information regarding currently existing medical conditions, over the 
counter, and prescription medications, was evaluated in the context of the study 
parameters. 
Blood Pressure, Heart Rate,  
and Pulse Oximetry  
 
Initial resting values of blood pressure (BP) were obtained from subjects via 
auscultation methods as outlined in Heyward (2006). Participants were asked to sit 
quietly for at least five minutes. With the participant’s arm resting approximately at heart 
level the deflated blood pressure cuff was placed around the participant’s bare arm and 
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attached via Velcro® strapping. The placement of the blood pressure cuff was secured 
approximately one inch above the antecubital fossa. The manometer was positioned so 
that the center of the dial was visible at the eye level of the assessor. The head of the 
stethoscope was placed approximately one centimeter medial and superior to the 
antecubital fossa over the brachial artery. Following the asking of each client what his or 
her typical systolic blood pressure was, the assessor closed the valve and steadily and 
rapidly inflated the cuff air bladder to approximately 30mmHg above the client reported 
values. If the values that the client reported were not sufficient to result in an accurate 
measure of blood pressure, the assessor re-inflated the cuff to a value great enough to 
produce accurate assessments of blood pressure. The assessor then slowly opened the 
valve to reduce air pressure and listened for phase I of the Korotkoff sounds. Phase I 
sounds have been reported to equate to systolic pressure (Hayward, 2006). Pressure 
reduction continued while listening for phase IV and V. Phase V is generally considered 
as equating to diastolic blood pressure. The assessor continued deflating the pressure in 
the cuff until the complete cessation of audible sounds occurred. A minimum of 30 
seconds was allowed between each measure of BP as recommended by Heyward (2006). 
Measures of BP were recorded on assessment data collection sheets with the average of 
the two measures chosen as the final value. In addition, percentage of O2 bound to 
hemoglobin was measured via pulse oximetry. 
Assessment of Cardiorespiratory 
Fitness 
 
 The RMCRI treadmill protocol was administered to evaluate each participant’s 
cardiorespiratory fitness (CF). In 2010, this progressive treadmill protocol was designed 
specifically for cancer survivors. Participants were made privy to all elements of the 
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pending treadmill testing prior to commencement. If health-related concerns presented 
themselves that would have inhibited the participant from executing an appropriate 
performance during the advancement of the initial assessment, then secondary measures 
of CF such as, submaximal cycle-ergometer testing measures would have been employed. 
However, no such circumstances presented themselves during the course of this study.      
 The RMCRI protocol was carefully monitored and administered. Each stage was 
one minute in length with the intensity adjusted as a means of belt speed, incline, or both 
each successive minute. Stage one walking speed started at 1.0 mph and was increased by 
0.5 mph until the participant verbalized his/her commitment to aborting the continuation 
of the test. During stages one through four, grade consistency was maintained at 0% until 
stage five began. The first grade inclination was set to 2% and was maintained 
throughout the sixth stage. From stage seven until stage 21 or at the onset of volitional 
fatigue, grade and belt speed was increased 1% and 0.1 mph, respectively. HR and SpO2 
were recorded each minute while BP and RPE were recorded every third minute until test 
completion. Table 2 further details the staging, administration, and determination of 
VO2peak for the RMCRI protocol. The test was terminated if the client reached volitional 
fatigue, asked to stop for any reason, HR or SBP did not increase as intensity increased, 
DBP fluctuated more than 10mmHg from baseline, SpO2 dropped below 80 via pulse 
oximetery, and HR exceeded calculated maximum HR determined by the following 
formula (HRmax = 205.8 – (.685 x age). The test completion time was measured in 
conjunction with age, gender, and whether or not the participant used the handrails. 
VO2peak was determined based on these variables. Lastly, table 3 describes how the 
classification of CF analogous to the aerobic capacity (mL·kg-1·min-1) was determined. 
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Table 2 
Estimation of cardiorespiratory fitness (mL·kg-1·min-1) 
S mph % 
Estimated VO2 peak  
(mL/kg/min) 
METS 
Estimated VO2 peak (H) 
(mL/kg/min) 
METS 
(H) 
1 1.0 0 6.2 (walk) 1.7 6.2 (walk) 1.7 
2 1.5 0 7.5 (walk) 2.1 7.5 (walk) 2.1 
3 2.0 0 8.9 (walk) 2.5 8.9 (walk) 2.5 
4 2.5 0 10.2 (walk) 2.9 10.2 (walk) 2.9 
5 2.5 2 12.6 (walk) 3.6 12.1 (walk) 3.5 
6 3.0 3 15.9 (walk) 4.5 14.4 (walk) 4.1 
7 3.3 3 17.1 (walk) 4.9 15.2 (walk) 4.3 
8 3.4 4 19.1(walk) 5.5 16.6 (walk) 4.7 
9 3.5 5 21.3(walk) 6.1 18.1 (walk) 5.2 
10 3.6 6 28.0 (run) 
23.6 
(walk) 
8.0 / 6.7 22.8 (run) 
19.7 
(walk) 
6.5 / 
5.6 
11 3.7 7 29.6 (run) 
25.9 
(walk) 
8.5 / 7.4 23.9 (run) 
21.3 
(walk) 
6.8 / 
6.1 
12 3.8 8 31.3 (run) 
28.4 
(walk) 
8.9 / 8.1 25.0 (run) 
23.0 
(walk) 
7.1 / 
6.6 
13 3.9 9 32.9 (run) 
30.9 
(walk) 
9.4 / 8.8 26.2 (run) 
24.8 
(walk) 
7.5 / 
7.1 
14 4.0 10 34.6 (run) 
33.5 
(walk) 
9.9 / 9.6 27.3 (run) 
26.6 
(walk) 
7.8 / 
7.6 
15 4.1 11 36.4 (run) 
36.3 
(walk) 
10.4 / 
10.4 
28.6 (run) 
28.5 
(walk) 
8.2 / 
8.1 
16 4.2 12 38.2 (run) 
39.0 
(walk) 
10.9 / 
11.1 
29.8 (run) 
30.4 
(walk) 
8.5 / 
8.7 
17 4.3 13 40.0 (run) 
42.0 
(walk) 
11.4 / 
12.0 
31.1 (run) 
32.5 
(walk) 
8.9 / 
9.3 
18 4.4 14 41.9 (run) 
45.0 
(walk) 
12.0 / 
12.9 
32.4 (run) 
34.6 
(walk) 
9.3 / 
9.9 
19 4.5 15 43.9 (run) 
48.1 
(walk) 
12.5 / 
13.7 
33.8 (run) 
36.7 
(walk) 
9.7 / 
10.5 
20 4.6 16 45.9 (run) 
51.3 
(walk) 
13.1 / 
14.7 
35.2 (run) 
38.9 
(walk) 
10.0 / 
11.1 
21 4.7 17 48.0 (run) 
54.6 
(walk) 
13.7 / 
15.6 
36.6 (run) 
41.2 
(walk) 
10.5 / 
11.8 
Note: (H) denotes the usage of handrails by the participant 
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Table 3  
RMCRI cancer-specific cardiorespiratory fitness norms (mL·kg-1·min-1) 
 Age Low Fair Avg. Good Ex. M ± SD 
Women 19-39 < 22.2 22.2 - 25.0 25.0 - 26.6 26.6 - 28.3 > 28.3 26.0 ± 5.6 
 40-49 < 18.6 18.6 - 22.3 22.3 - 24.5 24.5 - 27.6 > 27.6 23.5 ± 5.5 
 50-59 < 17.6 17.6 - 21.1 21.1 - 23.4 23.4 - 27.8 > 27.8 22.5 ± 6.3 
 60-69 < 15.4 15.4 - 17.6 17.6 - 21.3 21.3 - 23.6 > 23.6 19.7 ± 5.6 
 70+ < 10.9 10.9 - 15.0 15.0 - 16.7 16.7 - 19.2 > 19.2 16.1 ± 5.1 
Men 19-39 < 23.9 23.9 - 24.8 24.8 - 25.0 25.0 - 31.7 > 31.7 25.3 ± 5.4 
 40-49 < 18.5 18.5 - 24.1 24.1 - 29.1 29.1 - 33.0 > 33.0 26.3 ± 6.9 
 50-59 < 14.5 14.5 - 19.6 19.6 - 23.5 23.5 - 29.2 > 29.2 22.5 ± 7.4 
 60-69 < 15.7 15.7 - 17.7 17.7 - 23.4 23.4 - 27.9 > 27.9 21.3 ± 6.7 
 70+ < 13.6 13.6 - 17.1 17.1 - 21.3 21.3 - 24.3 > 24.3 19.2 ± 6.0 
 
Flexibility 
 In the evaluation of flexibility, the modified sit and reach test was administered. 
The modified sit and reach test allows for the determination of flexibility while 
controlling for limb length differences between individuals. The participant began the 
assessment by first removing his or her shoes and seating themselves on the floor with his 
or her head, shoulders, and buttocks placed firmly against a wall, and with his or her legs 
positioned straight ahead of them. The sit and reach measurement apparatus was then 
placed against his or her shoeless feet with the “zero” end of the measurement arm facing 
toward the participant. The participant was instructed to hold his or her arms straight 
forward while keeping his or her back, head, and buttocks firmly placed against the wall. 
The measurement arm was then moved toward the fingertips of the participant’s extended 
arms. Once that measure was secure, the participant was subsequently instructed to reach 
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forward as far as possible, pushing the sliding measurement tab as far as he or she could. 
The participant was also instructed to keep his or her hands together and knees fully 
extended during each trial. The furthest of three trials was considered the final 
measurement of flexibility.   
Psychological Indices 
 Before preliminary assessment, and following the completion of the 12-week 
intervention, the following indices of psychological assessment were completed: Beck 
Depression Inventory, Piper Fatigue Scale, and Ferrans and Powers Quality of Life Index 
Cancer Version III. Following antineoplastic treatment, a commonly experienced side 
effect is depression.  
Beck Depression Inventory  
 In this study, depression was measured using the Beck Depression Inventory. The 
Beck Depression Inventory is composed of 21 items which are declarative statements 
analogous to values ranging from zero to three. Statements that reflect values of zero are 
indicative of the most extreme positive position. Opposing assertions, valued as three, 
indicate the most extreme negative statement. A sense of neutrality exists for values 
represented by one and two, although either the three or the zero on the opposing ends of 
the continuum may be favored. Values for all 21 items are added; scores range from zero 
to 63 with zero indicative of no depression and > 40 reflecting extreme depression 
(Salkind, 1969).   
Piper Fatigue Inventory  
 Piper fatigue Inventory results yield an inclusive score, indicating the overall 
extent of cancer-related fatigue (CRF). Aspects of participants’ lives that may be 
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significantly impaired or hindered by CRF were further delineated using the calculated 
values obtained for cognitive/mood, behavioral, affective, and sensory subscales. There 
are 22 items in the inventory composed of four subscales as previously mentioned. Each 
possible score per subscale ranges from zero to ten. Overall measures of CRF range from 
zero to ten and is evaluated from the average of all subscales. A combined score of zero 
is redolent of a lack of perceived fatigue. Scores ranging from one-three, four-six, and 
seven+ indicate mild, moderate and severe fatigue, respectively (Piper, Dibble, Dodd, 
Weiss, Slaughter, & Paul, 1998). 
Quality of Life Index 
 In cancer rehabilitation settings, outcomes on QOL assessments are ideal for 
determining efficacy and impact of rehabilitative programs (Ferrans, 2010). Utilizing 
Ferrans and Powers Quality of Life Index Cancer Version III, QOL measures were 
administered at baseline and at three months following the intervention. Sixty-six 
questions are included in this assessment which pertain to the significance and 
importance the individual places on psychological, social, health, and family associated 
issues. The Ferrans and Powers QOL assessment is a valid, criterion-based instrument, 
and was determined as such based on correlational values between overall satisfaction 
with QOL and the instrument with dialysis patients (r = 0.7) and graduate students (r = 
0.8). Test-retest correlations substantiated the reliability of the instrument (graduate 
students, α = 0.9, r = 0.9; dialysis patients, α = 0.9, r = 0.9). Observed total scorings that 
are higher indicate an agreement between importance placed on each dimension and 
individual satisfaction with that element, which can be attributed to an overall condition 
of well-being (Ferrans & Powers, 1985). 
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Exercise Intervention 
Prior to beginning the study, participants who were assigned to an aerobic activity 
group were seated and leg-to-pedal distance was measured to allow individual flexion 
and extension comfort while cycling in the recumbent position. Seat position was 
recorded on data collection sheets for the purpose of consistency during the following 
training sessions. Resting heart rate was recorded to evaluate % of heart rate reserve 
(HRR, Karvonen Method) intensity each aerobic training group participant exercised at 
during each training session. Aerobic training sessions were progressive and began at 
55% HRR for weeks one-four, 60% HRR for weeks five-eight, and 65% HRR for weeks 
nine-12, as detailed in Table 4. Before each warm-up session, participants were initially 
required to attach a telemetric heart rate monitoring device (Polar®). However, during the 
Spring of 2012 when three similar studies were being conducted and multiple clients 
were being scheduled back-to-back, having participants wear heart rate monitors became 
a substantial disadvantage to collecting data on time within a tight schedule (for both the 
data collectors and the clients), and therefore necessitated the reliance on pulse oximetery 
and heart rate monitoring via handles of the Brain Bike® apparatuses. For example, under 
the assumption that the client arrived for training on time (rarely occurred), it often took 
upwards of ten extra minutes to have clients grab the heart rate monitor, walk to the 
bathroom, attach the monitor, stop to use the restroom, walk out of the restroom, and then 
(finally) sit down to begin warming up. If the participant did not have any problems 
adjusting the strap on the heart rate monitor and it was reading appropriately then training 
could start only slightly behind schedule. However, many times the participants had 
difficulty in putting their heart rate monitors on and an extra few minutes would have to 
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be spent in order to make proper adjustments and ensure that it was reading 
appropriately. In addition, because of the amount of participants training was chaotic 
between three studies, many times, participants left without removing their heart rate 
monitors which negatively affected the amount of heart rate monitors for clients of the 
RMCRI not participating in a study. When training began, participants were asked to seat 
themselves and commence their warm-up consisting of five minutes of low intensity, 
self-paced cycling. Following completion of warm-up, each participant had resistance 
applied to the Motion Fitness Brain Bike® recumbent cycle ergometer in order to 
stimulate elevations in heart rate to the training range associated with % of HRR and 
weekly progression for the duration of 30 minutes in addition to 30 minutes of flexibility 
training. Those who were in the CAN-AER-COG group cycled and completed cognitive 
training at the same time. In the event that the client was unable to maintain the 
prescribed percentages of HRR, RPE was utilized to maintain voluntary levels of exertion 
that were numerically (1-10 scale) equivalent to HRR intensities. The first Brain Bike® 
recumbent cycle ergometer we obtained was generously donated by Brain Center 
International (BCI) located in Quebec City, Canada. Upon completion of cognitive 
training, data were wirelessly transmitted to BCI databases for analysis.  
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Table 4  
Aerobic training schedule and cognitive training exercises 
Week % HRR Session Training Exercises 
1 .55 1 - 3 1 - 5, 1 - 5, 1 - 5 
2 .55 4 - 6 1 - 5, 1 - 5, 6 (step 
10) 
3 .55 7 - 9 6 (step 9 - 7) 
4 .55 10 - 12 6 (step 6 - 4) 
5 .60 13 - 15 6 (step 3 - 1) 
6 .60 16 - 18 1 - 5, 1 - 5, 1 - 5 
7 .60 19 - 21 1 - 5, 1 - 5, 7 (step 
10) 
8 .60 22 - 24 7 (step 9 - 7) 
9 .65 25 - 27 7 (step 6 - 4) 
10 .65 28 - 30 7 (step 3 - 1) 
11 .65 31 - 33 1 - 5, 1 - 5, 1 - 5 
12 .65 34 - 36 1 - 5, 1 - 5, 1 - 5 
 
Stretching Protocol 
 In order to differentiate between interventions, a total-body stretching protocol 
was implemented as the control for this study. The stretching session consisted of 30 
minutes of static stretches designed to target major muscle regions throughout the body. 
The regions included: neck, shoulders/chest, posterior upper arm, upper back, lower back, 
hips, torso, anterior thigh and hip flexor, posterior thigh, groin, and calf (Baechle & 
Earle, 2008).  
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Table 5   
Regional bodily areas covered with stretching 
Body Region Stretching Motion Muscles Actuated Time 
(min) 
Neck 
 
Look Right/ Left  
Flexion/ Extension 
-Sternocleidomastoid (SC) 
-SC, Suboccipitals, Spenae 
1 
1 
 
Shoulders/ Chest Straight Arms 
Behind Back 
Seated Lean-Back 
-Anterior Deltoid, Pectoralis 
Major 
- Deltoids, Pectoralis Major 
 
1 
1 
Posterior Upper 
Arm 
Behind-Neck 
Stretch 
-Triceps Brachii, Latissimus Dorsi 
 
2 
Upper Back Cross Arms In 
Front of Chest 
Arms Straight Up 
Above Head 
 
-Posterior Deltoid, Rhomboids, 
Mid Trapezius 
-Latissimus Dorsi 
1 
1 
Lower Back Spinal Twist 
 
 
Semi-Butterfly 
-Int/Ext Oblique, Piriformis, 
Erector Spinae 
-Erector Spinae 
2 
 
2 
Hips Forward Lunge 
Supine Knee Flex 
-Iliopsoas, Rectus Femoris 
-Gluteus Maximus, Hamstrings 
 
1 
1 
Torso Side Bend With 
Straight Arms 
-External Oblique, Lattissimus 
Dorst, Serratus Anterior 
 
1 
1 
Anterior Thigh 
and Hip Flexor 
 
Side Quadriceps 
Stretch 
-Quadriceps, Iliopsoas 4 
Posterior Thigh Sitting Toe Touch-
Hurdler 
 
Semi-Straddle 
-Hamstrings, Erector Spinae, 
Gastrocnemius 
- Hamstrings, Erector Spinae, 
Gastrocnemius 
 
2 
 
2 
Groin Straddle 
Butterfly 
-Gastrocnemius, Hamstrings, 
Erector Spinae 
-Hip Adductors, Sartorius 
 
2 
1 
Calf Wall Stretch 
 
Step Stretch 
-Gastrocnemius, Soleus, Achiles 
Tendon 
-Gastrocnemius, Soleus, Achiles 
Tendon 
1 
 
2 
TOTAL TIME   30min 
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Cognitive Training Protocol 
 The cognitive training tasks were based on the recommendations from BCI. The 
tasks included exercises which emphasized training in working memory, visuo-spatial 
memory, processing speed, divided attention, selective attention, vigilance, attentional 
flexibility, useful field of view, verbal processing speed, cognitive control, temporal 
perception, and arithmetic operations. Division of time spent during each task was pre-
determined by BCI. Each of the cognitive training tasks (parking, driving, smart driving, 
the policeman, brain twister, the pilot, and the stock exchange) was composed of five 
minutes of training. Details of each cognitive training component are included in Table 6. 
For the first five sessions participants completed parking, driving, smart driving, the 
policeman, and brain twister exercises. On session six, participants then completed five 
sessions of the pilot consecutively until session 16. During sessions 16-20 participants 
then returned to completing parking, driving, smart driving, the policeman, and brain 
twister. On session 21, participants were then required to complete five sessions of the 
stock exchange consecutively until session 30. Finally, during sessions 31-36, 
participants were again required to complete parking, driving, smart driving, the 
policeman, and brain twister. Screenshots have been provided in Appendix C.  
Parking 
The parking training segment consisted of a simulated “pay to park” parking lot 
where cars appeared on screen as either not paid, paid in full, or had accidentally paid 
double the fee. The simulated cars that had paid the full amount blinked with a single 
dollar sign encircled in red. The cars that paid double appeared on the screen as having 
two dollar signs encircled in red above the car. Those cars that had not paid appeared as 
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not having a dollar sign appear above them. The participant has to then memorize each 
car and how they presented their status of payment and click the mouse to designate that 
status. For example, the cars that appeared as not having paid required one mouse click, 
cars that appeared as having paid double required two mouse clicks, and cars that 
appeared to have paid the correct amount did not require any mouse clicks since they 
paid correctly. The five-minute segment was broken down into smaller segments that 
changed once the participant validated the set of parked cars.  
Car Driving 
 During the car diving segment of training, the participant assumed the role of 
driving a car down a series of simulated intersections and was required to make decisions 
based on the appearance of oncoming street signs and lighted signals. At each 
intersection participants had to decide as soon as possible whether street signs that 
appeared were the same or different by inputting their response on a numerical keypad by 
pressing the “/” key for the designation of same street and the “*” for the designation of 
different street signs. Similarly, when each new intersection appeared, participants 
inputted whether the signal appeared red or green as quickly as possible on numerical 
keypad by pressing “2” for red and “3” for green. Throughout this training segment 
participants also needed to be aware of the sounds of honking horns from other drivers. 
Upon hearing each horn honking, participants were then required to press the “+” key on 
the numerical keypad as quickly as possible.   
Smart Driving 
 Unlike the aforementioned car driving task, smart driving doesn’t give the 
participant the feeling of driving throughout simulated intersections, but has the driver 
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sitting in their car during heavy, non-moving traffic. On the screen there are multiple 
interactive locations where objects such as kids crossing the street or the gas light on the 
dashboard that appeared randomly. Other on screen interactive areas included: the 
rearview mirror, a lighted street sign located at the top of the screen, and a large street 
sign in the middle of the screen. This large centrally located sign was different than the 
other interactive areas in that while participants were scanning the screen for the 
appearance of a lit gas can, or a child running out into the street, they needed to also 
observe what picture appeared and then clicked on one of two pictures that appeared 
immediately following the disappearance of the first picture. For example, the picture of 
a man lifting weights may have appeared on the first sign and upon disappearance, a sign 
with two picture choices appeared. Since the first picture was of a man lifting weights, 
the correct answer would have been for the participant to then click on the second picture 
that portrayed a man lifting weights.    
The Policeman 
 In the policeman, the participant was given the simulated experience of being a 
police officer wielding a radar gun monitoring the speeds of passing vehicles. On the top 
of the screen a dialogue box indicated a number from one to five. These numbers were 
reflective of the difficulty of the task. Participants were then required to remember radar 
speeds that corresponded to each car and compare them against cars that followed behind 
them. For example, in beginning stages of training participants may have had to compare 
one car’s speed to the next; however, in advanced stages, participants could potentially 
have had to compare every five cars. What makes this exceptionally difficult is that the 
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first car would be compared to the fifth car, the second car compared to the sixth car, the 
third car compared to the eighth car, and so on.     
Brain Twister 
 During this task, participants are shown a light blue screen with various shapes 
and descriptor terms that must be compared to a central “consistent” or “inconsistent” 
banner that appears in the middle of the screen. If the central banner reads “consistent” 
then participants must choose shapes and descriptors that embody consistency. For 
example, among other shapes and descriptor terms, a red circle may appear with the word 
“red” inside it. If the banner reads “consistent,” then the correct choice would be to 
choose the red circle as the only consistent choice. The task only allows for one correct 
answer, so there are no options for multiple correct answers.   
The Pilot 
 This training task allows the participant the feeling that they are behind the 
cockpit of a helicopter, although there is no motion other than the “dials” portion and the 
“calculator” portion. The instructions dictate that the participant is flying a helicopter and 
must evaluate the dials against the calculation portion of training. The dials are composed 
of a block of six dials of equal sizes and are round shaped. The dials are stacked ion 
columns of two and correspond with three different times with “24 seconds”, “12 
seconds”, and “8 seconds” appearing from left to right below the dials. The calculation 
panel consists of a keypad very similar to that of a standard calculator. During the 
training the participant is told which task to provide a greater amount of their attention to 
in conjunction with the other. For example, one segment of training may ask that the 
participant prioritize the dials portion of training over the calculations panel. In this case, 
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the participant must give a greater amount of their attention to the dials as opposed to the 
calculations. This training segment is broken down into three parts wherein each part will 
state a new training objective that the participant must prioritize. Prioritization is never 
only one or the other and may state that the participant prioritize both tasks equally.    
Stock Exchange 
 This set of cognitive training tasks gives the participant the simulated feeling of 
being on the trading floor at the New York stock exchange. On the computer display, 
there is a central screen which will have a stock ticker symbol (BCI) that will move from 
location to location. The participant must also be aware of a vocalized numerical value as 
it pertains to the trading price of the BCI stock. During the training, the participant must 
prioritize either the location of the stock symbol (same or different location) or the value 
(higher or lower) by pressing corresponding keys on the keypad. This training task is 
composed of five levels which will alter the prioritization of tasks and speed of delivery 
as the participant increases in level of difficulty.   
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Table 6  
Cognitive training exercises 
Number Exercise Trained Functions Description 
1 Parking Working Memory 
Visio-Spatial Memory 
Adaptation and 
classic visuo-spatial 
span task 
 
2 Car Driving Processing Speed 
Divided Attention 
Selective Attention 
Vigilance 
Two simultaneous 
biconditional 
discrimination (S-
R) tasks with a 
vigilance task 
 
3 Smart 
Driving 
Processing Speed 
Selective Attention 
Attentional Flexibility 
Useful Field of View 
Divided Attention 
Vigilance  
 
Derived from  
ACTIVE trial; with 
UFOV program 
4 The 
Policeman 
Working Memory 
Verbal Processing Speed 
Standard n-back 
task with adaptable 
time limit 
 
5 Brain Twister Processing Speed 
Cognitive Control 
Attentional Flexibility 
Stroop-like based 
on cue and reponse 
conflict and 
attentional set-shift 
paradigm 
 
6 The Pilot Divided Attention 
Temporal Perception 
Arithmetic 
 
Dual monitoring 
task 
7 Stock 
Exchange 
Processing Speed 
Divided Attention 
Working Memory 
Two simultaneous 
n-back tasks: one 
audio-verbal and the 
other visuo-spatial 
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Cognitive Testing 
 Prior to and following the 12-week exercise intervention, each participant 
underwent a comprehensive cognitive assessment (Appendix D) conducted by doctoral 
students from the University of Northern Colorado School of Psychological Sciences.  
Table 7  
Pre/post cognitive testing measures  
Neuropsychological 
Construct 
Instrument Abbreviation 
General cognitive 
functioning 
-Wechsler Memory Scale, 4th 
ed. (WMS-IV) - General 
Cognitive Screener 
 
BCOG 
Processing speed -Trail-Making A TMT-A 
 
Working memory, 
executive function, 
attention 
-Wechsler Adult Intelligence 
Scale, 4th ed. (WAIS-IV) – 
Letter Number Sequencing, 
Coding. 
 
-Trail Making B 
LNS raw or scaled 
CD raw or scaled 
TMT-B 
Verbal learning & 
memory 
-Wechsler Memory Scale, 4th 
ed. (WMS-IV) – Logical 
Memory I and II 
- Wechsler Memory Scale, 4th 
ed. (WMS-IV) – Delayed 
Recall 
 
LMI raw of scaled  
LMII raw or scaled 
LMII DR raw or scaled 
Verbal fluidity - Controlled Oral Word 
Association Test 
COWAT-Age 
COWAT-Gender 
COWAT-Education 
 
Perceptual reasoning -Wechsler Adult Intelligence 
Scale, 4th ed. (WAIS-IV) – 
Block Design  
BD raw or scaled 
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Statistical Analyses 
Data Transformation and  
Imputation 
 
Preliminary data frequency and descriptive analyses were run to visually represent 
the raw data set to address possible inconsistencies or anomalous numerical occurrences. 
When missing data occurred, a series mean imputation was conducted using the 
Statistical Package for the Social Sciences version 21 (SPSS, Armonk, NY) which is 
detailed in Appendix E. For the cognitive variables included in this study, approximately 
1.3% of data were missing and replaced. For the physiological variables included in this 
study, approximately 3.6% of data were missing and replaced. In light of the fact that 
group sample sizes were small and unequal, this required analysis by non-parametric 
methodologies. Pre-to-post differences were then performed on all variables as a data 
reduction method resulting in singular data points, and were therefore considered for 
analysis.  
Global Analyses 
An omnibus Kruskal-Wallis Test of k independent samples [ =  ∑
	

	
−
 

 ] was conducted to assess group median differences between the four training 
interventions (aerobic, cognitive, and flexibility) against randomized controls for 
physiological, psychological, and cognitive measures (Conover, 1999). Elliot and Hynan 
(2011) reported that although the Kruskal-Wallis non-parametric analysis of variance is 
an equivalent substitution for a one-way Analysis of Variance (ANOVA), it is still an 
omnibus or global statistical procedure. This means that when rejection of the null 
hypothesis occurs (one or more groups differ significantly) that follow-up procedures 
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should be conducted to evaluate any pairwise comparisons that may be responsible for 
the significant main effects observed. Data utilized in these analyses were in direct 
violation of parametric one-way ANOVA assumptions and, precisely necessitated the 
adoption of non-parametric equivalents. The Kruskal-Wallis test does not provide any 
specific follow-up analyses; however, Elliot and Hynan (2011) reported that GraphPad 
PRISM® is a readily available statistical analysis software package that has the capability 
to appropriate run this analysis with post hoc testing (Conover, 1999; Elliot & Hynan, 
2011). Therefore, Kruskal-Wallis analyses were employed using GraphPad PRISM® 
version 4.03 (GraphPad Inc., La Jolla, CA). Post hoc analyses are described in the 
adjustments and post hoc analyses section. Wilcoxon sign ranks tests and pre-to-post 
percentages were also conducted to address individual group pre-to-post changes for each 
dependent variable (Glass & Hopkins, 1996). Wilcoxon sign ranks tests were performed 
using Statistical Package for the Social Sciences version 21 (SPSS, Armonk, NY). 
Assumptions 
 Data were assessed for adherence to four assumptions of Kruskal-Wallis testing 
(Conover, 1999). These are: independence of observation, mutual independence among 
various samples, the measurement scale is at least ordinal, and either the k observation 
distribution functions are identical, or else some observations may tend to yield greater 
values than other observations do.  
Randomization 
Randomization of groups was performed using the PROC PLAN protocol for the 
Statistical Analysis Software version 9.3 (SAS, Cary, NC). Given the number of 
proposed subjects and the amount of treatment groups, PROC PLAN randomly assigned 
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each subject to a treatment which was then utilized as a list to follow when recruiting and 
training subjects. The quasi aspect of this investigation pertained to individual discretion 
as to the placement of certain subjects who presented with particular health or cognitive 
issues that otherwise may have excluded them from participating in the study. For 
example, a particular participant presented as a stage III oligodendroma brain cancer 
patient. She expressed a profound interest in participating in the study, yet was 
randomized to the flexibility only group. In light of this situation, the ethical decision was 
made to allow her to participate in the aerobic and cognitive training group strictly 
because of her precarious position and recommendations from her physician. 
Groups 
 As previously mentioned, participants were randomized into one of five groups as 
outlined in Table 1 and Figure 1.  
Factors  
 Cancer status and treatment groups were the factors evaluated. Factor A was 
indicative of cancer status; being those who had cancer and those who did not have 
cancer. Factor B was indicative of the five training groups. In light of the fact that there 
are greater than three levels to Factor B, multiple comparison procedures were 
implemented.  
Adjustments and Post Hoc  
Analyses 
 
Although parametric post hoc analyses and adjustments such as a Bonferroni 
correction during multiple comparisons are employed to decrease the familywise error 
rate [FWα = 1-(1-α)c] for the purposes of reducing Type I error risk or rejecting the null 
hypothesis when it may actually be true, these methods were not employed for 
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nonparametric analyses conducted (Vincent, 2005). As reported previously, the Kruskal-
Wallis test does not provide specific post hoc pairwise comparisons (Conover, 1999). 
However, Kruskal-Wallis analyses were conducted using GraphPad PRISM® software 
(Elliot & Hynan, 2011). Although no significant (p < 0.05) main effects were observed 
between groups for each independent variable, any observed main effects, would have 
been followed up with a Dunn’s post hoc assessment. For all analyses, a p-value of 0.05 
was considered statistically significant.
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CHAPTER IV 
 
RESULTS 
 
Participant Characteristics 
 This study comprised a total of 35 subjects which included 28 cancer survivors 
and seven apparently healthy age-matched adults who had never been diagnosed with 
cancer (10 males, 25 females). The percentage of adherence to this study was 76%. 
Cancer diagnoses included anaplastic oligodendroma of the left frontal lobe (1), breast 
(14), breast/colon (1), colon (1), Hodgkin’s lymphoma (1), lung (1), lymphoma (1), 
multiple myeloma (1), non-small cell lung/brain (1), ovarian (2), ovarian/breast (1), 
prostate (1), supraglottic/laryngeal (1), and throat/tongue (1). All participants completed 
each of the required 36 training sessions; however, not one participant adhered to the 
requirements of completing their training within 12 weeks (average time to complete 36 
sessions was approximately 20 weeks). All participants completed pre and post cognitive 
assessments. Assessments were conducted by cognitive assessors from the University of 
Northern Colorado School of Psychological Sciences. A total of eight different assessors 
worked on this project. Because of this turnover, there were some aspects of the battery 
of cognitive assessments that were unintentionally overlooked or forgotten. Therefore, 
series mean imputation methodologies were employed to statistically account for missing 
data (Appendix E). All participants, with the exception of one, completed pre and post 
physiological assessments. Specifically, this one participant who did not complete her 
post physiological assessment refused to come back because she verbally stated she was 
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feeling better and the demands of her work schedule was of much greater importance 
than continuing with her rehabilitation. 
Physiological Assessment 
 Independent samples Kruskal-Wallis testing revealed no significant main (p > 
0.05) effects between all five groups and all measures of physiological function, therefore 
nullifying the need for post hoc analyses (Figures 2 and 3). Pre-to-post Wilcoxon sign 
ranks tests revealed that SANDR increased by 39% in the CAN-AER-COG group (Table 
9). VO2peak and SANDR increased by 20% and 17%, respectively in the CAN-AER group 
(Table 11). SANDR increased by 22% and VO2peak significantly (p < 0.05) increased 
(16%) from pre-to-post in the CAN-CON group (Table 13). RHR trended toward a 
significant (p = 0.09) decrease (-13%) in the NC-CON group (Table 15). There were no 
significant (p > 0.05) pre-to-post changes observed in the CAN-COG group. However, 
SANDR and VO2peak increased by 24% and 12%, respectively (Table 17).  
Psychological Indices 
 There were no significant (p > 0.05) main effects observed between all five 
groups and Piper fatigue (index and subcategories), Beck Depression Inventory, and 
QOL. Figures 4-10 graphically depict these comparisons. Pre-to-post percentage 
decreases were observed among Beck depression and all Piper fatigue subcategories 
ranging from -15 to -33% for the CAN-AER-COG group, and QOL increased by 9% 
(Table 9). Specifically, the CAN-AER-COG group significantly (p < 0.05) decreased 
from pre-to-post in the Piper behavioral subcategory. The CAN-AER group significantly 
(p < 0.05) decreased (-34%) from pre-to-post in the Piper sensory subcategory. All other 
Piper fatigue subcategories and Beck depression decreases ranged from -25% to -32%, 
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while QOL increased by 13% in the CAN-AER group (Table 11). There was a significant 
decrease (-55%, p < 0.05) in Beck depression, and a significant (p < 0.05) increase (26%) 
in QOL observed in the CAN-CON group. In addition, the CAN-CON group also 
decreased in all subcategories of Piper fatigue ranging from -40% to -67%, with the Piper 
cognitive/mood subcategory trending toward significance (p = 0.09) (Table 13). There 
were no significant (p > 0.05) pre-to-post differences observed in the NC-CON group. 
However, Beck depression scores did decrease (-42%) (Table 15). There was a 
significant (p < 0.05) decrease (-59%) and a significant (p < 0.05) increase (6%) in QOL 
observed in CAN-COG pre-to-post analyses. In addition, all Piper fatigue subcategories 
decreased with a range from -23% to -52% with the Piper index, affective, and 
cognitive/mood subcategories trending toward significance (p = 0.08) (Table 17).  
Cognitive Function 
 There were no significant (p > 0.05) main effects observed between all 5 groups 
and for each cognitive variable (Figures 11-27). There were no significant (p > 0.05) 
differences observed in any measure of cognitive function in the CAN-AER-COG group. 
However, the CAN-AER-COG group did decrease from pre-to-post in measures of 
reaction time (-49%, TMT-A), and increase in verbal fluidity (675%, COWAT-Z-G and 
280%, COWAT-Z-A) (Table 8). There were significant (p < 0.05) increases (28%-39%) 
observed among all Weschler Memory Scale (WMS-IV) raw and scaled scores, with the 
exception of WMS-IV-LMII cumulative percentage scores and BCOG scores in the 
CAN-AER group. In addition, there were significant (p < 0.05) increases in Weschler 
Adult Intelligence Scale (WAIS-IV) block design raw and scaled scores (20% and 19%, 
respectively). Furthermore, the CAN-AER group significantly (p < 0.05) increased (12%) 
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from pre-to-post in the WAIS letter number sequence scaled scores, and trended toward 
significance (p = 0.07). Finally, the CAN-AER group increased in 2 of the 3 measures of 
verbal fluidity (70%, COWAT-Z-A and 44%, COWAT-Z-ED) (Table 10). There were no 
significant pre-to-post increases in measures of cognitive function observed with the 
exceptions of significant (p < 0.05) increases (750%, COWAT-Z-G; 320%, COWAT-Z-
A; and 205%, COWAT-Z-ED) in all COWAT verbal fluidity scores (Table 12). There 
were no significant (p > 0.05) pre-to-post differences observed in the NC-CON group. 
However, reaction time (TMT-B) decreased (-22%) and all 3 COWAT measures 
increased (420%, COWAT-Z-G; 71%, COWAT-Z-A; and 78%, COWAT-Z-ED) (Table 
14). There were no significant (p > 0.05) pre-to-post differences observed for the CAN-
COG group. However, all WMS-IV scores increased ranging from 6%-20% with the 
exception of WMS-IV cumulative percentage (CP) scores. Reaction times (TMT-B) also 
decreased (-26%). All measures of verbal fluidity increased (156%, COWAT-Z-G; 
574%, COWAT-Z-A; and 60%, COWAT-Z-ED) (Table 16).  
 
 
82 
 
 
 
 
 
Figure 2. Group Comparisons of VO2peak. CAN, cancer; COG, cognitive training; AER, 
aerobic training; CON, non-cancer controls. Data are mean ± SD.  
 
 
Figure 3. Group Comparisons of Sit and Reach Scores. CAN, cancer; COG, cognitive 
training; AER, aerobic training; CON, non-cancer controls. Data are mean ± SD. 
 
 
 
 
CAN-AER-COG CAN-AER CAN-CON NC-CON CAN-COG
-4
-3
-2
-1
0
1
2
3
4
5
6
P
r
e
-t
o
-P
o
st
 D
if
fe
r
e
n
c
e
s
 (
m
L
/k
g
/m
in
-1
)
CAN-AER-COG CAN-AER CAN-CON NC-CON CAN-COG
-3
-2
-1
0
1
2
3
4
5
6
7
P
o
st
-t
o
-P
r
e
 D
if
fe
r
e
n
c
e
s 
(i
n
.)
83 
 
 
 
 
 
Figure 4.Group Comparisons of Piper Fatigue Index Overall Scores. CAN, cancer; COG, 
cognitive training; AER, aerobic training; CON, non-cancer controls. Data are mean ± 
SD. 
 
 
Figure 5. Group Comparisons of Piper Fatigue Index Behavioral Scores. CAN, cancer; 
COG, cognitive training; AER, aerobic training; CON, non-cancer controls. Data are 
mean ± SD. 
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Figure 6. Group Comparisons of Piper Fatigue Index Affective Scores. CAN, cancer; 
COG, cognitive training; AER, aerobic training; CON, non-cancer controls. Data are 
mean ± SD. 
 
 
 
Figure 7. Group Comparisons of Piper Fatigue Index Sensory Scores. CAN, cancer; 
COG, cognitive training; AER, aerobic training; CON, non-cancer controls. Data are 
mean ± SD. 
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Figure 8. Group Comparisons of Piper Fatigue Index Cognitive Scores. CAN, cancer; 
COG, cognitive training; AER, aerobic training; CON, non-cancer controls. Data are 
mean ± SD. 
 
 
Figure 9. Group Comparisons of Beck Depression Inventory Scores. CAN, cancer; COG, 
cognitive training; AER, aerobic training; CON, non-cancer controls. Data are mean ± 
SD. 
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Figure 10. Group Comparisons of Ferrans and Powers Quality of Life Index Scores. 
CAN, cancer; COG, cognitive training; AER, aerobic training; CON, non-cancer 
controls. Data are mean ± SD. 
 
 
 
 
Figure 11. Group Comparisons of General Cognitive Screening. CAN, cancer; COG, 
cognitive training; AER, aerobic training; CON, non-cancer controls. Data are mean ± 
SD. 
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Figure 12. Group Comparisons of Logical Memory I Raw Scores. CAN, cancer; COG, 
cognitive training; AER, aerobic training; CON, non-cancer controls. Data are mean ± 
SD. 
 
 
 
 
Figure 13. Group Comparisons of Logical Memory I Scaled Scores. CAN, cancer; COG, 
cognitive training; AER, aerobic training; CON, non-cancer controls. Data are mean ± 
SD. 
 
 
CAN-AER-COG CAN-AER CAN-CON NC-CON CAN-COG
-3
-2
-1
0
1
2
3
4
5
6
7
P
r
e
-t
o
-P
o
st
 D
if
fe
r
e
n
c
e
s
in
 L
M
I 
R
a
w
 S
c
o
r
e
s
CAN-AER-COG CAN-AER CAN-CON NC-CON CAN-COG
0
1
2
3
P
r
e
-t
o
-P
o
st
 D
if
fe
r
e
n
c
e
s
in
 L
M
I 
S
c
a
le
d
 S
c
o
r
e
s
88 
 
 
 
 
 
Figure 14. Group Comparisons of Logical Memory II Delayed Recall Raw Scores. CAN, 
cancer; COG, cognitive training; AER, aerobic training; CON, non-cancer controls. Data 
are mean ± SD. 
 
 
 
Figure 15. Group Comparisons of Logical Memory II Delayed Recall Scaled Scores. 
CAN, cancer; COG, cognitive training; AER, aerobic training; CON, non-cancer 
controls. Data are mean ± SD. 
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Figure 16. Group Comparisons of Logical Memory II Cumulative Percentage Scores. 
CAN, cancer; COG, cognitive training; AER, aerobic training; CON, non-cancer 
controls. Data are mean ± SD. 
 
 
 
Figure 17. Group Comparisons of Trail Making Test-A Scores. CAN, cancer; COG, 
cognitive training; AER, aerobic training; CON, non-cancer controls. Data are mean ± 
SD. 
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Figure 18. Group Comparisons of Trail Making Test-B Scores. CAN, cancer; COG, 
cognitive training; AER, aerobic training; CON, non-cancer controls. Data are mean ± 
SD. 
 
 
 
 
Figure 19. Group Comparisons of WAIS Block Design Raw Scores. CAN, cancer; COG, 
cognitive training; AER, aerobic training; CON, non-cancer controls. Data are mean ± 
SD. 
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Figure 20. Group Comparisons of WAIS Block Design Scaled Scores. CAN, cancer; 
COG, cognitive training; AER, aerobic training; CON, non-cancer controls. Data are 
mean ± SD. 
 
 
 
 
Figure 21. Group Comparisons of WAIS Letter Number Sequencing Raw Scores. CAN, 
cancer; COG, cognitive training; AER, aerobic training; CON, non-cancer controls. Data 
are mean ± SD. 
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Figure 22. Group Comparisons of WAIS Letter Number Sequencing Scaled Scores. 
CAN, cancer; COG, cognitive training; AER, aerobic training; CON, non-cancer 
controls. Data are mean ± SD. 
 
 
 
 
Figure 23. Group Comparisons of WAIS Coding Raw Scores. CAN, cancer; COG, 
cognitive training; AER, aerobic training; CON, non-cancer controls. Data are mean ± 
SD. 
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Figure 24. Group Comparisons of WAIS Coding Scaled Scores. CAN, cancer; COG, 
cognitive training; AER, aerobic training; CON, non-cancer controls. Data are mean ± 
SD. 
 
 
 
 
Figure 25. Group Comparisons of Controlled Oral Word Association Test-Gender. CAN, 
cancer; COG, cognitive training; AER, aerobic training; CON, non-cancer controls. Data 
are mean ± SD. 
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Figure 26. Group Comparisons of Controlled Oral Word Association Test-Age. CAN, 
cancer; COG, cognitive training; AER, aerobic training; CON, non-cancer controls. Data 
are mean ± SD. 
 
 
 
 
 
Figure 27. Group Comparisons of Controlled Oral Word Association Test-Education. 
CAN, cancer; COG, cognitive training; AER, aerobic training; CON, non-cancer 
controls. Data are mean ± SD. 
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Table 8   
CAN-AER-COG wilcoxon sign ranks test: cognitive variables and percentage changes 
Variable Pre Mean Pre SD Post Mean Post SD SIG. % Change 
WMS_IV_BCOG 54.55 3.64 54.67 3.54 0.93 0.22 
WMS_IV_LMI_RAW 26.89 7.90 25.89 4.54 0.57 -3.72 
WMS_IV_LMI_SCALED 10.33 3.00 10.33 2.00 0.87 0.00 
WMS_IV_LMII_DR_RAW 24.33 6.56 26.22 4.97 0.26 7.77 
WMS_IV_LMII_DR_SCALED 11.44 2.74 12.22 2.17 0.27 6.82 
WMS_IV_LMIICP_RAW 26.89 2.47 26.22 1.20 0.40 -2.49 
TMT_A_RAW 60.44 80.02 30.67 10.00 0.14 -49.26 
TMT_B_RAW 69.44 20.34 72.22 29.75 0.95 4.00 
WAIS_IV_BD_RAW 32.00 12.34 35.56 12.00 0.27 11.13 
WAIS_IV_BD_SCALED 9.00 2.96 9.89 2.89 0.26 9.89 
WAIS_IV_LNS_RAW 20.67 3.16 20.56 2.79 0.89 -0.53 
WAIS_IV_LNS_SCALED 11.56 3.43 11.44 2.88 1.00 -1.04 
WAIS_IV_CD_RAW  68.78 19.57 68.33 24.00 0.87 -0.65 
WAIS_IV_CD_SCALED 11.78 3.87 11.78 4.06 1.00 0.00 
COWAT_Z_G -0.04 1.60 0.23 1.80 0.31 675.00 
COWAT_Z_A 0.10 1.57 0.38 1.78 0.26 280.00 
COWAT_Z_ED -0.20 1.52 -0.17 1.75 0.86 15.00 
Note: WMS IV, Weschler Memory Scale (4th Ed.) (BCOG, general cognitive screener; LMI & LMII, Logical Memory delayed recall 
(DR), or cumulative percentage (CP)); TMT A or B, Trail Making Test version A or B, WAIS IV, Weschler Adult Intelligence Scale 
(4th Ed.) (BD, block design; LNS, letter number sequence; CD, coding); COWAT, Controlled Oral Word Association Test (Z, z-score; 
G, gender; A, age; ED, education).     
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Table 9  
CAN-AER-COG wilcoxon sign ranks test: physiological and psychosocial variables with percentage changes 
Variable Pre Mean Pre SD Post Mean Post SD SIG. % Change 
SBP 122.67 13.56 120.22 10.89 0.40 -2.00 
DBP 74.78 6.00 72.56 7.92 0.41 -2.97 
RHR 73.78 10.45 70.89 12.33 0.31 -3.92 
VO2PEAK 21.07 8.35 21.62 8.48 0.95 2.61 
SANDR 9.58 2.28 13.28 8.52 0.31 38.62 
PIPER_I 4.60 1.39 3.52 2.35 0.07 -23.48 
PIPER_B 3.81 2.71 2.57 2.48 *0.01 -32.55 
PIPER_A 5.02 2.06 3.93 3.25 0.25 -21.71 
PIPER_S 5.18 1.06 4.38 2.22 0.24 -15.44 
PIPER_C 4.78 0.73 3.48 2.16 0.07 -27.20 
BECK 9.78 4.76 7.44 6.15 0.10 -23.93 
QOL 20.87 2.01 22.79 6.00 0.09 9.20 
Note: SBP, systolic blood pressure; DBP, diastolic blood pressure; RHR, resting heart rate; VO2PEAK, the highest rate of oxygen 
consumed measured regardless of reaching VO2 plateau; sit and reach test; PIPER, piper fatigue index (B, behavioral; A, affective; S, 
sensory; C, cognitive/mood subscales); BECK, beck depression inventory; QOL, quality of life. * denotes results were significant (p < 
0.05).  
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Table 10 
CAN-AER wilcoxon sign ranks test: cognitive variables and percentage changes 
Variable Pre Mean Pre SD Post Mean Post SD SIG. % Change 
WMS_IV_BCOG 54.00 5.26 52.71 4.54 0.61 -2.39 
WMS_IV_LMI_RAW 19.00 4.16 24.29 5.25 *0.03 27.84 
WMS_IV_LMI_SCALED 7.00 1.73 9.29 2.29 *0.03 32.71 
WMS_IV_LMII_DR_RAW 15.57 6.43 21.71 5.09 *0.04 39.43 
WMS_IV_LMII_DR_SCALED 7.86 3.13 10.00 2.31 *0.05 27.23 
WMS_IV_LMIICP_RAW 24.00 2.94 24.29 3.15 0.79 1.21 
TMT_A_RAW 36.86 7.60 36.43 14.19 0.75 -1.17 
TMT_B_RAW 87.29 9.79 98.14 34.19 0.50 12.43 
WAIS_IV_BD_RAW 33.57 8.60 40.43 7.13 *0.03 20.43 
WAIS_IV_BD_SCALED 9.00 1.83 10.71 1.11 *0.03 19.00 
WAIS_IV_LNS_RAW 16.86 1.07 18.14 1.35 0.07 7.59 
WAIS_IV_LNS_SCALED 8.14 0.69 9.14 0.90 *0.04 12.29 
WAIS_IV_CD_RAW  51.14 17.23 57.43 8.52 0.35 12.30 
WAIS_IV_CD_SCALED 9.14 1.46 10.28 1.38 0.20 12.47 
COWAT_Z_G -0.54 0.31 -0.63 1.10 0.74 -16.67 
COWAT_Z_A -0.46 0.37 -0.14 0.61 0.13 69.57 
COWAT_Z_ED -0.80 0.56 -0.45 0.81 0.13 43.75 
Note: WMS IV, Weschler Memory Scale (4th Ed.) (BCOG, general cognitive screener; LMI & LMII, Logical Memory delayed recall 
(DR), or cumulative percentage (CP)); TMT A or B, Trail Making Test version A or B, WAIS IV, Weschler Adult Intelligence Scale 
(4th Ed.) (BD, block design; LNS, letter number sequence; CD, coding); COWAT, Controlled Oral Word Association Test (Z, z-score; 
G, gender; A, age; ED, education. * denotes results were significant (p < 0.05).
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Table 11 
 
CAN-AER wilcoxon sign ranks test: physiological and psychosocial variables with percentage changes 
Variable Pre Mean Pre SD Post Mean Post SD SIG. % Change 
SBP 129.14 21.87 128.77 23.4 0.46 -0.29 
DBP 78.71 8.18 78.8 14.05 1.00 0.11 
RHR 76.86 8.45 69.69 11 0.24 -9.33 
VO2PEAK 18.67 5.43 22.4 8 0.09 19.98 
SANDR 10.64 4.44 12.48 2.83 0.25 17.29 
PIPER_I 4.62 3.61 3.39 3.26 0.18 -26.62 
PIPER_B 5.39 3.7 3.69 3.53 0.08 -31.54 
PIPER_A 5.66 4.21 4.1 2.83 0.09 -27.56 
PIPER_S 5.26 2.78 3.49 2.54 *0.04 -33.65 
PIPER_C 5.02 2.83 3.74 2.68 0.06 -25.5 
BECK 10.86 7.86 7.8 7 0.18 -28.18 
QOL 19.45 6.68 22.04 4.12 0.12 13.32 
Note: SBP, systolic blood pressure; DBP, diastolic blood pressure; RHR, resting heart rate; VO2PEAK, the highest rate of oxygen 
consumed measured regardless of reaching VO2 plateau; sit and reach test; PIPER, piper fatigue index (B, behavioral; A, affective; S, 
sensory; C, cognitive/mood subscales); BECK, beck depression inventory; QOL, quality of life. * denotes results were significant (p < 
0.05). 
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Table 12 
CAN-CON wilcoxon sign ranks test: cognitive variables and percentage changes 
Variable Pre Mean Pre SD Post Mean Post SD SIG. % Change 
WMS_IV_BCOG 54.29 3.20 55.71 4.27 0.28 2.62 
WMS_IV_LMI_RAW 25.14 6.79 27.43 6.13 0.24 9.11 
WMS_IV_LMI_SCALED 9.43 2.88 10.71 2.21 0.14 13.57 
WMS_IV_LMII_DR_RAW 20.43 7.81 23.86 6.54 0.13 16.79 
WMS_IV_LMII_DR_SCALED 12.14 5.27 11.29 2.36 0.83 -7.00 
WMS_IV_LMIICP_RAW 25.14 3.48 24.87 3.63 0.93 -1.07 
TMT_A_RAW 29.43 7.96 30.00 11.11 0.93 1.94 
TMT_B_RAW 74.71 22.51 72.43 46.84 0.50 -3.05 
WAIS_IV_BD_RAW 37.14 9.60 40.71 8.14 0.60 9.61 
WAIS_IV_BD_SCALED 10.43 2.51 11.00 1.91 0.91 5.47 
WAIS_IV_LNS_RAW 20.38 1.83 20.10 2.04 0.92 -1.37 
WAIS_IV_LNS_SCALED 10.60 2.21 10.76 2.86 0.67 1.51 
WAIS_IV_CD_RAW  65.00 5.42 66.71 17.34 0.40 2.63 
WAIS_IV_CD_SCALED 10.71 1.63 11.43 3.31 0.29 6.72 
COWAT_Z_G 0.06 0.83 0.51 0.84 *0.04 750.00 
COWAT_Z_A 0.15 0.86 0.63 0.85 *0.03 320.00 
COWAT_Z_ED -0.22 0.91 0.23 1.00 *0.05 204.55 
Note: WMS IV, Weschler Memory Scale (4th Ed.) (BCOG, general cognitive screener; LMI & LMII, Logical Memory delayed recall 
(DR), or cumulative percentage (CP)); TMT A or B, Trail Making Test version A or B, WAIS IV, Weschler Adult Intelligence Scale 
(4th Ed.) (BD, block design; LNS, letter number sequence; CD, coding); COWAT, Controlled Oral Word Association Test (Z, z-score; 
G, gender; A, age; ED, education. * denotes results were significant (p < 0.05). 
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Table 13 
CAN-CON wilcoxon sign ranks test: physiological and psychosocial variables with percentage changes 
Variable Pre Mean Pre SD Post Mean Post SD SIG. % Change 
SBP 123.00 9.71 121.14 7.36 0.74 -1.51 
DBP 74.00 7.67 77.14 7.19 0.35 4.24 
RHR 92.71 10.56 100.29 17.26 0.24 8.18 
VO2PEAK 16.93 8.25 19.59 7.59 *0.05 15.71 
SANDR 13.19 2.49 16.15 7.37 0.24 22.44 
PIPER_I 2.43 2.51 1.42 1.44 0.40 -41.56 
PIPER_B 3.20 3.28 1.05 1.11 0.12 -67.19 
PIPER_A 2.74 2.83 1.64 1.48 0.35 -40.15 
PIPER_S 3.63 3.01 1.86 1.58 0.13 -48.76 
PIPER_C 2.92 2.81 1.39 1.76 0.09 -52.40 
BECK 9.29 7.43 4.20 3.20 *0.04 -54.79 
QOL 19.76 4.80 24.91 3.13 *0.02 26.06 
Note: SBP, systolic blood pressure; DBP, diastolic blood pressure; RHR, resting heart rate; VO2PEAK, the highest rate of oxygen 
consumed measured regardless of reaching VO2 plateau; sit and reach test; PIPER, piper fatigue index (B, behavioral; A, affective; S, 
sensory; C, cognitive/mood subscales); BECK, beck depression inventory; QOL, quality of life. * denotes results were significant (p < 
0.05).  
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Table 14  
NC-CON wilcoxon sign ranks test: cognitive variables and percentage changes 
Variable Pre Mean Pre SD Post Mean Post SD SIG. % Change 
WMS_IV_BCOG 56.66 1.46 56.86 1.46 0.50 0.35 
WMS_IV_LMI_RAW 24.71 3.73 26.00 3.92 0.34 5.22 
WMS_IV_LMI_SCALED 10.00 1.83 10.43 1.81 0.33  4.30 
WMS_IV_LMII_DR_RAW 20.57 3.87 22.86 4.98 0.10 11.13 
WMS_IV_LMII_DR_SCALED 9.42 1.40 10.57 1.99 0.07 12.21 
WMS_IV_LMIICP_RAW 25.73 1.76 25.57 2.44 0.69 -0.62 
TMT_A_RAW 37.57 12.50 33.86 7.43 0.35 -9.87 
TMT_B_RAW 66.14 16.15 51.86 6.62 0.06 -21.59 
WAIS_IV_BD_RAW 40.86 14.60 43.86 14.72 0.40 7.34 
WAIS_IV_BD_SCALED 10.71 4.11 11.43 3.31 0.52 6.72 
WAIS_IV_LNS_RAW 20.14 1.95 20.00 1.41 0.83 -0.70 
WAIS_IV_LNS_SCALED 10.57 1.99 10.14 0.69 0.52 -4.07 
WAIS_IV_CD_RAW  74.00 9.38 69.71 15.68 0.89 -5.80 
WAIS_IV_CD_SCALED 11.57 1.81 11.43 2.07 0.72 -1.21 
COWAT_Z_G 0.05 0.67 0.26 0.48 0.35 420.00 
COWAT_Z_A 0.17 0.62 0.29 0.49 0.53 70.59 
COWAT_Z_ED -1.30 2.71 -0.29 0.53 0.35 77.69 
Note: WMS IV, Weschler Memory Scale (4th Ed.) (BCOG, general cognitive screener; LMI & LMII, Logical Memory delayed recall 
(DR), or cumulative percentage (CP)); TMT A or B, Trail Making Test version A or B, WAIS IV, Weschler Adult Intelligence Scale 
(4th Ed.) (BD, block design; LNS, letter number sequence; CD, coding); COWAT, Controlled Oral Word Association Test (Z, z-score; 
G, gender; A, age; ED, education).* denotes results were significant (p < 0.05). 
  
1
0
1
 
 
 
94 
 
Table 15 
NC-CON wilcoxon sign ranks test: physiological and psychosocial variables with percentage changes 
Variable Pre Mean Pre SD Post Mean Post SD SIG. % Change 
SBP 127.86 14.31 127.34 10.25 0.55 -0.41 
DBP 77.71 12.35 76.80 12.91 0.93 -1.17 
RHR 88.14 14.72 77.12 12.95 0.09 -12.50 
VO2PEAK 31.25 8.83 28.96 6.47 0.17 -7.33 
SANDR 11.67 3.68 10.68 3.89 0.61 -8.48 
PIPER_I 2.58 1.80 2.37 1.94 0.87 -8.14 
PIPER_B 1.24 1.26 1.42 2.64 0.72 14.52 
PIPER_A 2.69 2.84 2.51 2.29 0.92 -6.69 
PIPER_S 3.54 2.49 3.66 2.37 0.87 3.39 
PIPER_C 2.63 2.34 2.38 1.84 0.83 -9.61 
BECK 5.40 2.72 3.14 5.37 0.18 -41.85 
QOL 24.18 3.77 24.84 3.46 0.50 2.73 
Note: SBP, systolic blood pressure; DBP, diastolic blood pressure; RHR, resting heart rate; VO2PEAK, the highest rate of oxygen 
consumed measured regardless of reaching VO2 plateau; sit and reach test; PIPER, piper fatigue index (B, behavioral; A, affective; S, 
sensory; C, cognitive/mood subscales); BECK, beck depression inventory; QOL, quality of life. * denotes results were significant (p < 
0.05). 
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Table 16 
CAN-COG wilcoxon sign ranks test: cognitive variables and percentage changes 
Variable Pre Mean Pre SD Post Mean Post SD SIG. % Change 
WMS_IV_BCOG 53.20 5.31 56.60 1.67 0.13 6.39 
WMS_IV_LMI_RAW 21.60 7.92 24.40 3.91 0.41 12.96 
WMS_IV_LMI_SCALED 8.00 3.39 9.60 1.67 0.13 20.00 
WMS_IV_LMII_DR_RAW 18.40 8.56 21.80 6.72 0.08 18.48 
WMS_IV_LMII_DR_SCALED 9.20 3.70 10.20 2.95 0.16 10.87 
WMS_IV_LMIICP_RAW 24.40 2.30 24.00 2.35 0.58 -1.64 
TMT_A_RAW 29.20 10.99 31.69 9.92 0.47 8.53 
TMT_B_RAW 92.60 33.65 68.98 20.50 0.14 -25.51 
WAIS_IV_BD_RAW 27.40 5.98 31.40 3.97 0.23 14.60 
WAIS_IV_BD_SCALED 7.80 1.64 9.00 1.41 0.10 15.38 
WAIS_IV_LNS_RAW 20.00 1.22 19.20 1.10 0.10 -4.00 
WAIS_IV_LNS_SCALED 9.60 0.89 9.60 0.55 1.00 0.00 
WAIS_IV_CD_RAW  66.20 10.40 69.80 8.29 0.14 5.44 
WAIS_IV_CD_SCALED 12.00 1.58 11.80 1.92 0.71 -1.67 
COWAT_Z_G -0.14 0.78 0.08 0.66 0.35 155.56 
COWAT_Z_A -0.04 0.75 0.18 0.67 0.28 573.68 
COWAT_Z_ED -0.62 0.63 -0.25 0.60 0.23 59.68 
Note: WMS IV, Weschler Memory Scale (4th Ed.) (BCOG, general cognitive screener; LMI & LMII, Logical Memory delayed recall 
(DR), or cumulative percentage (CP)); TMT A or B, Trail Making Test version A or B, WAIS IV, Weschler Adult Intelligence Scale 
(4th Ed.) (BD, block design; LNS, letter number sequence; CD, coding); COWAT, Controlled Oral Word Association Test (Z, z-score; 
G, gender; A, age; ED, education).  
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Table 17 
CAN-COG wilcoxon sign ranks test: physiological and psychosocial variables with percentage changes 
Variable Pre Mean Pre SD Post Mean Post SD SIG. % Change 
SBP 99.60 47.14 126.28 11.35 0.23 26.79 
DBP 79.20 13.75 72.93 8.45 0.27 -7.92 
RHR 84.60 15.11 85.37 14.43 0.69 0.91 
VO2PEAK 20.08 4.88 22.50 5.21 0.35 12.05 
SANDR 11.62 5.01 14.39 2.88 0.23 23.84 
PIPER_I 6.07 2.68 2.91 1.44 0.08 -52.06 
PIPER_B 3.41 2.06 1.73 1.70 0.23 -49.27 
PIPER_A 4.00 1.98 3.08 1.67 0.08 -23.00 
PIPER_S 5.80 1.33 3.60 2.31 0.14 -37.93 
PIPER_C 4.73 0.56 3.23 1.30 0.08 -31.71 
BECK 8.20 1.79 3.40 1.52 *0.04 -58.54 
QOL 22.12 1.47 23.54 1.47 *0.04 6.42 
Note: SBP, systolic blood pressure; DBP, diastolic blood pressure; RHR, resting heart rate; VO2PEAK, the highest rate of oxygen 
consumed measured regardless of reaching VO2 plateau; sit and reach test; PIPER, piper fatigue index (B, behavioral; A, affective; S, 
sensory; C, cognitive/mood subscales); BECK, beck depression inventory; QOL, quality of life. * denotes results were significant (p < 
0.05). 
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CHAPTER V 
 
DISCUSSION 
 
 Cancer is a multifaceted phenomenon that negatively affects millions of people 
worldwide (Jemal et al., 2011). It requires the development of scientifically-based tactics 
that are of holistic and multi-faceted in nature for not only the treatment of the disease, 
but for the rehabilitation process. Current progressive methods of prevention, detection, 
education, and treatment, along with increased implementation of individualized cancer 
rehabilitation programs have played a substantial role in the current estimates of 
increased survival rates (ACS, 2014). However, incidences of cancer continue to increase 
therefore, unequivocally, calls for continued research that aims to holistically address the 
specific, multifaceted, needs of this growing population.  
Chemotherapy-related cognitive impairment has gained traction in the lay and 
scientific literature as being an ever increasing, disruptive, and frustrating phenomenon 
which negatively affects cancer survivors undergoing treatment. This project addressed 
factors that may play a role in the reduction or attenuation of CRCI, a side effect of 
treatment that has been reported to negatively affect the lives of upwards of 75% of those 
who have undergone treatment (Jackson, 2008; Myers, 2009; Konat et al., 2008; & Raffa 
& Tallarida, 2010). The purpose of this study was to examine the effects of a quasi-
randomized, controlled 12-week aerobic and cognitive intervention on cancer survivors 
(CAN) versus non-cancer participants (NC).
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  It was hypothesized that aerobic cycling on a recumbent cycle ergometer would 
increase measures of cognitive function in CAN. Second, cognitive training using 
computer software consisting of brain training exercises was hypothesized to increase 
measures of cognitive function in CAN. Finally, it was hypothesized that the combined 
cognitive and aerobic training would have a synergistic effect on increases in cognitive 
function in CAN. Despite global analyses revealing no significant (p > 0.05) differences 
between each of the groups for physiological, psychosocial, or cognitive measures, the 
within group results suggest that aspects of these types of modalities may be effective at 
targeting CRCI. Although the methodology needs refinement to better focus the efforts 
on CRCI, the results of this investigation has provided fertile groundwork for research 
investigations in the future. For example, at home cognitive training using commercially 
available programs such as Posit-Science® and Lumosity® may actually remove the 
combined difficulty and cognitive demand observed in the groups that had the combined 
cognitive and aerobic training, thereby allowing participants better focus on aerobic 
training.  
Aerobic, Cognitive, and Flexibility Training  
(CAN-AER-COG) 
 
 Although the hypothesis that the combined CAN-AER-COG group would 
generate the greatest overall increases in measures of aerobic and cognitive function, this 
group produced the least amount of improvements compared to any other group from 
pre-to-post. Yet, there were still aspects of this treatment group that deserve mention. 
Increases in TMT-A speed suggest that training may have an impact on their ability to 
reproduce the task with greater speed and efficiency. The TMT-A test has been reported 
to be utilized in multiple population samples as a test of mental processing speed and 
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executive function (Park & Larson, 2015). Processing speed has been roughly defined as 
being the speed of completing a task with a relative or reasonable accuracy (Jacobson et 
al., 2011). In addition, Lezak, Howieson, Bigler, and Tranel (2012) defined executive 
function as individual capacitance to engage successfully in self-directed, purposive, 
independent, and self-serving behavior. Part “A” of the Trail Making Test A and B is 
focused on the former being the processing speed. In this case, the CAN-AER-COG 
group increased in their speed of processing by 49% (pre 60.4 ± 80.0 vs. post 30.7 ± 10 
seconds, p = 0.14) from pre-to-post. Although insignificant, a 49% increase in processing 
speed among cancer survivors may be a factor in the gaining of confidence in abilities or 
capabilities that had been reduced or abandoned while undergoing treatment. For 
example, a particular client in this group was told she absolutely should not drive her 
vehicle, (A) because of the high dosages of chemotherapy and radiation she was 
undergoing, and (B) because of how unwell she felt on a daily basis. Following the 
completion of chemotherapy and radiation treatment and at the discretion of her 
physician, she was then allowed to drive. This increase of 49% increase in the ability of 
the brain to process signals may appear as statistically insignificant, but to a cancer 
survivor, who is beginning to drive again after three months of not driving, a 49% 
increase in processing speed may be quite important.  
Controlled Oral Word Association Test gender and age scores also improved by 
675% and 275%, respectively (pre -0.04 ± 1.6 vs. post 0.2 ± 1.8; pre 10 ± 1.6 vs. post 0.4 
± 1.8) for the CAN-AER-COG group, suggesting that improvements were made for word 
association following training. Foster et al. (2013) noted that the COWAT test requires 
participants to come up with as many words as they possibly can within the given time 
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limit for a specified letter. These particular assessments make an adjustment for gender 
and age. However, regardless of the insignificance, it is important to note that the sheer 
number of word associations (or verbal fluidity) increased following the intervention.  
Fatigue significantly decreased in the CAN-AER-COG group (-33%) (pre 3.8 ± 
2.7 vs. post 2.6 ± 2.5, p < 0.05) in the Piper Fatigue Index Behavioral subcategory and 
there was a trend toward significant decreases (-24%) (pre 4.6 ± 1.4 vs. post 3.5 ± 2.4, p 
= 0.07) in the overall Piper Fatigue Index score. There was a trend toward a significant 
decrease (-27%) (pre 4.8 ± .7 vs. 3.5 ± 2.2, p = 0.07) in the Cognitive subcategory, and 
there were decreases (-22%, -15%, -24%) in the Piper Fatigue Index Affective and 
Sensory subcategories. This is still a matter of importance for the cancer survivor. 
Fatigue has been reported to manifest itself much differently in cancer survivors than 
apparently healthy adults. Finsterrer and Mahjoub (2014) described CRF as being 
overwhelming resting tiredness that may inhibit activities of daily living, decrease vigor 
and endurance, and may persist for long periods of time, ultimately affecting QOL in a 
negative manner. In addition, CRF may also negatively impact psychosocial aspects of 
function such as those measured in this study, consequently acting as a disabling factor to 
the individual’s life (Finsterer & Mahjoub, 2014). It is important to note that depression 
and fatigue are all factors that play a substantial role in not only activities of daily life, 
but more importantly, overall QOL.  
Quality of Life only improved by 9% in the CAN-AER-COG group suggesting 
that this type of training may not be the preferred method of intervention for cancer 
survivors going through treatment. Anecdotal information received from multiple clients 
helped to substantiate this. Many clients would state that they would have to reduce their 
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pedal rate in order to focus on the extremely difficult games, suggesting a neurological 
conflict of sorts may have been occurring such that the ability of the brain to appropriate 
the amount of processing capability between two difficult tasks. In addition, there were 
many times where clients had actually broken down in tears because they were so 
incredibly frustrated with the difficulty of not only their current treatment regimens, but 
how hard it was for them to concentrate with CRCI. Among the non-pharmacological 
approaches to addressing CRCI, these results suggest that combined training may not be 
the most appropriate for this particular population.   
Aerobic and Flexibility Training  
(CAN-AER) 
 
 Recently it was reported that among apparently healthy males that exercise of a 
moderate intensity (65% HRR) for 20 minutes significantly (p < 0.05) increased accuracy 
and speed as a measure of cognitive performance (Stroop test) when compared to ten or 
45 minutes of cycling, suggesting a dose-response relationship between aerobic exercise 
and cognitive function (Chang et al., 2015). Although the aforementioned comparison is 
a much different group, it is important to state that among all treatment groups, those that 
were randomized to the CAN-AER group were by far the most significantly improved 
group among pre-to-post measures of cognitive function. Measures of WMS-LMI raw 
and scaled scores significantly (pre 19.0 ± 4.2 vs. post 24.3 ± 5.3, p < 0.05; pre 7.0 ± 1.7 
vs. post 9.3 ± 2.3, p < 0.05) increased (28%, 33%, respectively). WMS-LMII DR raw and 
scaled scores significantly (pre 15.6 ± 6.4 vs. post 21.7 ± 5.1, p < 0.05; pre 7.9 ± 3.1 vs. 
post 10.0 ± 2.3, p < 0.05) increased (39%, 27%, respectively). The WMS-LMI has been 
reported by the British Psychological Society (2012) to be a measure of narrative 
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working memory, while the WMS-LMII-DR has been reported to be a measure of 
narrative delayed recall, or longer term memory (BPS, 2012). 
Various structures in the brain are associated with memory; of particular 
importance to this investigation, in the hippocampus. A particular study evaluating the 
effects of seven weeks of aerobic training (50-75% HRR) on brain volumetric changes in 
apparently healthy older adults revealed significant increases in hippocampal volumes 
and increases in cognitive tests of memory (Erickson et al., 2011). Results from the 
current investigation corroborate those observations: (A) aerobic training does increase 
aspects of memory, but for cancer survivors undergoing treatment, it may necessitate 
reductions in training percentages of HRR to account for the added physical and 
cognitive demand of chemotherapy treatment, and (B) increases of memory observed 
within the CAN-AER group during this study may have been due to volumetric increases 
in the hippocampus.  
Weschler Adult Intelligence Scale Block Design raw and scaled scores both 
significantly increased (pre 33.5 ± 8.6 vs. post 40.4 ± 7.1, p < 0.05; pre 9.0 ± 1.8 vs. post 
10.7 ± 1.1, p < 0.05) by 20% and 19%, respectively. The WAIS block design test has 
been reported to be a visual test of perceptual reasoning and visual processing (Benson, 
Hulac, & Kranzler, 2010; Ward, Bergman, & Hebert, 2012). Cognitive assessors show 
participants various shapes that the participant is encouraged to reproduce using their 
own set of multi-colored blocks. These results suggest that perceptions and processing of 
the visual components increased potentially as a result of aerobic exercise. WAIS LNS 
scaled scores significantly (pre 8.1 ± .7 vs. post 9.1 ± .9, p < 0.05) increased (12%). 
WAIS CD raw and scaled scores were statistically insignificant (p > 0.05) yet increased 
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by 12% and 13%, respectively. Both the LNS and CD tests are visual assessments of 
executive function and working memory (Benson et al., 2010; Ward et al., 2012) again 
suggesting that aerobic exercise corroborates with findings of previous studies.  
Finally, measures of COWAT age and education scores, although statistically 
insignificant (p > 0.05) increased by 70% and 44%, respectively. Whether this was a 
function of the intervention itself or a recovery of previously attained levels of verbal 
fluidity, is yet to be determined. Yet, COWAT gender scores decreased by 17%, 
suggesting that there may have been a different response between males and females in 
verbal fluidity. Formulating a judgment on this particular result is difficult because (A) 
this group was disproportionately composed of females (n = 5) vs. males (n = 2), and (B) 
one of the female participants in this group had stage III brain cancer and had significant 
difficulties with verbal tasks due to the removal of large portions of her temporal lobe. 
This circumstance may have potentially affected the results which suggested that this 
group decreased in measures of verbal fluidity. For example, words that began with “s” 
were particularly difficult to say.  
Chang et al. (2015) suggested that cognitive improvements as a function of 
moderate intensity (65% HRR) aerobic exercise may in fact follow the inverted U 
paradigm such that an optimal intensity and time may be necessary to yield the greatest 
amount of intervention-related cognitive changes, at least in apparently healthy males. 
When data collection commenced for the current study, some of the first participants had 
been out of treatment for a few weeks and the appropriate HRR values for each 
corresponding segment of training were accomplished. However, following a shift in 
oncologist referring, most participants from that point forward were still undergoing 
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treatment. During this study, 30 minutes of aerobic cycling was attempted at 55%, 60%, 
and 65% (HRR), however, maintaining each exact HRR was often times difficult to 
accomplish during many training sessions throughout data collection because subject 
functional capacity often changed from day-to-day with treatment. For example, a 
particular participant who was undergoing chemotherapy and radiation would often 
complete training at the required intensities, but on the one day per week that followed 
her chemotherapy infusions, she often could only complete a few minutes at the 
prescribed intensity due to overwhelming fatigue. This aspect of training transcended all 
of the CAN groups with the exception of the CAN-CON group and necessitated the 
implementation of the RPE scale to better equalize the training and allow participants to 
complete the session.  
In light of the prevalence of this issue among those in groups that trained 
aerobically (who were undergoing treatment), it should be noted that intensities proposed 
in this study could not be strictly adhered to. In addition, intensities proposed in this 
study may have very well been appropriate for those who had completed treatment weeks 
prior, but not for those undergoing treatment. Furthermore, even though the results do 
suggest that this model of aerobic training produced significant increases in measures of 
cognitive function in this sample, a more appropriate level of intensity, perhaps between 
40% and 55% HRR may more appropriately reflect the specific needs of the population. 
Piper sensory subscale significantly (pre 5.3 ± 2.8 vs. post 3.5 ± 2.5, p < 0.05) 
decreased (34%). The Piper cognitive subscale trended toward significance (pre 5.0 ± 2.8 
vs. post 3.7 ± 2.7, p < 0.05) and decreased by 26%. Piper behavioral and affective scores 
both trended toward significant decreases (pre 5.4 ± 3.7 vs. post 3.7 ± 5.5, p = 0.08; pre 
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5.7 ± 4.2 vs. post 4.1 ± 2.8, p = 0.09) (-32% and -28%, respectively). Piper index scores 
and Beck depression also decreased -27% and -28%, respectively. VO2peak, sit and reach, 
and QOL scores, although statistically insignificant, increased by 20%, 17%, and13% 
from pre-to-post. Overall increases in measures of cognitive function, VO2peak, sit and 
reach, decreases in fatigue, depression, and increases in QOL all suggest that the 
combination of aerobic and flexibility training should be further examined to better 
understand how best to implement this type of training in cancer survivors.           
Flexibility Training (CAN-CON) 
 Multiple studies have indicated the impact of various types of flexibility training 
on cancer survivors. For example, in a review of literature composed of 25 studies 
evaluating the effects of yoga as a component of cancer interventions, Culos-Reed et al. 
(2012) found that among various interventions that implemented yoga that this type of 
training may be quite effective as a rehabilitative modality for cancer survivors. 
Furthermore, Culos-Reed et al. (2012) noted that yoga was associated with increases in 
QOL and spiritual well-being, decreases in anxiety, depression, and fatigue. Although, 
the CAN-CON group did not participate in yoga, the participants did complete 36 
sessions of whole-body static stretching. Results from this study do, somewhat, 
corroborate findings from studies that evaluated the effects of yoga. VO2peak trended 
toward significant increases (pre 16.9 ± 8.3 vs. post 19.6 ± 7.6, p = 0.05; 16%). Quality 
of life significantly increased (pre 19.8 ± 4.8 vs. post 24.9 ± 3.1, p < 0.05) (26%) for the 
CAN-CON group. The Piper behavior and cognitive subscales decreased (pre 3.2 ± 3.3 
vs. post 1.1 ± 1.1, -67%; pre 2.9 ± 2.8 vs. post 1.4 ± 1.7, -52%). Beck depression 
significantly decreased (pre 9.3 ± 7.4 vs. post 4.2 ± 3.2, p < 0.05) (-55%).  
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Finally, Piper index, affective, and sensory subscales all decreased (-41.6, -40.5, 
and -48.8, respectively), and sit and reach increased by 22% in the CAN-CON group. 
These pre-to-post changes reflect an important component of cancer rehabilitation that 
may have been overlooked or underrated, which may actually be a substantial tool in the 
arsenal of cancer exercise specialists who are training clients that are currently 
undergoing treatment and may not be able to fully tolerate exercise. This area of cancer 
rehabilitation lacks a significant amount of research regarding physiological changes that 
may explain the results obtained during this study. However, other studies have 
implemented the Chinese therapeutic method of Qi-gong, which is not technically 
flexibility training or yoga. However, Qi-gong may be a much closer modality for 
comparison considering the subtlety of movements are slow-paced, require a modicum of 
active muscle stretch during each movement, and aid in breathing techniques which are 
mildly similar to static stretching (Yeh, Lee, Chen, & Chao, 2006; Lee, Loh, & Murray, 
2011). Of the few studies that have evaluated physiological alterations following Qi-gong 
interventions in cancer patients undergoing treatment, Yeh et al. (2006) reported the 
effects of Qi-gong on multiple blood parameters. The investigators concluded that 
following the intervention white blood cell count and platelet count significantly 
increased among those undergoing treatment for cancer. Although no definitive 
explanation can be given for the results obtained from the current study, it bears 
importance that future investigations include delving into potential mechanistic actions 
that may better elucidate the benefits of flexibility training on functional capacity and 
CRCI in cancer survivors.  
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Little research exists that has evaluated the effects of a static-stretching, yoga, or 
Qi-gong on measures of cognitive function. In addition, those reviewed had cognitive 
assessment batteries that were completely different from what was conducted in this 
study. Furthermore, there was even less research that evaluated the aforementioned in a 
cancer survivor population. However, in an investigation of the effects of a six-month 
yoga-based intervention on measures of cognitive function among apparently healthy 
adults over 60 years of age, Hariprasad et al. (2013) found that following the 
intervention, significant increases were observed among delayed recall of visual and 
verbal memory, executive function, working memory and attention, processing speed, 
and verbal fluency. In this study no other measure of cognitive function significantly 
increased for the CAN-CON group except the COWAT gender (pre .06 ± .8 vs. post .5 ± 
.84, p < 0.05), age (pre .15 ± .9 vs. post .6 ± .85, p < 0.05), and education scores (pre -.2 
± .9 vs. post .2 ± 1.0, p < 0.05), which partially substantiates the results presented in the 
Harisprasad et al. (2013) study suggesting that verbal fluency significantly increased 
following the intervention.  
Although not entirely understood, the main differences between the studies may 
have been responsible for the outcomes that were observed. These were: (A) apparently 
healthy older adults, (B) the intervention consisted of yoga as opposed to static 
stretching, and (C) the duration of the yoga intervention was six months as opposed to 
three in this study. It may very well be that because a vast majority of the participants in 
this study were undergoing chemotherapy and/or radiation treatment, that the targeted 
flexibility protocol was ineffective in the reduction of CRCI. However, measures of 
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verbal fluency significantly improved in this group from pre-to-post suggesting that a 
factor of training played a role in these observed improvements.  
Due to the nature of the flexibility protocol being very socially interactive, the 
one-on-one personal training administered during training may have played a role in 
increased verbal fluency. In addition, it would be near impossible to have implemented 
this type of training intervention without a modicum of social interaction or facilitation of 
the individual stretches, and regularly attending clients of RCMRI often report how they 
enjoy the time they get to spend interacting with their trainers. This suggests that 
participants are positively affected by this type of training which may explain the 
increases in measures of word association.   
Aerobic, Cognitive, and Flexibility Training (NC) 
 
 The apparently healthy control group appeared to increase the least when 
compared to pre-to-post changes among the CAN groups. This may be due to the fact that 
many of the age-matched, apparently healthy adults who were included in this study were 
actually more actively engaged in daily living activities of both physical and cognitive 
demand than they perceived. However, some aspects of cognitive function did increase 
following the completion of the study. WMS-LMII DR scaled scores trended toward 
significant increases (pre 9.4 ± 1.4 vs. post 10.6 ± 2.0, p = .07) (12%) which would 
indicate that aspects of long-term memory increased as a result of the training, which 
although beneficial, these results are not impactful enough to conclude that the cognitive 
training was responsible for outcomes observed. In addition, TMT-B scores trended 
toward significant decreases (pre 66.1 ± 12.2 vs. post 51.9 ± 6.6, p = 0.06) in speed of 
processing for TMT-B (-22%). All COWAT gender, age, and education scores increased 
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(420%, 71%, and 78%, respectively). No pre-to-post changes in physiological or 
psychosocial variables produced significant changes following the completion of the 
study. However, RHR trended toward a significant decrease (pre 88.14 ± 14.7 vs. post 
77.12 ± 13.0, p = 0.09) (-13%). Finally, Beck depression decreased by (-42%). This could 
be explained in part because of the married couple who participated together in the study. 
The husband was a Greeley police officer who was part of a cyber team that investigated 
computer equipment of individuals that were suspects in cases where there were crimes 
against children. The wife was in the middle of completing her Master’s degree at UNC 
in chemistry. Both the husband and wife were adamantly vocal about their levels of stress 
at their occupations. Near the completion of their training both the husband and wife 
were in totally different occupations, which were much less stressful and may have 
accounted for the decreases observed in depression. They both expressed how much 
happier they were that those chapters in their lives had closed.     
The lack of significant increases in measures of cognitive function do not agree 
with multiple research investigations showing significant increases in measures of 
cognitive function following a cognitive training protocol (Ball et al., 2007; Cherrier et 
al., 2013; Ferguson et al., 2007b; Hassler et al., 2010; Kawashima, 2013; Kesler et al., 
2013; Mahncke et al., 2006; Smith et al., 2009; & Wolinsky et al., 2006) and aerobic 
exercise at similar intensities as presented in this study (Barnes et al., 2003; Barnes et al., 
2013; Lautenschlager et al., 2008; Masley et al., 2009; Potter & Keeling, 2005; & 
Zoeller, 2010). This, similar to the CAN-AER-COG group did not support the hypothesis 
that this type of training would produce synergistic increases observed in measures of 
cognitive function. Yet, like the CAN-AER-COG group the results suggest that there may 
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be other factors responsible for the lack of substantial and significant increases. Perhaps, 
the results of the combined training suggest a neurological conflict of sorts which, like 
the equivalent CAN-AER-COG group, may have played a role in the lack of ability of the 
brain to appropriate the amount of processing capabilities between two difficult tasks.               
Cognitive and Flexibility Training  
(CAN-COG) 
 
 The results of this study for the CAN-COG group do not fully corroborate with 
other studies that have shown increases in aspects of cognitive function with multiple 
interventions consisting of various populations (Ball et al., 2007; Cherrier et al., 2013; 
Ferguson et al., 2007b; Hassler et al., 2010; Kawashima, 2013; Kesler et al., 2013; 
Mahncke et al., 2006; Smith et al., 2009; & Wolinsky et al., 2006). It was hypothesized 
that cognitive training would elicit increases in cognitive function, yet the CAN-COG 
group showed no significant increases in any measure of cognitive function. A few 
reasons to explain the lack of juxtaposition between the specifically designed training 
software and the outcomes observed may be (A) the level of difficulty was consistently 
high and may not be entirely appropriate for those who are undergoing treatment for 
cancer, (B) the type of games may not have been engaging or stimulating enough to 
encourage full cognitive involvement from the participants, or (C) the software itself fails 
to accurately train cognitive processes that its designers suggested it would.  
A factor that should be considered, but was excluded from this evaluation because 
of low sample size and a wide variety of completed education levels, was how education 
played a role as a covariate in these analyses. Although insignificant, LMI scaled, LMII 
DR raw, COWAT gender, age, and education all increased (20%, 19%, 156%, 574%, 
60%, respectively) from pre to post. TMT-B reaction time to completion also decreased 
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(-26%). These results may suggest that cognitive training, especially in this population 
does have a place with regards to the reduction of CRCI; however, it would appear that 
the training itself may have been far too difficult for those who were undergoing 
treatment for cancer, and potentially the NC-CON group as well. 
Psychosocial measures of Beck depression significantly (pre 8.2 ± 1.8 vs. post 3.4 
± 1.5, p < 0.05) decreased (-59%) and QOL significantly (pre 22.1 ± 1.5 vs. post 23.5 ± 
1.5, p < 0.05) increased (6%). All measures of Piper fatigue (index, behavioral, affective, 
sensory, and cognitive) also decreased (-52%, -49%, -23%, -38%, -32%, respectively), 
which may actually be attributable to the flexibility component of this intervention. The 
results do not suggest that the cognitive training alone using NeuroActive® software was 
responsible for the results observed for this group. Again, anecdotally, multiple 
participants who were in this group reported that they felt like the tasks were far too 
difficult to process while undergoing treatment. Participants also mentioned that they 
often times felt overwhelmed and frustrated by the complexity of the tasks, which many 
times resulted in a tearful participant. 
Summary 
Taken together, it appears that for the purpose of this study that aerobic training at 
an often self-reported (RPE) moderate intensity was the most effective intervention to 
increase measures of cognitive function, flexibility, VO2peak, and QOL, and reduce fatigue 
and depression in cancer survivors.   
Conclusion 
 To our knowledge, there have been no studies examining the effects of a 
combined cognitive and aerobic training intervention on cognitive function in cancer 
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survivors, specifically, a majority of those undergoing treatment. Although results of this 
current study failed to show significant differences between each of the training groups in 
cognitive, physiological, or psychosocial function, there are five important outcomes that 
were observed. 
First, it is imperative that cognitive and aerobic training at a moderate intensity 
not be overlooked with regards to CRCI reduction methodologies. For the CAN-AER-
COG group, there were no significant increases observed in measures of cognitive 
function, yet there were observed pre-to-post increases observed among each of the 
individual treatment groups, with the exception of controls. This may imply that 
combined training of this nature may be too demanding for the individual to do well at 
both cognitive and aerobic training, simultaneously. 
Second, among individual treatment groups, 30 minutes of aerobic cycling at an 
often self-reported (RPE) moderate intensity was observed to produce the overall greatest 
number of pre-to-post increases in measures of cognitive, physiological, and psychosocial 
function. For those who are working with cancer survivors in a rehabilitative setting, 
these results should further reinforce the importance of this type of activity during 
training. Specifically, those following intensity-based programming can readily follow 
the aerobic training conducted in this study. Intensities that were mostly tolerable for 
those undergoing treatment are adaptable in cases where side effects of treatment 
overwhelmed the client (e.g., fatigue, depression, nausea, diarrhea). Upon occurrence, the 
reduction of revolutions per minute or resistance applied to the flywheel of the ergometer, 
may be appropriately substituted with RPE. In addition, for emerging rehabilitation 
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programs, a cycle ergometer is a cost-effective, durable apparatus that should not be 
excluded when developing a program. 
Third, 30 minutes of flexibility training as detailed in this investigation should 
also not be overlooked. During the development of this project, it was thought that 
flexibility training would serve as an ethically appropriate control group that would not 
force our lab to require cancer survivors to be subjected to the “wait list.” Results 
obtained following this intervention that verbal measurements of cognitive function, 
VO2peak, Sit and Reach, all Piper fatigue scores, Beck depression scores, and QOL all 
improved were unexpected. Although the mechanisms are not currently known, 
flexibility training as presented in this investigation should (A) be further investigated to 
identify mechanisms of action, (B) be incorporated to a greater extent in cancer 
rehabilitation, (C) to be considered as a more ethically appropriate control group for 
studies conducted in cancer survivors as opposed to the “wait list” control group, and (D) 
investigated further to see if similar results are obtained in other studies. 
Fourth, cognitive training alone should be considered when developing cancer 
rehabilitation programs that are aiming to address CRCI. Multiple studies presented in 
this investigation have corroborated the efficacy of cognitive training interventions in 
many different populations, but few have aimed to address CRCI in cancer survivors. It 
appears that cognitive training using NeuroActive® software may be mild-to-moderately 
beneficial, but may not be the most appropriate type of cognitive training software for 
this population. Many anecdotal comments included frustration with the level of 
difficulty of this program. In addition, the design of the BrainBike® itself with computer 
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interfaces that are grossly elevated and force participants to be in a constant state of neck 
extension may have compounded the level of frustration among this sample.  
Finally, despite small sample sizes, replacement of missing data, treatment 
adjustments by subject, and attrition issues this investigation still breaks ground on 
multiple levels considering the novelty of designing an intervention that is addressing an 
issue in cancer survivors that is just beginning to come to light from two respected and 
substantiated intervention methods. This investigation was an attempt to evaluate how 
these two methods may be best utilized to reduce CRCI, thereby increasing QOL in 
cancer survivors. These results, although not revolutionary or conclusive, do provide 
fertile ground for future studies.    
Future Research 
 Research in this field is just surfacing in regards to the effectiveness of cognitive 
training among the general apparently healthy population and even less in a cancer 
survivor population. Translational research should be the next avenue of focus to evaluate 
further how aerobic and cognitive training may best affect volumetric and functional 
aspects of brain physiology for both animal and human models. Methods such as fMRI, 
CT scan, and EEG technology should be employed to better elaborate upon possible 
mechanisms behind changes in measures of cognitive function and the relationship to 
volumetric alterations in brain tissue.  
 The least effective intervention was observed to be the CAN-AER-COG group; 
however, the individual treatment groups produced a myriad of differing but positive 
increases in cognitive, physiological, and psychosocial function. At this time, it would be 
unwise to abandon cognitive and aerobic training altogether, but rather modify the levels 
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of physical and cognitive difficulty. NeuroActive® software was designed to address 
multiple aspects of cognitive function, but was anecdotally reported to be far too difficult 
for both CAN and NC participants to do while cycling. It was evident during training that 
those who were undergoing cancer treatment experienced the greatest amount of 
difficulty. The next phase of this type of research should be to compare at-home types of 
cognitive training programs against the results of this study. In addition, the creation of a 
blocked schedule that would maintain three days a week of aerobic and flexibility 
training, but incorporate cognitive training between each of the aerobic and flexibility 
training sessions should be the next logical course of action. 
 Treatment-related differences in outcomes with cognitive and aerobic training 
need to be further developed. Our group has also evaluated the effects of cognitive and 
aerobic training on participants who underwent radiation treatment only. Research has 
indicated that radiation treatment for cancer may result in cognitive and/or psychosocial 
deficits similar to those undergoing chemotherapy (Attia, Page, Lesser, & Chan, 2014; 
Kim et al., 2009; Noal et al., 2011). Therefore, by evaluating response differences 
between both types of broad treatment groups this may better elucidate methods of 
rehabilitation that are more focused on the individual needs of the participant. 
 Finally, dose-related treatment responses to cognitive and aerobic training need to 
be evaluated. Multiple reports have suggested that with a greater dosage of chemotherapy 
and/or radiation that aspects cognitive dysfunction become much more apparent Collins, 
Mackenzie, Tasca, Scherling, & Smith, 2013; Lawrence et al., 2010).   
124 
 
 
 
 
 
 
 
 
REFERENCES 
 
American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer 
Society; 2014.  
American College of Sports Medicine’s guidelines for exercise testing and prescription 
(8th ed.). (2010). Philadelphia, PA: Lippincott-Williams & Wilkins. 
Ahles, T.A., & Saykin, A.J. (2007). Candidate mechanisms for chemotherapy-induced 
cognitive changes. Nature, 7, 192-201. doi:10.1038/nrc2073  
Angevaren, M., Aufdemkampe, G., Verhaar, H.J.J., Aleman, A., & Vanhees, L. (2008). 
Physical activity and enhanced fitness to improve cognitive function in older 
people without known cognitive impairment. Cochrane Database of Systematic 
Reviews, 3, 1-56. doi: 10.1002/14651858.CD005381.pub3 
Attia, A., Page, B.R., Lesser, G.J. & Chan, M. (2014). Treatment of radiation-induced 
cognitive decline. Current Treatment Options in Oncology, 15, 539-550. 
doi:10.1007/s11864-014-0307-3  
Ball, K., Berch, D.B., Helmers, K.F., Jobe, J.B., Leveck, M.D., Mariske, M., … Willis, 
S.L. (2007). Effects of cognitive training interventions with older adults: a 
randomized controlled trial. Journal of the American Medical Association, 
288(18), 2271-2281. doi:10.1001/jama.288.18.2271 
Baechle, T.R., & Earle, R.W. (Eds.). (2008). Essentials of Strength Training and 
Conditioning (3rd Ed.) Human Kinetics: Champaign, IL. ISBN: 978-0-7360-
5803-2   
125 
 
 
 
Barnes, D.E., Yaffe, K., Satarino, W.A., & Tager, I.B. (2003). A longitudinal study of 
cardiorespiratory fitness and cognitive function in healthy older adults. Journal of 
the American Geriatric Society, 51, 459-465. doi: 10.1046/j.1532-
5415.2003.51153.x 
Beaulieu, C. (2002). The basis of anisotropic water diffusion in the nervous system: a 
technical review. Radiology Nuclear Medicine & Medical Imagining in 
Biomedicine, 15, 435-455. doi:10.1002/nbm.782 
Belleville, S., Gilbert, B., Fontaine, F., Gagnon, L., Menard, E., & Gauthier, S. (2006). 
Improvements of episodic memory in persons with mild cognitive impairment and 
healthy older adults: evidence from a cognitive intervention program. Dementia 
and geriatric Cognitive Disorders, 22, 486-499. doi: 10.1159/000096316 
Benson, N., Hulac, D.M., & Kranzler, J.H. (2010). Independent examination of the 
weschler adult intelligence scale-fourth edition (wais-iv): what does the wais-iv 
measure? Psychological Assessment, 22(1), 121-130. doi:10.1037/a0017767  
Bourke, R.S., West, C.R., Chheda, G., & Tower, D.B. (1973). Kinetics of entry and 
distribution of 5-fluorouracil in cerebrospinal fluid and brain following 
intravenous injection in a primate. Cancer Research, 33, 1735-1746. 
British Psychological Society. Psychological Testing Center:Test Review, 2012.Leicester: 
The British Psychological Society; 2014. 
Butterfield, D.A., & Kanski, J. (2001). Brain protein oxidation in age-related 
neurodegenerative disorders that are associated with aggregated proteins. 
Mechanisms of Aging and Development, 122, 945-962. doi:10.1016/S0047-
6374(01)00249-4 
126 
 
 
 
Carlsson, M., Strang, P., & Bjurstrom, C. (2000). Treatment modality affects long-term 
QOL in gynaecological cancer. Anti-cancer Research, 20, 563-568. 
Chang, Y., Chu, C., Wang, C., Wang, Y., Song, T., Tsai, C., … Etnier, J.L. (2015). Dose-
response relation between exercise duration and cognition. Medicine & Science in 
Sports and Exercise, 47(1), 159-165. doi:10.1249/MSS.0000000000000383 
Cherrier, M.M., Anderson, K., David, D., Higano, C.S., Gray, H., Church, A., …Willis, 
S.L. (2013). A randomized trial of cognitive rehabilitation in cancer survivors. 
Journal of Life Sciences, 93, 617-622. doi:10.1016/j.lfs.2013.08.011   
Collins, B., MacKenzie, J., Tasca, G.A., Scherling, C., & Smith, A. (2013). Cognitive 
effects of chemotherapy in breast cancer patients: a dose-response study. Psycho-
oncology, 22, 1517-1527. doi:10.1002/pon.3163 
Conover, W.J. (1999). Practical nonparametric statistics (3rd. Ed.). New York, NY: John 
Wiley & Sons, Inc. 
Culos-Reed, S.N., Mackenzie, M.J., Sohl, S.J., Jesse, M.T., Zahavich, A.N.R., & 
Danhauer, S.C. (2012). Yoga and cancer interventions: a review of the clinical 
significance of patient reported outcomes for cancer survivors. Evidence-Based 
Complementary and Alternative Medicine, ID:642576,1-17. 
doi:10.1155/2012/642576 
Deprez, S., Amant, F., Yigit, R., Porke, K., Verhoeven, J., Van den Stock, J., … Sunaert, 
S. (2011). Chemotherapy-induced structural changes in cerebral white matter and 
its correlation with impaired cognitive functioning in breast cancer patients. 
Human Brain Mapping, 32, 480-493. doi: 10.1002/hbm.21033 
127 
 
 
 
Elliot, A.C., & Hynan, L.S. (2011). A sas micro implementation of a multiple comparison 
post hoc test for a Kruskal-Wallis analysis. Computer Methods and Programming 
in Biomedicine, 102, 75-80. doi:10.1016/j.cmpb.2010.11.002 
Erickson, K.I., Voss, M.W., Prakash, R.S., Basak, C., Szabo, A., Chaddock, L., 
…Kraemer, A.F. (2011). Exercise training increases size of hippocampus and 
improves memory. Procedings of the National Academy of Sciences of the United 
States, 108(7), 3017-3022. doi:10.1073/pnas.1015950108  
Fairey, A.S., Courneya, K.S., Field, C.J., Bell, G.J., Jones, L.W., St. Martin, B., & 
Mackey, J.R. (2005). Effect of exercise training on c-reactive protein in post-
menopausal breast cancer survivors: a randomized controlled trial. Brain, 
Behavior, and Immunity, 19(5), 381-388. doi:10.1016/j.bbi.2005.04.001 
Ferguson, R.J., Ahles, T.A., Saykin, A.J., McDonald, B.C., Furstenburg, C.T., Cole, B.F., 
& Mott, L.A. (2007a). Cognitive-behavioral management of chemotherapy-
related cognitive change. Psycho-Oncology, 16, 772-777. doi:10.1002/pon.1133 
Ferguson, R.J., McDonald, B.C., Saykin, A.J., & Ahles, T.A. (2007b). Brain structure 
and function differences in monozygotic twins: possible effects of breast cancer 
chemotherapy. Journal of Clinical Oncology, 25(25), 3866-3870. doi: 
10.1002/pon.1133 
Ferguson, R.J., Cassel, A.G., & Dawson, R.F.S. (2010). Cognitive effects of cancer 
chemotherapy in adult cancer survivors: cognitive-behavioral management. 
Journal of Rational-Emotive Cognitive-Behavioral Therapy, 28(1), 25-41. doi: 
10.1007/s10942-010-0108-y 
128 
 
 
 
Ferrans, C.E. (2010). Advances in measuring quality of life outcomes in cancer care. 
Seminars in Oncology Nursing, 26(1), 2-11. doi:10.1016/j.soncn.2009.11.002 
Ferrans, C.E., & Powers, M.J. (1985). Quality of life index: development and 
psychometric properties. Advances in Nursing Science, 8(1), 15-24. 
Finsterer, J. & Mahjoub, S.Z. (2014). Fatigue in healthy and diseased individuals. 
American Journal of Hospice & Palliative Medicine, 31(5), 562-575. 
doi:10.1177/1049909113494748  
Foley, J.J., Raffa, R.B., & Walker, E.A. (2008). Effects of chemotherapeutic agents 5-
fluorouracil and methotrexate alone and combined in a mouse model of learning 
and memory. Psychopharmacology, 199, 527-538. doi: 10.1007/s00213-008-
1175-y 
Fong, D.Y.T., Ho, J.W.C., Hui, B.P.H., Lee, A.M., Macfarlane, D.J., Leung, S.S.K., … 
Cheng, K. (2012). Physical activity for cancer survivors: meta-analysis of 
randomized controlled trials. British Medical Journal, 344(70), 1-14. doi: 
10.1136/bmj.e70 
Foster, P.S., Drago, V., Yung, R.C., Pearson, J., Stringer, K., Giovanneti, T., …Heilman, 
K.M. (2013). Differential lexical and semantic spreading activation in alzheimer’s 
disease. American Journal of Alzheimer’s Disease & Other Dementias, 28(5), 
501-507. doi:10.1177/1533317513494445   
Glass, G.V., & Hopkins, K.D. (1996). Statistical methods in education and psychology 
(3rd Ed.). Needham Heights, MA: Allyn and Bacon.  
 
129 
 
 
 
Han, R., Yang, Y.M., Dietrich, J., Luebke, A., Mayer-Proschel, M., & Noble, M. (2008). 
Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin 
destruction in the central nervous system. Journal of Biology, 7(12), 1-22. doi: 
10.1186/jbiol69 
Hariprasad, V.R., Koparde, V., Sivakumar, P.T., Varambally, S., Thirthalli, J., Varghese, 
M., …Gangadhar, B.N. (2013). Randomized clinical trial of yoga-based 
intervention in residents from elderly homes: effects on cognitive function. Indian 
Journal of Psychiatry, 55, 357-363. doi:10.4103/0019-5545.116308 
Hassler, M.R., Elandt, K., Preusser, M., Lehrner, J., Binder, P., & Dieckmann, K., … 
Marosi, C. (2010). Neurocognitive training in patients with high grade glioma: a 
pilot study. Journal of Neurooncology, 97, 109-115. doi: 10.1007/s11060-009-
0006-2 
Hess, L.M., & Insel, K.C. (2007). Chemotherapy-related change in cognitive function: a 
conceptual model. Oncology Nursing Forum, 34(5), 981-994. 
doi:10.1188/07.ONF.981-994 
Heyward, V. (2006). Advanced fitness assessment and exercise prescription (5th Ed.). 
Champaign, IL: Human Kinetics.        
Hillman, C.H., Pontifex, M.B., Raine, L.B., Castelli, D.M., Hall, E.E., & Kramer, A.F. 
(2009). The effect of acute treadmill walking on cognitive control and academic 
achievement in preadolescent children. Neuroscience, 159(3); 1044-1054. doi: 
10.1016/j.neuroscience.2009.01.057 
 
130 
 
 
 
Hillman, C.H., Motl, R.W., Pontifex, M.B., Posthuma, D., Stubbe, J.H., Boomsma, D.I., 
& DeGeus, E.J.C. (2006). Physical activity and cognitive function in a cross 
section of younger and older community-dwelling individuals. Health 
Psychology, 25(6), 678-687. doi:10.1037/0278-6133.25.6.678 
Hsieh, C., Sprod, L.K., Hydock, D.S., Carter, S.D., Hayward, R., & Schneider, C.M. 
(2008). Effects of a supervised exercise intervention on recovery from treatment 
regimens in breast cancer survivors. Oncology Nursing Forum, 35(6), 909-915. 
doi: 10.1188/08.ONF.909-915 
Inagaki, M., Yoshikawa, E., Matsuoka, Y., Sugawara, Y., Nakano, T., Akechi, T., 
…Wada, N. (2007). Smaller regional volumes of brain gray and white matter 
demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. 
Cancer, 109, 146-156. doi:10.1002/cncr.22368 
Jackson, G.E. (2008). Chemo brain: a psychotropic phenomenon? Medical Hypotheses, 
70, 572-577. doi: 10.1016/j.mehy.2007.06.019 
Jacobson, L. A., Ryan, M., Martin, R. B., Ewen, J., Mostofsky, S. H., Denckla, M. 
B., & Mahone, E. M. (2011). Working memory influences processing speed and 
reading fluency in ADHD. Child Neuropsychology, 17, 209-224. 
Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E., & Forman, D. (2011). Global 
cancer statistics. Cancer: A Cancer Journal for Clinicians, 61(2), 69-90. 
doi:10.3322/caac.20107 
 
 
131 
 
 
 
Joshi, G., Sultana, R., Tangpong, J., Cole, M.P., St. Clair, D.K., Vore, M., …Butterfield, 
D.A. (2005). Free radical medicated oxidative stress and toxic side effects in brain 
induced by the anti-cancer drug adriamycin: insight into chemobrain. Free 
Radical Research, 39(11), 1147-1154. doi:10.1080/10715760500143478  
Kawashima, R. (2013). Mental exercises for cognitive function: clinical evidence. 
Journal of Preventative Medicine & Public Health, 46, 22-27. 
doi:10.3961/jpmph.2013.46.S.S22 
Kerr, I.G., Zimm, S., Collins, J.M., O’Neill, D., & Poplack, D.G. (1984). Effect of 
intravenous dose and schedule on cerebrospinal fluid pharmacokinetics of 5-FU in 
the monkey. Cancer Research. 44, 4929-4932. 
Kessler, S., Hosseini, S.M.H., Heckler, C., Janelsins, M., Palesh, O., Mustian, K., 
…Morrow, G. (2013). Cognitive training for improving executive function in 
chemotherapy-treated breast cancer survivors. Clinical Breast Cancer, 13(4), 299-
306. doi:10.1016/j.clbc.2013.02.004  
Kim, E., Jahan, T., Aouizerat, B., Dodd, M., Cooper, B., Paul, S., …Miaskowski, C. 
(2009). Changes in symptom clusters in patients undergoing radiation therapy. 
Support Care Cancer, 17, 1383-1391. doi: 10.1007/s00520-009-0595-5 
Kohler, B.A., Ward, E., McCarthy, B.J., Schymura, M.J., Ries, L.A.G, & Eheman, C. et 
al. (2011). Annual report to the nation on the status of cancer, 1975-2007, 
featuring tumors of the brain and other nervous system. Journal of National 
Cancer Institute, 103, 1-23. doi:10.1093/jnci/djr077 
 
132 
 
 
 
Konat, G.W., Kraszpulski, M., James, I., Zhang, H.T., & Abraham, J. (2008). Cognitive 
dysfunction induced by chronic administration of common cancer 
chemotherapeutics in rats. Metabolic Brain Disease, 23, 325-333. doi: 
10.1007/s11011-008-9100-y 
La Rue, A. (2010). Healthy brain aging: role of cognitive reserve, cognitive stimulation 
and cognitive exercises. In A.K. Desai (Ed.), The healthy aging brain: evidence 
based methods to preserve brain function and prevent dementia. Clinics in 
Geriatric Medicine, 26, 99-111.   
Lautenschlager, N.T., Cox, K.L., Flicker, L., Foster, J., Bockxmeer, F.M.V., & Xiao, J. et 
al. (2008). Effect of physical activity on cognitive function in older adults at risk 
for alzheimer’s disease. Journal of the American Medical Association, 300(9), 
1027-1038. doi:10.1001/jama.300.9.1027 
Lawrence, Y.R., Li, A., Naqa, I.E., Hahn, C.A., Marks, L.B., …Dicker, A.P. (2010). 
Radiation dose-volume effects in the brain. International Journal of Radiation 
Oncology, Biology, and Physics, 76(3), 20-27. doi:10.1016/j.ijrobp.2009.02.091 
Lee, S.Y., Loh, S.Y., & Murray, L. (2011). Study protocol in investigate the efficacy of 
participation in qi-gong by breast cancer survivors. Journal of Cancer Therapy, 2, 
715-724. doi:10.4236/jct.2011.25097 
Lezak, M. D., Howieson, D. B., Bigler, E. D., & Tranel, D. (2012). Neuropsychological 
assessment (5th ed.). New York, NY: Oxford University Press. 
 
 
133 
 
 
 
Liedke, P. E. R., Reolon, G.K., Kilpp, B., Brunetto, A. L., Roesler, R., & Schwartsmann, 
G. (2009). Systemic administration of doxorubicin impairs aversively motivated 
memory in rats. Pharmacology, Biochemistry, and Behavior, 94, 239-243. doi: 
10.1016/j.pbb.2009.09.001 
Macleod, J.E., DeLeo, J.A., Hickey, W.F., Ahles, T.A., Saykin, A.J., & Bucci, D.J. 
(2007). Cancer chemotherapy impairs contextual but not cue-specific fear 
memory. Behavioral Brain Research. 181(1), 168-172. 
doi:10.1016/j.bbr.2007.04.003 
Madhyastha, S., Somayaji, S.N., Rao, M.S., Nalini, M.S., & Laxminarayana-Bairy, K. 
(2002). Hippocampal brain amines in methotrexate-induced learning and memory 
deficit. Canadian Journal of Pharmacology, 80, 1076-1084.  
doi:10.1016/j.bbr.2007.04.003 
Mahncke, H.W., Bronstone, A., & Merzenich, M.M. (2006). Brain plasticity and 
functional losses in the aged: scientific bases for a novel intervention. Progress in 
Brain Research, 157, 81-109. doi:10.1016/S0079-6123(06)57006-2  
Mahncke, H.W., Connor, B.B., Appelman, J., Asanuddin, O.N., Hardy, J., & Wood, 
R.A., et al., (2006). Memory enhancement in healthy older adults using a brain 
plasticity-based training program: a randomized, controlled study. Proceedings of 
the National Academy of Sciences, 103(33), 12523-12528. 
doi:10.1073/pnas.0605194103 
Marieb, E.N., & Mallatt, J. (1997). Human anatomy. (2nd Ed.). Menlo Park, CA: 
Benjamin Cummings.  
134 
 
 
 
Masley, S., Roetzheim, R., & Gualtieri, T. (2009). Aerobic exercise enhances cognitive 
flexibility. Journal of Clinical Psychology in Medical Settings, 16, 186-193. 
doi:10.1007/s10880-009-9159-6 
Matsuda, T., Takayama, T., Tashiro, M., Nakamura, Y., Ohashi, Y., & Shimozuma, K. 
(2005). Mild cognitive impairment after adjuvant chemotherapy in breast cancer 
patients: evaluation of appropriate research design and methodology to measure 
symptoms. Breast Cancer. 12(4), 279-287. doi:10.2325/jbcs.12.279 
McAfoose, J., & Baune, B.T. (2009). Evidence for a cytokine model of cognitive 
function. Neuroscience and Biobehavioral Reviews, 33(3), 355-366. 
doi:10.1016/j.neubiorev.2008.10.005  
Mitchell, T. & Turton, P. (2011). ‘Chemobrain’: concentration and memory effects in 
people receiving chemotherapy- a descriptive phenomenological study. European 
Journal of Cancer Care, 20, 539-548. doi: 10.1111/j.1365-2354.2011.01244.x 
Morris, R.G., Garrud, P., Rawlins, J.N., & O’Keefe, J. (1982). Place navigation impaired 
in rats with hippocampal lesions. Nature, 297, 681- 683. 
Mustafa, S., Walker, A., Bennett, G., & Wigmore, P.M. (2008). 5-fluorouracil 
chemotherapy affects spatial working memory and newborn neurons in the adult 
rat hippocampus. European Journal of Neuroscience. 28, 323-330. doi: 
10.1111/j.1460-9568.2008.06325.x 
Myers, J.S. (2009). Chemotherapy-related cognitive impairment: neuroimaging, 
neuropsychological testing, and the neuropsychologist. Clinical Journal of 
Oncology Nursing. 13(4), 413-421. doi:10.1188/09.CJON.413-421 
135 
 
 
 
Noal, S., Levy, C., Hardouin, A., Rieux, C., Heutte, N., Segura, C.,… Joly, F. (2011). 
One-year longitudinal study of fatigue, cognitive functions, and quality of life 
after adjuvant radiotherapy for breast cancer. Int. J. Radiation Oncology Biol. 
Phys., 81(3), 795-803. doi: 10.1016/j.ijrobp.2010.06.037 
Parisi, J.M., Stine-Morrow, E.A.L., Noh, S.R., & Morrow, D.G. (2009). Predispositional 
engagement, activity engagement, and cognition among older adults. Aging, 
Neuropsychology, and Cognition, 16(4), 485-504. 
doi:10.1080/13825580902866653 
Park, S.K., & Larson, J.L. (2015). Cognitive function as measured by trail making test in 
patients with copd. Western Journal of Nursing Research, 37(2), 236-256. 
doi:10.1177/0193945914530520  
Piper, B. F., Dibble, S.L., Dodd, M. J., Weiss, M. C., Slaughter, R.E., & Paul, S.M. 
(1998). The revised Piper Fatigue Scale:  psychometric evaluation in women with 
breast cancer. Oncology Nursing Forum, 25, 677-684. pmid:9599351 
Peterson, B.M., Repka, C.P., Hayward, R., & Schneider, C.M. (2010). Five-year survival 
rates at an exercise based cancer rehabilitation institute. Medicine Science in 
Sports and Exercise, 42(5), 345. doi:10.1249/01.MSS.0000384626.61126.ea 
Potter, D., & Keeling, D. (2005). Effects of moderate exercise and circadian rhythms on 
human memory. Journal of Sport and Exercise Psychology, 27(1), 117-125. 
Raffa, R.B. (2011). A proposed mechanism for chemotherapy-related cognitive 
impairment (‘chemo-fog’). Journal of Clinical Pharmacy and Therapeutics, 36, 
257-259. doi: 10.1111/j.1365-2710.2010.01188.x 
136 
 
 
 
Raffa, R.B., & Tallarida, R.J. (2010). Effects on the visual system might contribute to 
some of the cognitive deficits of cancer chemotherapy-induced “chemo-fog.” 
Journal of Clinical Pharmacy and Therapeutics, 35, 249-255. doi: 
10.1111/j.1365-2710.2009.01086.x 
Roine, E., Roine, R.P., Rasanen, P., Vuori, I., Sintonen, H., & Saarto, T. (2009). Cost-
effectiveness of interventions based on physical exercise in the treatment of 
various diseases: a systematic literature review. International Journal of 
Technology Assessment in Health Care, 25(4), 427-454. 
doi:10.1017/S0266462309990353 
Salkind, M. R. (1969). Beck depression inventory in general practice. Journal of the 
Royal College of General Practice, 18(88), 267-271. pmcid: PMC2237076 
Saykin, A.J., Ahles, T.A., & McDonald, B.C. (2003). Mechanisms of chemotherapy 
induced cognitive disorders: neuropsychological, pathophysiological, and 
neuroimaging perspectives. Seminars in Clinical Neuropsychiatry. 8(4), 201-216. 
pmid:14613048 
Schilling, V., Jenkins, V., Morris, R., Deutsh, G., & Bloomfield, D. (2005). The effects 
of adjuvant chemotherapy on cognition in women with breast cancer- preliminary 
results of an observational longitudinal study. Breast, 14(2), 142-150. 
doi:10.1016/j.breast.2004.10.004 
Schneider, C.M., Hsieh, C.C., Sprod, L.K., Carter, S.D., & Hayward, R. (2007a). Cancer 
treatment-induced alterations in muscular fitness and quality of life: the role of 
exercise training. Annals of Oncology, 18, 1957-1962. 
doi:10.1093/annonc/mdm364 
137 
 
 
 
Schneider, C.M., Hsieh, C.C., Sprod, L.K., Carter, S.D., & Hayward, R. (2007b). 
Exercise training manages cardiopulmonary function and fatigue during and 
following cancer treatment in male survivors. Integrative Cancer Therapies, 6(3), 
235-241. doi: 10.1177/1534735407305871 
Schneider, C.M., Hsieh, C.C., Sprod, L.K., Carter, S.D., & Hayward, R. (2007c). Effects 
of supervised exercise training on cardiopulmonary function and fatigue in breast 
cancer survivors during and after treatment. Cancer, 110(4), 918-925. doi: 
10.1002/cncr.22862 
Segal, R.J., Reid, R.D., Courneya, K.S., Sigal, R.J., Kenny, G.P., Prud’Homme, D.G., … 
D’Angelo, M.E.S. (2009). Randomized controlled trial of resistance or aerobic 
exercise in men receiving radiation therapy for prostate cancer. Journal of 
Clinical Oncology, 27(3), 344-351. doi:10.1200/JCO.2007.15.4963  
Segal, R.J., Reid, R.D., Courneya, K.S., Malone, S.C., Parliament, M.B., Scott, C.G., … 
Wells, G.A. (2003). Resistance exercise in men receiving androgen deprivation 
therapy for prostate cancer. Journal of Clinical Oncology, 21(9), 1653-1659. doi: 
10.1200/JCO.2003.09.534 
Siegel, R., Naishadham, D., & Jemal, A. (2013). Cancer statistics, 2013. Cancer Journal 
for Clinicians, 63, 11-30. doi: 10.3322/caac.21166 
Silverman, D.H.S., Dy, C.J, Castellon, S.A., Lai, J., Pio, B.S., Abraham, L., …Ganz, P.A. 
(2007). Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-
treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer 
Research Treatment, 103, 303-311. doi:10.1007/s10549-006-9380-z 
138 
 
 
 
Smith, G.E., Housen, P., Yaffe, K., Ruff, R., Kennison, R.F., Mahncke, H.W., & 
Zelinski, E.M. (2009). A cognitive training program based on the principles of 
brain plasticity: results from the improvement in memory with plasticity-based 
adaptive cognitive training (IMPACT) study. Journal of the American Geriatrics 
Society, 57(4), 594-603. doi: 10.1111/j.1532-5415.2008.02167.x  
Smith, T.J., & Hillner, B.E. (2011). Bending the cost curve in cancer care. The New 
England Journal of Medicine, 364(21), 2060-2065. pmid:21612477 
Staat, K., & Segatore, M. (2005). The phenomenon of chemo brain. Clinical Journal of 
Oncology Nursing, 9(6), 713-721. doi:10.1188/05.CJON.713-721 
Van Dam, F.S.A.M, Schagen, S.B., Muller, M.J., Boogerd, W., Van Der Wall, E., 
Droogleever-Fortuyn, M.J., & Rodenhuis, S. (1998). Impairment of cognitive 
function in women receiving adjuvant treatment for high-risk breast cancer: high-
dose versus standard-dose chemotherapy. Journal of the National Cancer 
Institute, 90(3), 210-218. doi: 10.1093/jnci/90.3.210 
Van Der Kooy, D., Zito, K.A., & Roberts, D.C.S. (1985). Evidence of retrograde 
neurotoxicity of doxorubicin. Neuroscience Letters, 53, 215-219. 
doi:10.1016/0304-3940(85)90188-0 
Van Weert, E., May, A.M., Korstjens, I., Post, W.J., Van der Schans, C.P., Van den 
Borne, B., … Hoekstra-Weebers, J.E.H.M. (2010). Cancer-related fatigue and 
rehabilitation: a randomized controlled multi-center trial comparing physical 
training combined with cognitive-behavioral therapy with physical training only 
and with no intervention. Physical Therapy, 90(10), 1413-1425. 
doi:10.2522/ptj.20090212   
139 
 
 
 
Vincent, W.J. (2005). Statistics in Kinesiology. (3rd Ed.). Champaign, IL: Human 
Kinetics. 
Yeh, M.L., Lee, T.I., Chen, H.H., & Chao, T.Y. (2006). The influences of chan-chuang 
qi-gong therapy on complete blood cell counts in breast cancer patients treated 
with chemotherapy. Journal of Cancer Nursing, 29(2), 149-155. 
Wallace, G.L., Lee, N.R., Prom-Wormley, E.C., Medland, S.E., Lenroot, R.K., Clasen, 
L.S., … Giedd, J.N. (2010). A bivariate twin study of regional brain volumes and 
verbal and nonverbal intellectual skills during childhood and adolescence. 
Behavioral Genetics, 40, 125-134. doi:10.1007/s10519-009-9329-1 
Ward, C.L., Bergman, M.A., & Hebert, K.R. (2012). Wais-iv subtest covariance 
structure: conceptual and statistical considerations. Psychological Assessment, 
24(2), 328-340. doi:10.1037/a0025614 
Wefel, J.S., Lenzi, R., Theriault, R.L., Davis, R.N., & Meyers, C.A. (2004). The 
cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast 
carcinoma: results of a prospective, randomized, longitudinal trial. Cancer, 
100(11), 2292-2299. doi: 10.1002/cncr.20272 
Wefel, J.S., Saleeba, A.K., Buzdar, A.U., & Meyers, C.A. (2010). Acute and late onset 
cognitive dysfunction associated with chemotherapy in women with breast cancer. 
Cancer, 116, 3348-3356. doi:10.1002/cncr.25098   
Winocur, G., Vardy, J., Binns, M.A., Kerr, L., & Tannock, I. (2006). The effects of anti-
cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice. 
Pharmacology, Biochemistry, and Behavior, 85, 66-75. 
doi:10.1016/j.pbb.2006.07.010 
140 
 
 
 
Wolinsky, F.D., Unverzagt, F.W., Smith, D.M., Jones, R., Stoddard, A., & Tennstedt, 
S.L. (2006). The ACTIVE cognitive training trial and health-related quality of 
life: protection that lasts for 5 years. Journal of Gerontology, 61(12), 1324-1329.  
Wood, R.H., Alvarez-Reyes, R., Maraj, B., Metoyer, K.L., &Welsh, M.A. (1999). 
Physical fitness, cognitive function, and health-related quality of life in older 
adults. Journal of Aging and Physical Activity, 7, 217-230.  
Yoshikawa, E., Matsuoka, Y., Ienagaki, M., Nakano, T., Akechi, T., Kobayakawa, M., 
…Uchitomi, Y. (2005). No adverse effects of adjuvant chemotherapy on 
hippocampal volume in Japanese breast cancer survivors. Breast Cancer Research 
and Treatment, 92, 81-84. doi:10.1007/s10549-005-1412-6 
Zoeller, R.F. (2010). Exercise and cognitive function: can working out train the brain, 
too? American Journal of Lifestyle Medicine, 4(5), 397-409. 
doi:10.1177/1559827610374413 
141 
 
 
 
 
 
APPENDIX A 
Informed Consent Form 
 
 
 
 
142 
 
 
 
 
 
 
 
143 
 
 
 
 
 
APPENDIX B 
Institutional Review Board Approval  
144 
 
 
 
 
 
 
 
145 
 
 
 
 
 
APPENDIX C 
Cognitive Training Tasks 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
146 
 
 
 Menu 
 
 
 
 
 
 
 
 
 
 
 
 
147 
 
 
Parking 
 
 
 
 
 
 
 
 
 
 
 
148 
 
 
Driving 
 
 
 
 
 
 
 
 
 
 
 
149 
 
 
Smart Driving 
 
 
 
 
 
 
 
 
 
 
 
150 
 
 
The Policeman 
 
 
 
 
 
 
 
 
 
 
 
151 
 
 
Brain Twister 
 
 
 
 
 
 
 
 
 
 
 
152 
 
 
The Pilot 
 
 
 
 
 
 
 
 
 
 
 
153 
 
 
The Stock Market 
 
 
 
 
 
 
 
 
 
 
 
 
154 
 
 
 
 
 
APPENDIX D 
Cognitive Testing 
 
 
155 
 
 
 
156 
 
 
 
 
 
 
 
 
 
157 
 
 
 
 
 
 
 
 
158 
 
 
 
 
 
 
159 
 
 
 
 
 
160 
 
 
 
 
 
 
161 
 
 
 
 
 
 
162 
 
 
 
 
 
 
 
APPENDIX E 
 
Series Mean Imputation Outpu
 163 
 
 
 
 
 Result Variable N of Replaced 
Missing 
Values 
Case Number of 
Non-Missing 
Values 
N of 
Valid 
Cases 
Creating Function 
First Last 
1 WMS_IV_Brief_Cog_RAW_PRE_1 1 1 35 35 SMEAN(WMS_IV_Brief_Cog_RAW_PRE) 
2 WMSIV_Brief_Cog_RAW_POST_1 0 1 35 35 SMEAN(WMSIV_Brief_Cog_RAW_POST) 
3 WMS_IV_LMI_RAW_PRE_1 0 1 35 35 SMEAN(WMS_IV_LMI_RAW_PRE) 
4 WMS_IV_LMI_RAW_POST_1 0 1 35 35 SMEAN(WMS_IV_LMI_RAW_POST) 
5 WMS_IV_LMI_SCALED_PRE_1 0 1 35 35 SMEAN(WMS_IV_LMI_SCALED_PRE) 
6 WMS_IV_LMI_SCALED_POST_1 0 1 35 35 SMEAN(WMS_IV_LMI_SCALED_POST) 
1
7
0
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 Result Variable N of 
Replaced 
Missing 
Values 
Case 
Number of 
Non-Missing 
Values 
N of 
Valid 
Cases 
Creating Function 
First Last 
7 WMS_IV_LMII_DR_RAW_PRE_1 0 1 35 35 SMEAN(WMS_IV_LMII_DR_RAW_PRE) 
8 WMS_IV_LMII_DR_RAW_POST_1 0 1 35 35 SMEAN(WMS_IV_LMII_DR_RAW_POST) 
9 WMS_IV_LMII_DR_SCALED_PRE_1 0 1 35 35 SMEAN(WMS_IV_LMII_DR_SCALED_PRE) 
10 WMS_IV_LMII_DR_SCALED_POST_1 0 1 35 35 SMEAN(WMS_IV_LMII_DR_SCALED_POST) 
11 WMS_IV_LMIICP_RAW_PRE_1 3 1 35 35 SMEAN(WMS_IV_LMIICP_RAW_PRE) 
12 WMS_IV_LMIICP_RAW_POST_1 1 1 35 35 SMEAN(WMS_IV_LMIICP_RAW_POST) 
 
 
 
 
 
 
 
 Result Variable N of 
Replaced 
Case 
Number of 
N of 
Valid 
Creating Function 
1
7
1
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 Result Variable N of Replaced 
Missing Values 
Case 
Number of 
Non-
Missing 
Values 
N of 
Valid 
Cases 
Creating Function 
First Last 
13 TMT_A_RAW_PRE_1 0 1 35 35 SMEAN(TMT_A_RAW_PRE) 
14 TMT_A_RAW_POST_1 1 1 35 35 SMEAN(TMT_A_RAW_POST) 
15 TMT_B_RAW_PRE_1 0 1 35 35 SMEAN(TMT_B_RAW_PRE) 
16 TMT_B_RAW_POST_1 1 1 35 35 SMEAN(TMT_B_RAW_POST) 
17 WAIS_IV_BD_RAW_PRE_1 0 1 35 35 SMEAN(WAIS_IV_BD_RAW_PRE) 
18 WAIS_IV_BD_RAW_POST_1 0 1 35 35 SMEAN(WAIS_IV_BD_RAW_POST) 
19 WAIS_IV_BD_SCALED_PRE_1 0 1 35 35 SMEAN(WAIS_IV_BD_SCALED_PRE) 
 
 
 
 
1
7
2
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 Result Variable N of 
Replaced 
Missing 
Values 
Case Number 
of Non-
Missing 
Values 
N of 
Valid 
Cases 
Creating Function 
First Last 
20 WAIS_IV_BD_SCALED_POST_1 0 1 35 35 SMEAN(WAIS_IV_BD_SCALED_POST) 
21 WAIS_IV_LNS_RAW_PRE_1 1 1 35 35 SMEAN(WAIS_IV_LNS_RAW_PRE) 
22 WAIS_IV_LNS_RAW_POST_1 1 1 35 35 SMEAN(WAIS_IV_LNS_RAW_POST) 
23 WAIS_IV_LNS_SCALED_PRE_1 1 1 35 35 SMEAN(WAIS_IV_LNS_SCALED_PRE) 
24 WAIS_IV_LNS_SCALED_POST_1 1 1 35 35 SMEAN(WAIS_IV_LNS_SCALED_POST) 
25 WAIS_IV_CD_RAW_PRE_1 0 1 35 35 SMEAN(WAIS_IV_CD_RAW_PRE) 
 
 
 
 
 
 
1
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3
 
 167 
 
 
 Result Variable N of Replaced 
Missing Values 
Case Number of 
Non-Missing 
Values 
N of 
Valid 
Cases 
Creating Function 
First Last 
26 WAIS_IV_CD_RAW_POST_1 0 1 35 35 SMEAN(WAIS_IV_CD_RAW_POST) 
27 WAIS_IV_CD_SCALED_PRE_1 0 1 35 35 SMEAN(WAIS_IV_CD_SCALED_PRE) 
28 WAIS_IV_CD_SCALED_POST_1 0 1 35 35 SMEAN(WAIS_IV_CD_SCALED_POST) 
29 COWAT_Z_G_PRE_1 0 1 35 35 SMEAN(COWAT_Z_G_PRE) 
30 COWAT_Z_G_POST_1 0 1 35 35 SMEAN(COWAT_Z_G_POST) 
31 COWAT_Z_A_PRE_1 0 1 35 35 SMEAN(COWAT_Z_A_PRE) 
32 COWAT_Z_A_POST_1 0 1 35 35 SMEAN(COWAT_Z_A_POST) 
 
 
 
 
1
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4
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 Result Variable N of Replaced 
Missing Values 
Case Number of Non-
Missing Values 
N of Valid 
Cases 
Creating Function 
First Last 
33 COWAT_Z_ED_PRE_1 1 1 35 35 SMEAN(COWAT_Z_ED_PRE) 
34 COWAT_Z_ED_POST_1 0 1 35 35 SMEAN(COWAT_Z_ED_POST) 
35 SBP_PRE_1 0 1 35 35 SMEAN(SBP_PRE) 
36 SBP_POST_1 3 1 35 35 SMEAN(SBP_POST) 
37 DBP_PRE_1 0 1 35 35 SMEAN(DBP_PRE) 
38 DBP_POST_1 3 1 35 35 SMEAN(DBP_POST) 
39 RHR_PRE_1 0 1 35 35 SMEAN(RHR_PRE) 
40 RHR_POST_1 3 1 35 35 SMEAN(RHR_POST) 
41 HEIGHT_IN_1 0 1 35 35 SMEAN(HEIGHT_IN) 
42 WEIGHT_LBS_1 0 1 35 35 SMEAN(WEIGHT_LBS) 
 
 
1
7
5
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 Result Variable N of Replaced Missing 
Values 
Case Number of Non-Missing 
Values 
N of Valid 
Cases 
Creating Function 
First Last 
43 FVC_L_PRE_1 0 1 35 35 SMEAN(FVC_L_PRE) 
44 FVC_L_POST_1 3 1 35 35 SMEAN(FVC_L_POST) 
45 FVC_PRED_PRE_1 3 1 35 35 SMEAN(FVC_PRED_PRE) 
46 FVC_PRED_POST_1 6 1 35 35 SMEAN(FVC_PRED_POST) 
47 FEV1_PRE_1 1 1 35 35 SMEAN(FEV1_PRE) 
48 FEV1_POST_1 4 1 35 35 SMEAN(FEV1_POST) 
49 FEV1_PRED_PRE_1 3 1 35 35 SMEAN(FEV1_PRED_PRE) 
50 FEV1_PRED_POST_1 6 1 35 35 SMEAN(FEV1_PRED_POST) 
51 VO2PEAK_PRE_1 0 1 35 35 SMEAN(VO2PEAK_PRE) 
 
 
 
1
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6
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 Result Variable N of Replaced 
Missing Values 
Case Number of Non-Missing 
Values 
N of Valid 
Cases 
Creating Function 
First Last 
52 VO2PEAK_POST_1 2 1 35 35 SMEAN(VO2PEAK_POST) 
53 LAT_PD_PRE_1 3 1 35 35 SMEAN(LAT_PD_PRE) 
54 LAT_PD_POST_1 3 1 35 35 SMEAN(LAT_PD_POST) 
55 SPRESS_PRE_1 6 1 35 35 SMEAN(SPRESS_PRE) 
56 SPRESS_POST_1 5 1 35 35 SMEAN(SPRESS_POST) 
57 CPRESS_PRE_1 3 1 35 35 SMEAN(CPRESS_PRE) 
58 CPRESS_POST_1 4 1 35 35 SMEAN(CPRESS_POST) 
59 SROW_PRE_1 3 1 35 35 SMEAN(SROW_PRE) 
 
 
 
 
1
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7
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 Result Variable N of Replaced Missing 
Values 
Case Number of Non-Missing 
Values 
N of Valid 
Cases 
Creating Function 
First Last 
60 SROW_POST_1 3 1 35 35 SMEAN(SROW_POST) 
61 LCURL_PRE_1 0 1 35 35 SMEAN(LCURL_PRE) 
62 LCURL_POST_1 3 1 35 35 SMEAN(LCURL_POST) 
63 LEXT_PRE_1 2 1 35 35 SMEAN(LEXT_PRE) 
64 LEXT_POST_1 3 1 35 35 SMEAN(LEXT_POST) 
65 LPRESS_PRE_1 1 1 35 35 SMEAN(LPRESS_PRE) 
66 LPRESS_POST_1 3 1 35 35 SMEAN(LPRESS_POST) 
67 STWRU_PRE_1 0 1 35 35 SMEAN(STWRU_PRE) 
 
 
 
1
7
8
 
 172 
 
 
 Result Variable N of Replaced 
Missing Values 
Case Number of Non-Missing 
Values 
N of Valid Cases Creating Function 
First Last 
68 STWRU_POST_1 2 1 35 35 SMEAN(STWRU_POST) 
69 STWRL_PRE_1 1 1 35 35 SMEAN(STWRL_PRE) 
70 STWRL_POST_1 2 1 35 35 SMEAN(STWRL_POST) 
71 PLANK_PRE_1 6 1 35 35 SMEAN(PLANK_PRE) 
72 PLANK_POST_1 4 1 35 35 SMEAN(PLANK_POST) 
73 HGR_PRE_1 1 1 35 35 SMEAN(HGR_PRE) 
74 HGR_POST_1 2 1 35 35 SMEAN(HGR_POST) 
75 HGL_PRE_1 1 1 35 35 SMEAN(HGL_PRE) 
76 HGL_POST_1 2 1 35 35 SMEAN(HGL_POST) 
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 Result Variable N of Replaced 
Missing Values 
Case Number of Non-Missing 
Values 
N of Valid Cases Creating Function 
First Last 
77 SANDR_PRE_1 1 1 35 35 SMEAN(SANDR_PRE) 
78 SANDR_POST_1 3 1 35 35 SMEAN(SANDR_POST) 
79 PIPER_I_PRE_1 0 1 35 35 SMEAN(PIPER_I_PRE) 
80 PIPER_I_POST_1 1 1 35 35 SMEAN(PIPER_I_POST) 
81 PIPER_B_PRE_1 0 1 35 35 SMEAN(PIPER_B_PRE) 
82 PIPER_B_POST_1 1 1 35 35 SMEAN(PIPER_B_POST) 
83 PIPER_A_PRE_1 0 1 35 35 SMEAN(PIPER_A_PRE) 
84 PIPER_A_POST_1 2 1 35 35 SMEAN(PIPER_A_POST) 
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 Result Variable N of Replaced 
Missing Values 
Case Number of Non-Missing 
Values 
N of Valid Cases Creating Function 
First Last 
85 PIPER_S_PRE_1 0 1 35 35 SMEAN(PIPER_S_PRE) 
86 PIPER_S_POST_1 2 1 35 35 SMEAN(PIPER_S_POST) 
87 PIPER_C_PRE_1 0 1 35 35 SMEAN(PIPER_C_PRE) 
88 PIPER_C_POST_1 2 1 35 35 SMEAN(PIPER_C_POST) 
89 BECK_PRE_1 1 1 35 35 SMEAN(BECK_PRE) 
90 BECK_POST_1 2 1 35 35 SMEAN(BECK_POST) 
91 QOL_PRE_1 0 1 35 35 SMEAN(QOL_PRE) 
92 QOL_POST_1 4 1 35 35 SMEAN(QOL_POST) 
1
8
1
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